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Abstract
Novel symmetric and asymmetric water-soluble tetrabenzoporphyrins are
synthesized in relatively good yields. These compounds are synthesized by the
condensation of butanopyrrole with several aldehydes that contain masked water
solubilizing groups followed by metal insertion, oxidation and demetallation and
deprotection of the masked solubilizing groups. The biological evaluation (in vitro and in
vivo) studies are described in addition to the photophyiscal evaluations of the
corresponding compounds.
A novel versatile route to the syntheses of novel free-base and metallobenzoylbiliverdins is discussed. The treatment of metal free dodecasubstituted porphyrin
with sodium nitrite and trifluoroacetic acid at room temperature in the presence of
oxygen affords ring-opened benzoylbiliverdin in 77-80% yields. These compounds are
metallated with several diamagnetic metal ions and their structures confirmed by NMR
and X-Ray crystallography. Tetramerization of excess butanopyrrole and several
aldehydes also afforded novel metallo-butanocorroles and metallo-benzocorrole. The
structures of these compounds are also analysed using MS (MALDI), NMR and X-Ray
crystallography.
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Chapter 1:
1-1:

Introduction

Porphyrins
Porphyrins are biochemically important, medically useful, and synthetically

interesting compounds. Porphyrins that occur naturally play a major role in the life
sustaining biochemical reactions. They are a ubiquitous class of compounds with many
important biological representatives including hemes, chlorophylls, myoglobins,
cytochromes, catalases, peroxidases, and several others. Used by nature in the most
important processes of photosynthesis and solving transport and other problems in living
systems, these compounds have been described as “pigments of life”.1 Their aromatic
character, inner chelating pocket and varying peripheral carbon chains have allowed
scientists to discover new and unique chemical reactions. Porphyrins and their metal
complexes have also stirred interdisciplinary interest due to a multitude of their intriguing
physical, chemical and biological properties.2

NH
N

N
HN

Figure 1-1: Porphyrin macrocycle

The porphyrin macrocycle (Figure 1-1), consists of four pyrrole rings joined by
four interpyrrolic methine bridges to give a highly conjugated macrocycle. The
aromaticity of porphyrins has been well established both by its chemical and physical
properties.3 These tetrapyrrolic systems have a closed loop of edgewise overlapping p
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orbitals which interact favorably to stabilize the olefins; the 22 π electrons available in
porphyrins make up six different 18e-delocalization pathways, (Scheme 1-1) which
follow Huckel’s 4n + 2 rule for aromaticity. A lower number of delocalization pathways
results in less aromatic character that produces differences in spectroscopic properties.4
Kuster proposed the current model of the intricate porphyrin ring system in 1912.5
X-ray crystallography supports this model and shows that the porphyrin macrocycle
indeed consists of four pyrrole rings joined by interpyrrolic methine bridges. The entire
ring system is considered to be planar but flexible, although meso-substituted sterically
hindered porphyrins display less planarity.6a Lowered heats of combustion also
demonstrate considerable resonance energy, and electrophilic aromatic substitutions
readily occur at the periphery of the macrocycle. These substitution reactions can occur
both on the porphyrin and metalloporphyrin derivatives; typical examples are nitration,
halogenations, sulfonation, formylation, acylation and deuteration.6b
Porphyrins and their derivatives are highly colored absorbing strongly in the
visible region near 400 nm (molar extinction coefficients are about 105 Mol-1L)
characteristic of the macrocyclic conjugation and several weaker absorption bands known
as Q bands between 450-700 nm. The main intense absorption band is known as the Soret
band,7 named after the biochemist who first observed it in hemoglobin. A variation in the
peripheral substituents of the porphyrin ring normally results in a slight change in the
intensity and wavelength of the absorption bands. A disrupted porphyrin macrocycle
results in the disappearance of the Soret band.8 Each tetrapyrrolic system can be unique
and therefore different in color. Porphyrins that occur naturally are dark red while
chlorins, which are reduced tetrapyrrolic systems are dark green or blue green.
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Scheme 1-1: 18 pi-electron pathways which make up the
aromatic character of the porphyrin ring system

The absorbance energy intensities vary with chelation, pH, and differences in the
structure of peripheral substituents. However, as long as a cyclic 18 π e- path exists, the
intense Soret band is really a major characteristic of their optical spectra.
The porphyrin macrocycle and its derivatives are amphoteric, behaving both as
acids and bases. The nitrogen atoms at the centre of the porphyrin core are responsible for
this interesting characteristic. The NHs can be deprotonated with strong bases, while the
two-imine nitrogens can be protonated with acids. However, metallated porphyrins lack
this amphoteric quality because the nitrogens are chelated to the metal with both covalent
and dative bonds. The NMR spectrum of the aromatic tetrapyrrole shows anisotropic
effects.9, 10, 11, 12 The ring current generated by the applied field induces a local magnetic
field similar to that in benzene. The NH protons, inside the porphyrin ring system are
therefore shifted upfield to as high as -5 ppm in porphyrins whereas the deshielded mesoprotons appear at very low field (δ ~ 10 ppm),13 the pyrrolic protons are also deshielded
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and tend to resonate at δ 8 to 9, versus δ ~ 6 ppm in pyrrole. Although the aromaticity of
these porphyrin systems makes their NMR spectra a challenge to assign, the tendency
toward aggregation in some cases makes for even more complicated spectra. 14
Awareness of porphyrins importance to life has stimulated large amounts of research into
purification, structure determination, synthetic manipulation, and total synthesis of these
macrocycles.15
1-2:

Porphyrin Syntheses
The porphyrin field began with the synthesis of a large class of pyrroles. Most of

this early work was accomplished by Fischer16 in Munich, and was followed by the
synthesis of a variety of porphyrins. Known as the grandfather of porphyrin chemistry,
Hans Fischer has inspired a large number of research groups throughout the world to
improve upon his methodologies. In general, there are several routes that can be followed
to afford porphyrins. The first route entails the functionalization of an intact ring system
obtained from natural sources such as chlorophylls a or b, bacterio-chlorophylls and
hemin (Figure 1-2), which are and modified to give the desired porphyrin. The second
route is the formal total synthesis beginning with monopyrrolic subunits. The former
method although useful, severely limits the type of functional groups that can be
introduced. Regardless of the method of synthesis, porphyrins make up a selected class of
compounds, which are an important part of chemistry and possess some very important
applications that are yet to be completely explored. Most of the synthetic methodologies
that will be discussed in detail henceforth are important because some will be utilized
throughout this dissertation.
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Figure 1-2: Examples of porphyrin derivatives that occur in nature

1-2-1: Porphyrins from Tetramerization
The simplest porphyrins are symmetric and have a C4d symmetry element. These
porphyrins are easily prepared via the tetramerization of a suitable monopyrrolic
subunits.17, 18 These symmetric porphyrins can fall in either category of octa-ß substituted
or tetra-meso substituted porphyrins. The tetra-meso substituted porphyrins are prepared
by condensation of a 2,5-unsubstituted pyrrole 1-1 in the presence of a meso-carbon
providing reagent (e.g. benzaldehyde) 1-2 and in the presence of acid affording the
corresponding porphyrin 1-3.19 On the other hand, octa- ß substituted porphyrins are
synthesized via self-condensation of pyrroles 1-4 (R = electron-withdrawing groups) in
the presence of a base followed by heating in acid to give the desired porphyrin 1-5,
usually in yields as high as 40% or greater. Monopyrrole tetramerization works best for
pyrroles with identical 3- and 4 substituents because if the substituents on the
monopyrrole are not identical, acid catalyzed pyrrole ring scrambling reactions occur.20
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Scheme 1-2: Symmetric Porphyrins from tetramerization

1-2-2: Porphyrins from Dipyrromethenes
This procedure was developed by Fischer (who won a Nobel prize in 1930) and
used in the synthesis of Hemin 1-6, via a deutoroporphyrin IX (1-9) intermediate. This
procedure was effected by condensation of 1,9-dimethyl-dipyrromethene (1-7) and 1,9
dibromo-dipyrromethene (1-8) affording porphyrin (1-9). This dipyrromethene selfcondensation was accomplished in organic acid melts (e.g. tartaric, succinic) at
temperatures of up to 200 ºC.21 However, as a result of synthetic restriction, this
procedure is limited to only select symmetries. Very harsh thermal conditions are
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required thus hampering the introduction of sensitive substituents on the dipyrromethene
ring.
Me
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N Cl N
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H
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1-9
HOOC

1-8
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Scheme 1-3

1-2-3: Porphyrins from Condensation of Dipyrromethanes
MacDonald improved Fischer’s dipyrromethene condensation procedure in
1960.22 The so-called “2 + 2” MacDonald’s condensation utilizes milder conditions thus
allowing the use of dipyrromethanes, which are compounds that are generally much more
available than dipyrromethenes. Fischer had previously reported that dipyrromethanes
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were too unstable under the cyclization conditions.21 MacDonald’s route basically entails
the condensation of 1,9-diformyl dipyrromethane 1-10 with 1,9-unsubstituted
dipyrromethane 1-11 affording the desired porphyrin 1-12 in yields of up to 60%.
However, the major drawback of this route is that dipyrromethanes are inherently
unstable toward most acidic reagents resulting to scrambling or redistribution23
occurrences.
R2

R3

R1

R2
R4

R1

NH HN
OHC

1-10

R3
R4
NH

CHO

N
H
NH HN

1-11

R5
R6

R6

R5
R6

HN

R5

H

R5

N

1-12

R6

Scheme 1-4

1-2-4: Porphyrins from Cyclization of Open Chain Tetrapyrrolic Compounds
This methodology favors the synthesis of totally unsymmetrical porphyrins where
all four pyrrole rings are different. The previous methodologies discussed can only allow
select symmetries. This synthetic route was developed to circumvent the scrambling of
pyrrole subunits from occurring during the cyclization process and to facilitate the
formation of only one porphyrin isomer. A variety of intermediates are available: bilanes
1-13,24 a-oxobilanes 1-14,25 b-oxobilanes 1-15,26 a-bilenes 1-16, b-bilenes 1-17,27 and
a,c-biladienes 1-18.28 Corwin and Coolidge24 utilized the bilane route to synthesize
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etioporphyrin II, however this route was not very successful because it afforded a mixture
of inseparable isomers due to the instability of bilanes that resulted to redistribution.
O
NH HN

NH HN

NH HN

NH HN

NH HN

NH HN

1-13

1-14

O

N

HN

N

HN

NH HN

NH HN

1-16

1-17

1-15

N

N

N

HN

1-18

Figure 1-3: Examples of Open Chain Tetrapyrrolic Compounds

An improved method that prevented pyrrole redistribution was then developed by
Smith and Kenner.26 This method utilized the introduction of an electron withdrawing
group (oxobilane). In this route, the most successful oxobilane was the b-oxobilane
because the oxo-function at position a exerted such a stabilizing electron withdrawing
effect that it reduced the nucleophilicity of the pyrrole A ring to a point that cyclization
could not take place. One of the major drawbacks of the b-oxobilane route was that the
method was lengthy and required a large number of steps. Cyclization from a-bilenes
gives a mixture of porphyrins;29 all productive synthesis using bilenes have therefore
made the use of b-bilenes.30 b-Bilenes bearing methyl substituents in positions 1 and 19
have been readily cyclized to give copper porphyrins with copper salts in pyridine or
dimethylformadide.31
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This procedure can be used on many occasions for cyclization of b-bilenes bearing
electron withdrawing groups. The porphyrins can then be easily demetallated with
concentrated sulfuric acid. The most convenient and successful method via open chain
tetrapyrrolic porphyin synthesis is the use of a,c-biladiene 1-18.
a,c-Biladienes that are symmetrical can be easily prepared by treating a 1,9diacid or unsubstituted dipyrromethane 1-19 with formylpyrrole 1-20 as shown in scheme
1-5.32 Subsequent cyclization of the a,c-biladiene using Copper (II) salts in DMF affords
the Cu(II) complex porphyrin, high yields of the metal-free porphyrin are usually
obtained after removal of chelating copper atom 1-21.33 Synthesis of asymmetric
porphyrins using the a,c-biladiene route is achieved via a tripyrrene, by differentially
protecting the pyrromethane with terminally mixed esters. Selective removal of the esters
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affords an adequate intermediate for further elaboration.34 In the cyclization of a,cbiladiene to porphyrin, the reaction is believed to proceed via a free radical pathway
where one of the methyl groups is lost while the other is retained as the new methine
carbon.35
1-3:

Biological Applications of Porphyrins

1-3-1: Photodynamic Therapy (PDT)
PDT is a therapeutic method that employs the combination of light and a drug to
bring about a cytotoxic effect to cancerous or unwanted tissues. It is a developing
technique, which can destroy unwanted tissue while sparing the normal tissue. In PDT,
the drug (photosensitizer) of negligible dark toxicity is introduced to the body
accumulating preferentially in the rapidly dividing cells. This drug is harmless and has no
effect to both healthy and abnormal tissue and is only activated when exposed to a
carefully regulated light dose, rapidly destroying the tissue precisely where the light is
directed.36
Methods currently used to eliminate or control cancer are removing the cancer
cells by surgery, killing the cancer cells with lethal doses of radiation, and chemotherapy
or a combination of the above therapies. Although chemotherapy, radiotherapy and
surgery effectively extend the lives of approximately 50 percent of patients who develop
malignant tumors, the majority of the patients die from direct or indirect effect of tumor
metastases or from adverse consequences of these therapies.37 In PDT, adverse side
effects in normal tissues are minimal since the photosensitizer is taken up and retained in
the tumor tissue.38
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1-3-1-1:

Mechanism of Action in PDT

E

1. Absorption of Light
2. Internal Conversion
3. Fluorescene
4. Inter-system crossing
5. Phosphorence
6. singlet Oxygen prodution
(Type II Photoprocess)
7. Hydrogen or electron transfer
(Type I Photoprocess)

S3

2

S2
S
1

4

7

T1
1

O2

1

3

5
6

3

O2

S0

Figure 1-4: Mechanism of PDT39

PDT combines the preferential accumulation of the photosensitizer in the target
tissue with precise illumination to provide the selectivity of the treatment. The light
penetrates the tissue and causes excitation of the photosensitizer which then reacts with
molecular oxygen and other substrates generating highly cytotoxic species e.g. singlet
oxygen, super oxide anion, hydroxyl radicals that cause irreversible damage to the tumor
cells. Figure 1-4 shows a modified Jablonski diagram outlining the mechanism of PDT.39
Photosensitizers have a stable electronic configuration that is in a singlet state in their
lowest or ground state (S0). Irradiation of light of appropriate wavelength causes
excitation of the photosensitizer to its singlet excited state (S1). The singlet excited
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photosensitizer can decay back to the ground state with release of energy in form of
fluorescence enabling identification of tumor tissue or by internal conversion with energy
loss as heat as shown in Figure 1-4.40 The excited photosensitizer can also undergo a nonradiative process of inter-system crossing (ISC) thereby converting the photosensitizer to
a triplet excited state (T1).
ISC is a spin-forbidden pathway as it involves a change in the electron spin, but a
good photosensitizer goes through this path with very high efficiency. The
photosensitizer can then relax from the triplet excited state via at least two pathways:
radiatively by phosphorence, and non-radiatively by transferring its energy to another
molecule with a triplet ground state. Phosphorence is typically measured in
microseconds, and the tendency of a photosensitizer to reach the triplet state is measured
by the triplet state quantum yield. Phosphorence involves a spin-inversion and thus is a
spin-forbidden pathway therefore imposing a relatively long time on the triplet state and
allowing interaction with molecules in the vicinity of the photosensitizer. Molecular
oxygen, which is found in abundance in tissue, has a triplet ground and can interact with
the triplet state photosensitizer, thereby generating highly cytotoxic species via either the
type I or II mechanism as shown in Figure 1-3. Type I mechanism involves
electron/hydrogen transfer from the sensitizer or from substrate molecule producing ions
and free radical (e.g. super oxide and peroxide anions), which then attack the cellular
targets. Type II mechanism involves the direct interaction of the excited triple state
photosensitizer with molecular oxygen producing the electronically excited and highly
reactive singlet oxygen. The photosensitizer then returns to its single ground state and is
able to repeat the process of oxygen transfer to oxygen several times.41, 42
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Numerous porphyrin type chromophores have been shown to be effective as
photosensitizers for PDT of cancers.43 Porphyrins are the most explored sensitizer/tumor
active compounds because of their known ability to accumulate in tumor tissues and
persisting there for long periods of time.44 In comparison to other aromatic macrocycles
that also exhibit reasonable tumor selectivity in tissues such as acridine, florescein, eosin
and rhodamine, porphyrins have low-dark toxicities.45 Apart from exhibiting low dark
toxicity, they also have high chemical stability, high affinity for serum proteins, favorable
pharmacokinetic properties, formation of very stable complexes with a variety of metal
ions while retaining their in vivo properties, are fluorescent and absorb strongly in the
visible region of the optical spectrum.46
The distribution of porphyrin drugs in the body is still under investigation. It is
believed that the uptake and retention of porpyrin-type molecules in tumors is highly
dependent upon structural features that is the nature of peripheral groups, coordinated
metal ions and accompanying axial ligands.

46

Photosensitizers are administered

systemically (via injection into the bloodstream) and it is generally believed that
improved tumor-specificity is displayed by amphiphilic molecules that bear both
hydrophobic sites (for transversing through the lipid membrane) and hydrophilic sites
that favor water solubility at the macrocyclic periphery.47 The mechanisms responsible
for porphyrin tumor- selectivity are still under debate, however it has been hypothesized
that porphyrins have the tendency of association to plasma proteins,48 particularly low
density lipoproteins (LDL) and the increased level of LDL receptors on cancer cells.
Porphyrins effectiveness as therapeutic agents is also related to the developing
vasculature of the neoplastic cells 49,50 These compounds can be internalized to the cells
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via passive diffusion through the plasma membrane or fluid phase endocytosis and nonreceptor mediated processes.51
The first porphyrin evaluated for PDT was hematoporphyrin, which is readily
available from blood. In the early 1960’s, Lipson et al prepared a derivative of
Hematoporphyrin (HPD) that was shown to display an enhanced selectivity for PDT
efficiency. HPD is a complex mixture of compounds i.e., hematoporphyrin,
protoporphyrin-IX, hydroxyethylvinylporphyrin, as well as a complex dimeric and
oligomeric

fraction

containing

esters,

ether

and

carbon-carbon

linkages

of

hematoporphyrin.52
A more purified form of HPD known today as Photofrin® was prepared by
Dougherty et al in 1981 by using gel exclusion chromatography. Photofrin® was
approved in the US by the Food and Drug Administration (FDA) and in eleven European
countries and has been used successfully over the last two decades in the treatment of
patients with melanoma, early and advanced stages of cancer of the lung, digestive tract
and genitourinary tract.53 Although Photofrin® has proven curative for a range of cancers,
there some well documented drawbacks to treatment with this photosensitizer. Being a
complex mixture of HPD’s, there questions concerning the reproducibility of the
synthesis and pharmacological benchmarking. Photofrin® also absorbs weakly at 630 nm,
this wavelength of light can penetrate tissue to a depth of few mm, making the compound
unsuitable for treatment of deep-seated tumors. Prolonged skin sensitivity as a result of
long retention time of this drug in normal skin is also an undesirable side effect.54 These
considerations have led, since the early 1980’s to the search of new and improved
compounds for PDT. The profile of an ideal PDT photosensititizer is that the drug should
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have good pharmacokinetic properties, fluorescent with increased absorbance in the red
region of the optical spectrum, high quantum yield of triplet fomation, good cytotoxic
oxygen species generation, increased selectivity for malignant tissue over normal tissue
and exhibiting low dark toxicity.55
Research in the last decades has mainly centered on the synthesis of porphyrin
type sensitizers and the investigation of their structure-activity relationships.56 Chlorins,
benzoporphyrins, phthalocyanine, and texaphyrins (tripyrrole expanded macro cycles) are
long wavelength absorbers and are the most studied porphyrin-type photosensitizing
drugs. Compounds that absorb in the 650-750 nm spectral window are preferred, because
light of this wavelength penetrates deeper through tissue with minimal light scattering.
Mono-L-aspartyl

chlorin

e6

(MACE)57

1-22

obtained

from

chlorophyll

and

benzoporphyrin derivative mono-carboxylic acid (BPD-MA, VisudyneTM) 1-23, are
examples of naturally derived second generation photosensitizers currently undergoing
human clinical trials for treatment of various cancers using PDT. The FDA and the
Canadian Therapeutic Products Health Program recently approved VisudyneTM 1-23, for
the treatment of age-related macular degeneration.58 Synthetically derived second
generation photosensitizers currently in early clinical trials for the treatment of various
cancers are the symmetric meso-tetra (m-hydroxyphenyl)chlorin (m-THPC, Foscan®)59
and Sn(IV)-etiopurpin (SnET2, PuryltinTM).60, 61
Other synthetically derived compounds that display unique photo physical and
biological characteristics making them highly suitable for applications in PDT are
metallo-phthalocyanines and the related metallo-naphthalocyanine that have red shifted
absorbance bands in the 750-800 nm region.62, 63
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Figure 1-5: Examples of Porphyrin based Drugs

Texaphyrins and porphycenes64 are other polypyrrolic compounds that have also
shown excellent tumor localizing and photo physical properties. Texaphyrins, absorbing
very strongly in the 720-780 nm region form very stable metal complexes with trivalent
lanthanides.66
1-3-2: Boron Neutron Capture Therapy
Boron neutron capture therapy (BNCT) is a binary radiation modality that brings
together two components that do not have adverse effects on the cells when kept separate.
Like PDT, BNCT is a relatively new developing cancer therapy that has the potential of
destroying diseased tissue whilst sparing normal tissue.68 The first component is a stable
isotope of boron (10B) that can be concentrated in tumor cells by attaching it to a tumorseeking compound. The second component is a beam of low energy neutrons. After
capturing a neutron, the 10B disintegrates and the high-energy charged particles produced
destroy the cells in close proximity, primarily killing the cancer cells while leaving the
adjacent normal cells largely unaffected.69 BNCT is based on a nuclear reaction that
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occurs when a stable isotope of

10

B that has a relatively high neutron capture cross-

section value (σ = 3838), is irradiated with low energy/ thermal neutrons to yield highly
energetic helium-4 (4He2+) nuclei/ alpha particles and recoiling Lithium-7 (7Li3+) ions and
releasing about 2.4 MeV of kinetic energy (eq. 1).70
10

B + 1n →7Li3+ + 4He2+ +γ + 2.4 MeV

Therefore the higher the dose of

10

(eq. 1)

B existing in the tumor cells relative to the

normal cells results to a concomitantly higher dose being delivered to the tumor cells
during neutron irradiation.71

10

B is the most common nuclide used in neutron capture

therapy because it is non-radioactive and readily available comprising approximately 20
% of naturally occurring boron, secondly, the particles emitted by the neutron capture
reaction have combined travel paths of approximately 12 microns, about one cell
diameter limiting the radiation effects to the tumor cells. Boron chemistry is also well
studied and therefore several

10

B derivatives can be incorporated into a multitude of

different compounds.72 Other nuclides that occur abundantly in tissue like

12

C, 1H,

14

N

and 16O, do not exhibit a high nuclear cross-section for neutron capture therapy (0.0035,
0.333, 0.00019 and 1.83 barns) respectively.73
The treatment of malignant and therapeutically persistent brain tumors,
glioblastoma multiforme (GBM) with NCT, was first suggested by Sweet in 1951.74
Sweet et al75 demonstrated that certain compounds would concentrate in human brain
relative to normal brain tissue. However, a clinical trial of NCT76, 77 initiated in the early
1950 and 1960 period using a thermal neutron beam and sodium tetraborate, borax
(Na2B4O7*10H20) as the capture agent failed to show any evidence of therapeutic
efficacy.
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The two major reasons for their lack of success was that a rapid attenuation of the
thermal neutrons in tissue due to absorption and scattering occurred resulting to a limited
(3-4 cm) in depth penetration.

Figure 1-6: Schematic of Boron-10 Neutron Interaction
http://web.mit.edu/nrl/www/bnct/info/description/description.html#RTFToC2

The boron compounds used were also freely diffusible, low molecular weight substances
that did not achieve selective localization in the brain tumors.78 In the ensuing years,
second-generation boron based compounds based on polyhedralborane anions,
carboranes and substituted phenylboronic acids were developed.
SH

= BH
=B

Na2

(HO)2B

CO2
H

BSH

BPA

1-24

1-25

Figure 1-7: Examples of Boron-10 Containing Drugs

19

NH3

Because of their low toxicity and tumor localizing properties, L-4dihyroxyborylphenylalanine (BPA) 1-2579 and disodium mercapto-closo-dodecarborate
(BSH) 1-2480 were chosen for clinical studies and are currently undergoing Phase I/ II
clinical trials in US, Europe and Japan, for the treatment of patients with melanomas and
glioblastomas.81

Figure 1-8: Schematic depicting the concept of BNCT
http://web.mit.edu/nrl/www/bnct/info/description/description.html#RTFToC2

However, some of the major drawbacks of BPA (1-25) and BSH (1-24) are that
they only display moderate selectivity for tumor cells and low retention times in tumors.
BPA (1-25) also has a low boron content therefore a large dose is required to deliver
therapeutic amount of
~15-30 µg of

10

10

B to the tumor cells.82 For BNCT to be effective, there must be

B/g of tumor and a low concentration of (<5 µg of

10

B/g of cell) in the

surrounding normal cells and blood.83, 84 Less boron is needed for effective BNCT lethal
damage, if the 10B is located intracellularly as opposed to extracellularly and also if the
boron localizes inside or in close proximity to the cell nucleus.85
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The development of new

10

B-carriers with improved tumor selectivity and

retention over BPA and BSH has been a major challenge. Various boron-containing
analogues of biologically active compounds such as amino acids,86 peptides,87 and
nucleosides/nucleotides,88 have been synthesized. Boron-containing analogues of
porphyrins89 and DNA90 binders have also been considered as potential agents for PDT.
Of the new boron-delivery agents, boron-containing porhyrins appear to be the most
promising tumor-selective compounds because of their demonstrated tendency to
effectively accumulate within neoplastic cells and to be retained there for long periods of
time91 in addition to exhibiting most of the characteristics of an effective BNCT agent.92
Several boron containing porphyrins derivatives have been synthesized and
evaluated in vitro and in vivo.94 The source of boron in the new BNCT sensitizers is
usually hydrophobic o-carborane (o-C2B10H11) 1-26 or the amphiphilic nido-carborane
(o-C2B9H11-) 1-27. These cages are said to have relative high boron content and display
extraordinary thermal, kinetic and photochemical stabilities relative to other boron
clusters.93, 94

H

H

H

C

H

H

BH

closo-carborane
(o-isomer)

nido-carborane

1-27

1-26

Figure 1-9: Open and Closed Shell Carborane Cages
Some of the results achieved for some of the compounds have shown that
boronated porphyrins retain the ability to selectively accumulate in neoplastic tissues,

21

delivering seemingly high boron to tumor concentrations of >30 µg 10B/g of tumor. When
compared to PDT, NCT has an advantage because the epithermal neutron beams can
penetrate deeper than red light to reach deep-seated tumor sites. However several
questions concerning the stability of carborane-porphyrin linkages, and their excessive
hydrophobic nature still remain the topic of continuous research.95 In this dissertation, the
synthesis of a novel-carboranylated porphyrin and preliminary in vitro and in vivo results
will be discussed in the next Chapters.
1-4.
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Chapter 2: Syntheses and Characterization of Asymmetric Porphyrin Derivatives
2-1:

Introduction
meso-Substituted asymmetric porphyrins (A3B) have recently found specific

biomedical applications, particularly in the field of detection and treatment of neoplastic
tissue (PDT) and also labeling and analysis of nucleic acids.1a Not only have they found
use in the medicinal field, but they also display unique properties and find application in
several, optoelectronics, catalysis, biomimetic and material chemistry.1b The availability
of suitable building blocks through synthetic methodologies that have the flexibility for
structural modification is closely tied to the level of architectural sophistication achieved
in such systems. 5-Substituted dipyrromethanes are important synthetic intermediates and
are well-established precursors for the synthesis of symmetric and asymmetric mesosubstituted porphyrins, expanded porphyrins, and other porphyrin analogues.2a Not only
are they key precursors to meso-substituted asymmetric porphyrins, but also
calix[4]pyrroles and calix[4]phyrin macro cycles, which are well established as redoxactive or optical sensors for anions.2b
In the recent years, several convenient procedures for the synthesis of mesosubstituted porphyrins (A3B) bearing three identical molecular structure (A) and one
different group (B) have been developed from meso-substituted dipyrromethanes.3a (B),
bears a functional group which can be used to link the porphyrin with other biologically
active molecules, while A are substituted with functional groups that allow the changing
of the physical properties of the tetrapyrrolic macrocycle (i.e., water-solubilizing
groups).3b In PDT, the effective photosensitization can be enhanced by having
asymmetrically substituted porphyrins with a combination of hydrophobic and
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hydrophilic groups. This substitution pattern normally results in an intramolecular
polarity axis that facilitates membrane penetration of the porphyrin in subcellular
compartments.4 Considerable effort for the development of new methodologies for the
synthesis of these diverse building blocks towards the synthesis of asymmetric
porphyrins has been invested. However, there still remains a scope for shorter and more
efficacious approaches to contribute towards achieving the synthesis of these systems in a
synthetically useful manner.5 In this Chapter, two routes to asymmetric porphyrins will
be discussed. The first route entails the step wise synthesis of dipyrrolic intermediates
followed by their condensation and the second route utilizes the tetramerization of
pyrroles with several aryl aldehydes followed by para-functionalization of the mesophenyl substituents.
2-2:

“2+2” Condensation Route
The condensation of dipyrrolic intermediates to synthesize porphyrins is a useful

approach for the formation of porphyrins that are centrosymmetrically substituted as well
as porphyrins that have symmetry in one or both halves of the molecules.6 The first route
to the formation of centrosymmertrically substituted porphyrins was first developed by
Hans Fischer7 through the self condensation of 1-bromo-9-methyldipyrromethenes in an
organic acid melt (e.g., succinic acid) at temperatures of up to 200 °C giving good yields
of porphyrin. (See Chapter 1, Schemes 1-3).
Fischer’s synthesis dominated the way porphyrins were constructed but this was
subject to change when Ferguson MacDonald8 introduced the use of more reduced
building blocks than those of Fischer’s in the form of dipyrromethanes. Although known
in Fischer’s time, the dipyrromethane route was not widely used because of the problem
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of pyrrole redistribution during porphyrin formation. However, in 1960, this route
became common after MacDonald developed milder conditions for the reaction. The
MacDonald condensation is a two-step sequence involving initial 2+2 condensation of
dipyrromethane derivatives followed by oxidation. This procedure is useful for making a
wide variety of symmetric and asymmetric porphyrins. The original “ Mac Donald’s
2+2” approach involved the condensation of 1,9-diformyldipyrromethane with
unsubstituted dipyrromethane or the self condensation of monoformyldipyrromethane 21, affording a non-aromatic dication intermediate called a porphodimethene salt 2-2 as
shown in Scheme 2-1.9
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These intermediate chromophores exhibit a deep red color typical of
dipyrromethene species with a characteristic visible spectrum (maximum absorbances at
430 nm and 710 nm respectively). The condensations were generally catalyzed by a
protic acid such as p-toluene sulfonic acid or trifluoroacetic acid.10 On occasion, protic
acids have been substituted with Lewis acid catalysts such as boron triflouride dietherate
and have been used successfully under Lindsey conditions.16 Various oxidizing agents
including molecular oxygen, iodine and quinones and metallation with salts such as
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zinc(II) acetate then readily convert the porphodimethene intermediates into the
corresponding porphyrin.11
2-3:

Results and Discussion
Dipyrromethane derivatives are useful building blocks and have been synthesized

using a variety of procedures.12 Most of them are indefinitely stable in the purified form
when stored at 273 K in the absence of light.13 5-Unsubstituted dipyrromethanes have
been prepared in three steps from pyrrole. 5-Aryldipyrromethanes have also been
synthesized indirectly, requiring either the elimination of a protecting group from a
pyrrole, or through the formation of a Grignard reagent.14a In addition to these, other
syntheses based on the direct condensation of carbonyl reagents with pyrroles also
exist.14b An attractive small scale synthesis of dipyrromethanes, in which pyrrole is used
as a reagent as well as solvent with a catalytic amount of acid affords good yields of
dipyrromethane bearing many types of substituents at the meso position.15
Asymmetric porphyrins (A3B) have previously been prepared by the mixed
condensation of pyrrole and two aldehydes affording a statistical mixture of all six
substituted products, which are then separated by lengthy chromatographic methods
generally affording only small quantities of the desired porphyrin.16 Condensation of a
dipyrromethane with a binary mixture of aldehydes has also been explored to obtain
meso-substituted porphyrin with the A3B symmetry.17 This Chapter will focus on the
development of synthetic routes to novel asymmetric dodeca-substituted water-soluble
porphyrins with the A3B porphyrin symmetry pattern. The synthesis of porphyrins 2-4
using a 2+2 MacDonald’s route will be discussed in this Chapter.
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The retrosynthetic analysis to target asymmetric-meso-substituted TBP 2-4 is
described in detail in Scheme 2-2. The condensation of dipyrromethane-dicarbinol 2-5
with a 1,9-unsubstituted dipyrromethane 2-6 (route a), and the condensation of 1,9diformyldipyrromethane

2-7

with

a

Grignard
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reagent

and

1,9-unsubstituted

dipyrromethane 2-6 (route b) to synthesize porphyrin 2-4 will be discussed. As an
extension of MacDonald’s synthesis, the condensation of dicarbinol dipyrromethane 2-5
with

1,9-unsubstituted

dipyrromethane

2-6

afforded

the

asymmetric

cyclohexenylporphyrin. In both routes, the precursor cyclohexenylporphyrins obtained
are further aromatized to the corresponding tetrabenzoporphyrins (TBPs) with strong
oxidizing agents like DDQ. The synthesis of dicarbinoldipyrromethane 2-5, an important
intermediate in the 2 + 2 Macdonald’s route was achieved as outlined in Scheme 2-4 and
the synthesis of 2-6 as shown in Scheme 2-3.
Symmetric dipyrromethanes, that are the main building blocks in this synthetic
methodology, are normally synthesized by self-condensation of a monopyrrole18 or by
treatment of two moles of monopyrroles with a one carbon-reagent that provides the 5carbon.19 Reduction of dipyrromethene derivatives with NaBH4 also furnishes both
symmetrical and asymmetric dipyrromethanes.20 In this dissertation, the dipyrromethane
derivatives were synthesized by condensation of α-protected pyrroles with various
aldehydes. Aldehydes and pyrroles are known to readily undergo acid-catalyzed
condensations at room temperature.21 In solutions at equimolar concentrations, the
condensation yields oligomers and the cyclic porphyrinogen.21a Therefore in order to
achieve a direct synthesis of dipyrromethane, and to avoid continued oligomerization, a
slight excess of pyrrole was condensed with aldehyde.21b Various substituted
dipyrromethanes were synthesized via condensation of protected butanopyrrole 2-8 and
several commercially available aldehydes as shown in Scheme 2-3. Pyrrole 2-8 was
synthesized in 90% yield via treatment of commercially available 1-nitro-cyclohexene
with ethyl isocyanoacetate using Barton-Zard reaction conditions.22
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1-Nitro-cyclohexene was dissolved in freshly distilled THF under argon. This
solution was stirred for ten minutes, and ethyl isocyanoacetate was added dropwise. The
resultant mixture was cooled down to 0 °C and treated with DBU. The final mixture was
stirred under argon for twelve hours and the reaction followed by TLC until completion.
The reaction was then quenched by addition of 10% HCl, extracted into ethlyacetate
affording a brownish oil. This oil was purified on a silica gel column eluting with 10%
ethylacetate/ hexane to give pale yellow crystals of the desired pyrrole 2-8 in 90% yield.
This compound was characterized by 1H NMR, which showed a broad singlet NH peak at
8.5 ppm and the unsubstituted α-H pyrrolic signal at 6.5 ppm. Condensation of pyrrole 28 with several p-substituted benzaldehydes (R=H, NHAc, Br, CO2Me) with TFA as a
catalyst and montmorillonite K-10 clay afforded diyprromethane 2-9 in 60-70% yields as
is shown in Scheme 2-3. Montmorillonite K-10 clay has been shown to be a very useful
acid catalyst in dipyrromethane (and other pyrrolic) syntheses, the clay having the
advantage that it can be filtered from the reaction mixture prior to work up.23
Pyrrole 2-8 and montmorillonite K-10 clay were added to a flask of freshly
distilled dichloromethane under argon. Benzaldehyde and TFA were then added and the
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reaction mixture was stirred at room temperature and followed by TLC until completion.
After 12 hours, the reaction mixture was filtered through a pad of silica to separate the
clay, oxidized dipyrromethene derivatives, higher molecular weight oligomers and
unreacted aldehyde starting material. The solvent was reduced in vacuo to affording an
oil that was then redissolved in dichloromethane and neutralized by washing with basic
water and then dried over sodium sulfate and concentrated in vacuo. Dipyrromethanes are
very unstable compounds because they are easily oxidized to their dipyrromethene
derivatives upon exposure to light and air, they also decompose easily and can therefore
not be purified using silica gel columns which are slightly acidic, however purification
with slightly basic eluant systems are more reliable. Therefore, the desired
dipyrromethane compounds can be obtained via recrystallization processes that mainly
removes the oxidized dipyrromethene by products.17a Synthetic dipyrromethane
derivatives with R = H, Br, CO2Me, could be easily purified by a single recrystallization
out of hot methanol to afford beige colored crystals in 70% yield. However, this was not
the case for the synthesis of dipyrromethane when R = NHCOCH3. 1H NMR spectrum of
the crude product had a strong aldehyde signal at ~ 10 ppm, moreover, the TLC analysis
also showed the incomplete consumption of the acetamido-aldehyde starting material that
was very difficult to purify because of its close rf with the desired dipyrromethane. The
lower reactivity of this aldehyde results from the electron donating nature of the
acetamide group, which lowers the electrophilicity of the aldehyde group during
condensation with the pyrrole. This dipyrromethane was subjected to several silica gel
columns in order to get rid of the starting material thus leading to a significant loss of the
desired compound because of decomposition.
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Figure 2-1: 1H NMR of 5-(4-Bromo-phenyl)-dipyrromethane (2-9) in CDCl3

The 1H NMR spectra of dipyrromethanes have typical NH protons signals
appearing at ~ 8 ppm, the meso proton appeared as a sharp singlet at ~ 5.5 ppm and ortho
and meta protons appeared as doublets in the aromatic region. These compounds were
also characterized by MS, giving molecular ion peaks at 553.1, 532.8 and 475.2 for
dipyrromethanes 2-9 R= Br, NHAc and H, respectively. A typical 1HNMR spectrum of
the 5-(4-bromophenyl)-dipyrromethane is shown in Figure 2-1.
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Alkylation of dipyrromethane 2-9 to dicarbinol-dipyrromethane 2-5 (R=Br) was
first attempted via treatment of 2-9 with 4-bromophenyl zinc iodide. 2-9 (R=Br) was
dissolved in freshly distilled THF under argon and the solution stirred as the temperature
was lowered to 0 °C. The organometallic reagent was then added dropwise over a period
of 30 minutes while stirring and maintaining the reaction temperature at 0 °C. The
reaction was monitored using TLC and after two hours, the reaction mixture still had a
substantial amount of unreacted starting material. The reaction was warmed up to room
temperature and allowed to go for 24 hours but TLC analysis barely indicated the
formation of any other product apart from the starting material. A similar procedure was
then attempted by using an organolithium reagent rather than a organozinc to alkylate the
ethyl ester groups on the dipyrromethane to the dicarbinol dipyrromethane. The
organolithium reagent was prepared by treating 1,4-dibromobenzene with 1.5 equivalents
of n-BuLi in THF at -78 °C

23c

under argon, and added dropwise to a solution of 2-9

(R=Br) in freshly distilled THF, under argon. However after several hours, TLC analysis
only showed mainly starting material, and it became clear that the ester groups were less
reactive electrophiles.
An alternative route to dicarbinol 2-5 is via 2-6 as shown in Scheme 2-3. 2-9 was
suspended in ethylene glycol with an excess of NaOH.14b The solution was heated at 100
°C for half an hour so as to saponify the ethyl ester groups followed by concomitant
decarboxylation by reflux in ethylene glycol at 195 °C. The reaction was followed by
TLC to completion and was complete after 25 minutes. On cooling the reaction mixture,
an orange precipitate formed instantly, the precipitation was enhanced by addition of 1015 mL of water and cooling down the solution to 0 °C.
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Figure 2-2: 1H NMR of 5-(4-Bromo-phenyl)-1,9-diunsubstituted dipyrromethane 2-6 in
CDCl3
The precipitate was then filtered and washed with water to get rid of the high
boiling point ethylene glycol solvent and excess NaOH salt and finally dried under
vacuum, yielding the desired 1,9-diunsubstituted dipyrromethane in a 60-65% yield. This
compound was characterized by 1H NMR and MS giving the subsequent molecular ion
peaks at 394.2, 375.5 and 316.8 for dipyrromethane 2-6 R= Br, NHAc and H,
respectively. The 1H NMR spectrum had a sharp singlet peak at ~ 6.3 ppm corresponding
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to the two protons at the 1 and 9 positions, 2-NH protons are buried under the orthoprotons doublet peak at ~ 7.5 ppm and the proton at the meso position appeared at ~ 5
ppm as a sharp singlet. The 1H NMR of 2-6 (R= Br) is shown in Figure 2-2. Due to the
highly sensitive and reactive nature of 2-6, this compound was used without further
purification in the next step.
Diacylation with identical acyl groups at the 1- and 9 positions of
dipyrromethane 2-6 is a key reaction in the synthesis of A3B (asymmetric porphyrins).24
The treatment of dipyrromethane 2-6 with an excess of ethyl magnesium bromide in THF
and 4-bromo benzoyl chloride to form the dipyrromethane Grignard reagent produced
both the diacylated dipyrromethane 2-10 (Scheme 2-4) and undesired monoacylated
dipyrromethane, as was also obtained by Lindey et al.25 Both the monoacylated and
diacylated dipyrromethanes were obtained in relatively low yields (20% total) and the
desired diacylated compound was isolated using tedious silica gel chromatographic
procedures followed by recrystallization from methanol. The ratio of the monoacylated
and the diacylated product could be easily determined by integration of the peaks due to
the pyrrolic NH protons in the 1H NMR spectra of the crude product. The monoacyl NH
protons appeared at ~ 8.0 ppm and 9.1 ppm while the diacylated appeared at ~ 10.3 ppm.
To obtain higher yields of the diacylated dipyrromethane 2-10, 4-bromo-Nbenzoylmorpholine,26 which is a modified Vilsmeier Haack reagent and being more
electrophilic than 4-bromobenzoyl chloride was used. 4-Bromo-N-benzoyl morpholine
was prepared by dropwise addition of 4-bromo-benzoylchloride dissolved in dry
dichloromethane under argon to a solution of morpholine and triethylamine in dry
dichloromethane. The initially colorless solution started forming a white precipitate as the
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reaction progressed. The resultant mixture was stirred for 1 hour at room temperature and
then refluxed for another 2 hours. The mixture was allowed to cool and neutralized by
washing with a solution of 2 M HCl and basic water and dried over sodium sulfate. The
solvent was evaporated to dryness to afford a colorless oil, which crystallized on standing
giving pure white crystals of the N-4-bromobenzoyl morpholine quantitatively.
This compound was characterized by 1HNMR with two doublet peaks appearing
at 7.5 ppm and 7.0 ppm respectively as well as a broad peak at ~3.7 ppm that intergrated
for 8H which corresponds to the protons on the α and β position on the morpholine unit.
Subsequent

reaction

of

4-bromo-N-benzoylmorpholine

with

1,9-unsubstituted

dipyrromethane 2-6 (R = Br) afforded mostly the diacylated bisketone 2-10 in a 70%
overall yield.27 4-Bromo-N-benzoyl morpholine was treated with POCl3 at room
temperature in a flask under argon. This solution was warmed up to 35 °C for 1 hr before
the addition of a solution of 2-6 (R = Br) in 1, 2-dichloroethane. Followed closely by
TLC, the reaction was allowed to go for 14 hours before being quenched by the addition
of aqueous sodium bicarbonate solution. The subsequent reaction mixture was then
refluxed for 45 minutes, cooled down, washed with water, dried over sodium sulfate and
evaporated to dryness under reduced pressure. The crude mixture was purified on a silica
gel column eluting with 1% methanol and dichloromethane allowing the isolation of the
desired diacylated dipyrromethane 2-10 in 70% yield. MS (Maldi) gave a peak of 2-10 at
775.34. Higher yields of the desired 2-10 were isolated because treatment of the 4bromo-N-benzoyl morpholine with POCl3 facilitated the formation of the chloro-iminebenzoyl derivative, which is more electrophilic than 4-bromo-benzoyl chloride and is
prone to nucleophilic attack from the dipyrromethane 2-6.
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Figure 2-3: Activation of 4-Bromo-N-Benzoylmorpholine with POCl3

Figure 2-3 illustrates the mechanistic approach of activation. The 1H NMR spectrum of
diacylated dipyrromethane 2-10 (R= Br) is shown in Figure 2-4.
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Reduction to the dicarbinol-dipyrromethane 2-5 (Scheme 2-4) was achieved by
treatment of the corresponding dipyrromethane 2-10 in 2:1 THF/MeOH solution with 50
equivalents of NaBH4.28
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Figure 2-4: 1H NMR of 1,9-bis(4-Bromophenyl)-5-(4-bromophenyl)-dipyrromethane 210 in CDCl3 at 300 MHz
The NaBH4 was added in small portions because this reaction is highly
exothermic. The progress of the reaction was followed by TLC analysis; a spot
corresponding to the mono-reduced species appeared after 5 minutes, and after 20
minutes, a slightly more polar spot of the completely reduced species appeared. The
reaction has to be stopped after two hours because NaBH4 starts to decompose and is
therefore inactive. The reaction mixture was quenched with water and extracted into
dichloromethane, dried over sodium sulfate and the solvent reduced to dryness.
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A pink colored oil was obtained and due to the highly acid sensitive nature of the
dicarbinol obtained, 2-5 was used without further purification in the next porphyrin
synthesis step.
An alternative route to the asymmetric TBP is via the route b as described in
Scheme 2-5. 2-6 was easily formylated using adapted Vilsmeier-Haack29 conditions, by
treatment with trimethylorthoformate ester in trifluoroacetic acid (TFA) at 0°C (Scheme
2-5), followed by alkylation with phenylmagnesium bromide to dipyrromethane 2-5. This
procedure though successful only yielded 35% of 2-7. Dipyrromethane 2-6 was dissolved
in TFA under argon and stirred for ten minutes. The reaction mixture was then cooled
down to 0 °C, followed by the drop wise addition of trimethylorthoformate. The resultant
mixture was allowed to stir for 30 minutes at 0 °C and was then equilibrated to room
temperature. The TLC plate had two spots that corresponded to the diformylated and
monoformylated products. Prolonging the reaction time did not result to any significant
increase in the diformylated species and therefore the reaction was stopped by quenching
with water and extracting into dichloromethane, followed by repeated washing with
aqueous sodium bicarbonate solution and water for neutralization.
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Figure 2-5: 1H NMR of Diformylated Dipyrromethane 2-7 in CD2Cl2 at 300 MHz

The solvent was evaporated and the resultant crude mixture purified on a silica gel
column eluting with dichloromethane to get rid of the monoformylated product, gradually
increasing the polarity of the eluant to 2% methanol in dichloromethane so as to elute the
more polar diformylated dipyrromethane fraction 2-11. Further recrystallization from
dichloromethane and methanol yielded a pure light brownish powder of the desired
product 2-11. The 1H NMR of pure 2-11 (Figure 2-5) has a sharp singlet aldehyde peak at
a 9.2 ppm and a broader singlet corresponding to the 2 NH protons shifted more
downfield appearing at 10.2 ppm and a sharp singlet corresponding to the meso protons at
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5.5 ppm. Gas chromatography mass spectrometry (GCMS) had a molecular ion peak at
372.11 corresponding to the diformylated dipyrromethane.
Dipyrromethane 2-7 in dry THF under argon was cooled to -23 °C, followed by
the dropwise addition of 1 M phenyl magnesium bromide while maintaining the
temperature at -23 C. The resultant mixture was stirred at this temperature for 4 hours and
quenched by pouring into an aqueous ether/ice bath. The organic layer was collected and
washed with water, dried over sodium sulfate and solvent reduced to dryness to afford a
highly sensitive orange colored oil (dicarbinol dipyrromethane 2-5),29b that was used
without further purification in the next porphyrin synthesis step. This oil was taken up in
dichloromethane and degassed with argon for five minutes and then condensed with
dipyrromethane 2-6 (R= NHAc) using a catalytic amount of BF3.OEt2.16 Formation of the
porphyrinogen (an intermediate to the porphyrin) was monitored using UV-Vis, for a
broad band at around 500 nm. After one hour, the reaction was treated with DDQ and
monitored with UV-Vis for a Soret band30 for the dodeca substituted porphyrin that
appears at ~ 440 nm for the free base species and ~ 460 nm for the dication species.
However, the UV-Vis spectrum of this particular reaction mixture had a weak Soret band
at around 410 nm. This could be probably due to the formation of a porphyrin lacking
two meso-phenyl substituents.31 A plausible route to this porphyrin, Soret band at 410 nm
could be as a result of the self condensation of dipyromethane 2-6 as well as acidolysis of
the respective dicarbinol dipyrromethane.37 From this result, it was concluded that
probably the acid catalyst used [BF3. OEt2] was not acidic enough and therefore the
reaction was repeated using TFA which is a stronger acid. The reaction was monitored by
UV-Vis and after an hour of stirring in DDQ, a spectrum with a Soret band at 449 nm
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was obtained. The crude mixture isolated was passed through an alumina plug eluting
with 1% methanol/ dichloromethane so as to get rid of higher oligomers and excess
DDQ. Purification on an alumina column eluting with pure dichloromethane then ensued
affording several compounds that were also characterized by UV-Vis giving Soret bands
at 408, 418 and 439 nm respectively. Attempts to further characterize the several bands
obtained using 1H NMR were futile because the compounds were obtained in relatively
low amounts (< 2%) and still required further purification. MS (MALDI) results were
also inconclusive and after carefully analysis of the result, it was hypothesized that TFA
was a relatively strong acid catalyst that resulted in the self condensation of the respective
dicarbinol dipyrromethane and the 1,9-diunsubstituted dipyrromethane 2-6.17b In addition
to this, the alkylation step to the dicarbinol from the diformyl-dipyrromethane, might not
have been high yielding because the yields obtained of the desired porphyrin were very
low. However, none of these postulates were confirmed due to the sensitive nature of the
bis-carbinol derivative.
The asymmetric porphyrin 2-4 was finally prepared by an alternative route that
involved the condensation of the dicarbinol 2-5, synthesized via the NaBH4 reduction of
diacyl dipyrromethane (2-10) and the 1,9-diunsubstituted dipyrromethane 2-6 (R=
NHCOCH3) as is shown in Scheme 2-6. The condensation was done at 10 mM in
acetonitrile using a catalytic amount of BF3.OEt2 and NH4Cl at 0°C.17b The reaction was
followed using UV-Vis for 1 h and oxidized with DDQ. To ease up on the purification
process, the porphyrin formed was metallated with a diamagnetic metal Ni (II) and Zn
(II).32 However, the Zn (II) complex was very acid labile and Cu (II) complex resulted in
lower yields of porphyrin and could not be easily characterized using 1H NMR.
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The yields obtained for the Ni (II) complex of the desired asymmetric porphyrin were
low ~ 10% yield. TLC analysis had a total of 4 spots with the predominant spot being that
of the desired porphyrin. Purification was done on an alumina thick layer preparative
chromagraphy eluting with a 1:1 dichloromethane/ petroleum ether solution. This
procedure gave very low yields of the desired porphyrin. Nickel(II) porphyrin 2-4 was
characterized by UV-Vis spectra, Soret band at 427 nm and two Q bands at 544 and 571
nm and by electron spray ionization giving a molecular ion peak at 1184.26. The 1H
NMR spectrum in deuterated dichloromethane gave four characteristic doublets at 7.81,
7.76, 7.73 and 6.95, respectively. Figure 2-6 shows the 1H NMR spectrum of Ni(II)
asymmetric porphyrin.
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Figure 2-6: 1H NMR spectrum of Ni(II)-Asymmetric Porphyrin 2-4 in CD2Cl2 at 300
MHz
The other fractions isolated mainly had 1H NMR spectra corresponding to
symmetric porphyrins due to the presence of symmetric doublet peaks in the aromatic
region. These compounds were not fully be characterized because they were obtained in
relatively low yields compared to the predominant asymmetric porphyrins species.
Oxidation by refluxing in toluene using an eight equivalent excess of DDQ33 afforded the
corresponding asymmetric TBP. This compound was only characterized by UV-Vis by
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the presence of a strong Q band peak at 650 nm. This is because the pure starting material
of porphyrin 2-4 was approximately 10 mg, therefore resulting in isolation of a small
amount of the desired asymmetric TBP after oxidation that could not be characterized by
1

H NMR.
The 2 + 2 MacDonald’s route has been studied previously by several research

groups. Lindsey et al25 has studied the effects of reaction temperature, solvent, acid and
concentration on condensation of dicarbinol dipyrromethane and 1,9-diunsubstituted
dipyrromethane. In this dissertation, the conditions used were the ones reported to be able
to isolate high yields of the desired porphyrin. Some other conditions that were adapted
in this Chapter are from the studies done by Wallace and Smith et al29b who developed
methodologies on the acylation of dipyrromethane derivatives using modified Vilsmeier
Haack reagents. Regardless of using these refined procedures, the yields obtained of the
dodeca substituted asymmetric porphyrin were very low. This could be explained with
the fact that the starting material was different from the one studied by these groups. The
previous group synthesized A3B porphyrins that did not have any β-pyrrolic substituents.
Studies have reported that steric interactions between substituents on the meso and βpyrrolic positions normally cause the porphyrins to be ruffled and it has also been
reported that the syntheses of dipyrromethanes bearing both β and meso substituents to be
quite laborious accompanied with the isolation of relatively low yields.17a In addition to
these, studies done on substituted dipyrromethanes have shown that the substitution
pattern on the dicarbinol-dipyrromethane derivatives plays a major role in the 2+2
condensation reactions. The presence of an electron-withdrawing group at the para
position of the phenyl group at position 5 of the dicarbinol, normally gives high yields in
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the condensation reaction.25 However, lower yields were reported for dicarbinols that
posses electron-withdrawing substituents on all the 1,9 and 5 positions. This observation
also explains the low yields that were observed, because the dicarbinol-dipyrromethane
2-5 used had para-bromo aryl groups in all the meso positions. Molecular modeling
studies done by Boyle et al34 showed that there is a significant twisting of the two pyrrole
rings on a 5-phenyl dipyrromethane without any β substituents after energy minimization
and therefore a greater amount of steric strain is involved in the formation of the
porphyrinogen of the desired dodeca substituted porphyrin compared to the formation of
uroporphyrin IV methyl ester in the original MacDonalds 2+2 synthesis.8 The
incorporation of a metal template presumably stabilizes the intermediate cyclic tetrameric
structure, as used in phthalocyanine synthesis.35 However, in this case, insertion of a
metal template to facilitate cyclization to form the porphyrinogen was not feasible,
because the oxidation to from the porphyrinogen to the porphyrin is performed using an
excess amount of DDQ, and this can therefore increase the chances of the formation of
the completely aromatized porphyrin complex (TBP),32 which has significant solubility36
problems and will therefore hamper the purification process. Acidolysis of the
dipyrromethane derivatives plays a major role in this condensation reaction. The acidcatalyzed cleavage and reformation of polypyrranes is a well-known problem in
porphyrin chemistry,37 this explains the isolation of several porphyrin derivatives in the
2+2 condensations. The mixture of porphyrin products is normally produced in the acidcatalyzed final step of the reaction as a result of acid redistribution reactions common in
dipyrromethanes. The postulated mechanism of acidolysis is shown in Scheme 2-7
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2-4:

Tetramerization and Functionalization of the p-Phenyl Substituents
The functionalization of a symmetric dodeca-substituted porphyrin to the

asymmetric A3B porphyrin stemmed from previous work done by several research groups
on the direct peripheral functionalization of porphyrin macroclyles using various
electrophiles.38 Peripheral functionalization of porphyrins and their derivatives is an
important reaction because it offers an alternative to producing many new compounds
that could only be obtained by total synthesis.35 As mentioned earlier, we have seen that
typical routes to porphyrins that possesess more than one differing β-substituent have
employed condensations of the appropriate aldehydes with various monopyrroles,39
substituted dipyrromethane40 or pre-fabricated 1,19-dideoxybiladienes.41 As seen in the
previous attempted synthesis, due to the inherent unfavourable entropy associated with
multiple condensation reactions along with acidic and oxidative conditions, the classic
synthesis of porphyrins typically gives low yields and requires tedious purification
processes in addition to restrains on preparation of porphyrins with sensitive functional
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groups.16,42 Theoretical electron density calculations done on porphyrin derivatives have
shown that, nucleophilic and electrophilic substitutions tend to take place preferentially at
the meso positions of the macrocyclic ring. In addition to this, steric considerations are
also important since some bulky substituents can shield some of the sites on the porphyin
periphery.43
Electrophilic addition of sulfuric and chlorosulfonic acid to the phenyl groups of
tetraphenylporphyrin derivatives have been reported and are examples of aryl-group
modification without the concomitant attack of the electrophile on the macrocycle ring.44
Subsequent nitrations on the phenyl groups have been performed in our group45 utilizing
the nitration procedure using sodium nitrite and TFA as the reaction medium on TPP,
which results in the isolation of mono, di and tri-nitro derivatives depending on the
reaction times. The desired derivative can then be easily isolated by column
chromatography.
Tetraphenyltetracyclohexeno porphyrin 2-12 (R= H), which is the precursor
porphyrin to the electrophilic aromatic substitution reaction, was synthesized and isolated
in 85% yield.17 Treatment of 2-12 in TFA with sodium nitrite did not yield the desired
mono, di and tri-nitro derivatives as is reported for TPP.45 However several other
derivatives, as described in Scheme 2-7, were obtained.
When porphyrin 2-12 (R=H) was treated with neat TFA and excess sodium
nitrite, oxidative macrocyclic ring cleavage occurred and the products isolated were
biliverdins 2-15 and 2-16.46 When its Ni(II) derivative was dissolved in toluene and
treated with TFA and sodium nitrite and heated at 80 °C, 2-14 was isolated instead.46
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All these new compounds were characterized by 1H NMR, electron spray
ionization (ESI) and X-ray crystallography. An X-ray crystal structure of compound 2-14
is shown in the Figure 2-7. The mechanism of the synthesis of compound 2-14 is not
completely understood but could be postulated to occur via a tetraphenyl-cyclohexadiene
porphyrin intermediate as is shown in Scheme 2-8.
Heating of Ni(II)-tetracyclohexenoporphyrin, (Ni(II)-TCHP) 2-12 under air, could
have resulted in the partial oxidation of one of the cyclohexeno rings, ultimately leading
to the electrophilic nitration of the alkene to give 2-17. TLC analysis showed two spots
that had very close rf in addition to a main spot of the starting material.
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The two spots were isolated and characterized by MS (ESI), and they both giving a
similar molecular ion peak at 929.1 The yields of this reaction were very low, and
attempts to optimize these yields were not fruitful even after several attempts of varying
the reaction parameters such as increasing the reaction time and refluxing at higher
temperatures. Due to the asymmetric nature of the compound, 1H NMR peaks could not
be easily assigned, because there were several overlapping doublets in the aromatic
region, however a singlet at ~6.8 ppm corresponding to the vinylic proton of compound
2-17 was observed.
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Figure 2-7: X-ray structure of Ni(II)-nitro-cyclohexenotetraphenylporphyrin 2-14

Two sharp singlet peaks corresponding to the proton on the nitro-alkene were also
observed at 6.87 and 6.83 ppm, respectively for compound 2-14. It is interesting to note
that 2-17 stirring in dichloromethane at room temperature could easily isomerize to 2-14
on addition of a few drops of TFA. However, the reverse isomerization was not observed.
The mechanistic details of the formation of benzoyl-biliverdin derivatives 2-15 and 2-16
will be discussed in detail in the ensuing Chapters. Seeing that the proposed route was
not fruitful, other synthetic strategies to the asymmetric porphyrin were investigated.
Recently, the development of synthetic methodologies that involve the application
of transition-metal-mediated cross-coupling reactions have proved advantageous,
allowing efficient synthesis of a large number of derivatives from a single halogenated
porphyrin precursor.47 These strategies have been used to build several linkages i. e. C-C
linkages with Suzuki,48 stille and heck couplings49 and C-N50 bonds, from aryl halides
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and triflates. Palladium mediated cross-coupling reactions for phosphorus-carbon bond
formations have also been reported. These reactions have found a niche in the preparation
of phosphines, phosphine oxides and phosphorus acid derivatives. Pioneering work was
done by Hirao et. al. who reported on the palladium catalysed cross-coupling of aryl and
vinyl bromides with phosphonate derivatives, affording the dialkyl phosphonates in 91%
and 69% overall yields, respectively.51
Synthesis of the asymmetric porphyrin A3B derivative by employing various
palladium catalyzed cross-coupling reactions to form the carbon-phosphorus and carbon
amine bond on tetrabrominated tetracyclohexenoporphyrin was therefore attempted as is
shown

in

Scheme

2-10.

5,10,15,20-Tetra-bromophenyl-2:3,7:8,12:13,17:18-tetra-

butanoporphyrin, a precursor to 2-18, was prepared by the condensation of butano pyrrole
and 4-bromo-benzaldehyde in dichloromethane.16 The reaction was monitored by UV-Vis
for the appearance of the Soret band at ~ 460 nm that is typical of dication-dodecasubstituted porphyrins. On completion, the reaction mixture was washed with aqueous
sodium bicarbonate solution and once with water, dried over sodium sulfate and the
solvent reduced to dryness.
The free-base porphyrin was not isolated but was metallated with copper by
refluxing in toluene in the presence of a ten equivalent excess Cu(II)Cl2 for five
hours.36b,52 The reaction was monitored by UV-Vis for the appearance of a blue-shifted
Soret band ~ 425 nm. The metallated porphyrin complex was then filtered through an
alumina

plug,

concentrated

in

vacuo

and

immediately

aromatized

to

the

tetrabenzoporphyrin derivative 2-18, by refluxing in toluene with DDQ for fifteen
minutes.
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The reaction changed from a deep red to a deep green color while monitoring by
UV-Vis for the appearance of a strong Q-band at ~ 630 nm which is typical of
tetrabenzoporphyrins.33 The reaction mixture was filtered through an alumina plug
eluting with chloroform, concentrated in vacuo and recrystallization out of chloroform
and methanol afforded beautiful green crystals of 2-18 in an overall 41% yield. This
compound was characterized by MS (MALDI), showing a molecular ion peak at 1191.5.
As a result of the paramagnetic nature of the copper complex, the compound was not
characterized by 1H NMR.
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In our initial studies, we attempted to do the palladium catalyzed cross-coupling
reaction on the free-base derivative (M= 2H) of 2-18. 2-18 (M= 2H) was obtained easily
by demetallation of 2-18 (M = Cu(II)) by dissolving the compound in concentrated
sulfuric acid and stirring the corresponding solution at room temperature for 5 minutes.52
The reaction was monitored by UV-Vis by carefully taking a drop of the solution in a
cuvette and diluting it with concentrated HCl. The appearance of a red shifted Soret band
at ~ 490 nm and red shifted Q-bands confirmed the completion of the demetallation.
Pouring carefully into an ice-bath and extracting into chloroform quenched the reaction.
The dication porphyrin had very low solubility in most organic solvents including
chloroform, forming a reddish solution with and a greenish precipitate; therefore the
solubility was enhanced by adding a drop of triethylamine into the chloroform. The
solvent was rota-evaporated to dryness. A quick alumina plug followed by
recrystallization out of chloroform and methanol afforded the free-base porphyrin of 2-18
in 90% yield as green crystals. The free-base could be easily characterized by 1H NMR in
chloroform, two doublets corresponding to the ortho and meta protons of the phenyl
groups appeared at 8.51 and 8.13 ppm, respectively with a coupling constant J= 8.23 Hz,
while the protons corresponding to the benzene rings appeared as a broad single peak at ~
7.3 ppm. The cross-coupling palladium catalyzed reaction was performed in a completely
inert environment patterning a procedure adopted from Lin et al.53 2-18 (M = 2H) was
dissolved in toluene in a schlenk tube that had been previously evacuated of air and filled
with argon approximately three times. The solubility of the 2-18 (M = 2H) was not
instant, therefore the mixture had to be sonicated and heated for several hours for the
compound to go into solution. Triethylamine, hydrogen diethylphosphite and 10% mol of
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palladium-tetrakis-triphenylphosphine (Pd(PPh3)4) were added to the schlenk tube under
argon. The tube was then sealed with a rubber septum and heated in an oil bath at 100 °C
for four days. The reaction was monitored using TLC analysis and showed several spots
that corresponded to the starting material, the mono, di adjacent, di opposite, tri and
tetraphosphonylated 2-18 (M = 2H). However, after heating the solution for 4 days, there
was hardly any increase in the yield of the tri-phosphonate derivative 2-19. The addition
of more hydrogen diethyl phosphite to the reaction mixture did not result to any
significant increase of the yield of the desired product. The reaction was stopped, diluted
with chloroform and washed with water so as to get rid of the unreacted diethyl phosphite
starting material. This compound was then rota-evaporated to dryness and purified on a
silica gel column with a gradient elution starting from 10% acetone in chloroform and
gradually increasing the solvent polarity to 30% acetone in chloroform. However, some
of the fractions collected when evaluated by UV-Vis, had a Q-band typical of a
metallated TBP derivative. This could have occurred during the oxidative addition
reaction that goes through the formation of an intermediate Pd2+ species, therefore
metallating the free-base TBP. The fractions collected were characterized by MS
(MALDI) showing molecular ion peaks for the tri-and tetraphosphonate peaks at 1304.18
and 1368.23, respectively. These compounds were obtained in relatively low yields, the
tri-phosponate compound was obtained in 20% yield while the tetraphosphonate fraction
obtained in 25% yield. Seeing that this route resulted in the metallation of the 2-18 (M =
2H), the precursor, 2-18 (M = Cu (II)) was used instead. However, the solubility of the 218 (M = Cu (II)) was worse than its free-base derivative but after several hours of
sonicating and heating, most of the compound finally went into solution and the reaction
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was repeated employing the previously mentioned synthetic methodology. However,
there didn’t seem to be an increase in the yield of the desired compound even after
changing the reaction conditions i. e. increasing the catalyst load, heating the reaction at
reflux, using an alternative base with a higher boiling point than triethylamine. The
compounds isolated in substantial yields were still the mono, di and tetra-substituted
phosphonates. The tri-phosphonate 2-19 (M= Cu(II)) and tetra-phosphonate derivatives
were characterized by MS (MALDI) with molecular ion peaks at 1374.33 and 1421.87.
The tri-phosphonate copper complex was then purified further by preparative silica gel
TLC eluting with pure dichloromethane and increasing the solvent polarity to 1%
methanol dichloromethane in order to get rid of excess triphosphine ligand from the
catalyst. This purification process was very challenging because both the ligand and 2-19
had very close retention factors. Unfortunately this compound’s purity could not be
confirmed by 1H NMR due to the paramagnetic copper ion. The Schematic of the
oxidative elimination palladium catalyzed cross-coupling for the formation of the carbonphosphorus bond is illustrated in Scheme 2-11 below. 52
The next cross-coupling reaction involved formation of a C-N bond. The
procedure employed was adapted from the palladium catalyzed cross-coupling reaction of
ammonium surrogates to aryl halides and sulphonates by Hartwig et al.54 Earlier studies
conducted report on the formation of anilines being accomplished by using allyl and
diallyamines,55 benzyl and diphenyl amines and a benzophenone imine in the crosscoupling reactions.56
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However, some of the drawbacks encountered with these substrates are that they require
metal-catalyzed cleavage of their protecting groups, which are relatively expensive
reactions. Hartwig et al reported that the treatment of bis(trimethylsilyl) amides available
as solutions in hydrocarbon solvents with aryl halides and palladium catalyst at relatively
low temperatures afforded protected aniline groups that were then deprotected easily
using an acidic workup. The procedure could be carried out conveniently without the use
of a glove box and isolation of relatively good yields of the desired compounds that were
dependent on the temperature and time. Relatively high temperatures could not be used in
this procedure due to the highly reactive nature of the lithium hexamethyl-disilyl amide
base (LHMDS), which could decompose easily.
2-19 was dissolved in toluene in a schlenk tube, the solution was then degassed
for approximately 15 minutes and filled with argon before the addition of 10 mol % of
the palladium catalyst. The reaction was heated to 80 °C for twelve hours and the
progress of the reaction monitored by TLC using 1% methanol/chloroform solution for
elution. The desired compound appeared as a streaking less polar spot on the plate. The

64

reaction was stopped, cooled down and the toluene evaporated to dryness. The mixture
was then demetallated according to the procedure used previously, affording the free-base
2-20. Purification using preparative TLC and eluting with 1% methanol in chloroform
afforded 2-20 in an 85% yield. This compound was characterized by 1H NMR and MS
(MALDI) with a peak at 1387.48 that corresponded to the asymmetric TBP 2-20.
Due to the solubility set backs that were encountered in the previous crosscoupling reaction, an alternative synthetic methodology to 2-20 was attempted. The route
employed was similar to the one on scheme 2-9, the only difference was that the crosscoupling reaction were performed on the non-aromatized precursor of 2-18 i.e on the
cyclohexenoporphyrin. The solubility of the non-aromatized precursor porphyrin of 2-18
was better than its fully aromatized derivative 2-18, because this complex required
sonicating for a few minutes for the compound to go completely into solution. However,
the yields obtained of the mono, di, tri and tetra-phosphonate derivatives were no
different, with mostly the isolation of starting material, mono and di-derivatives. There
was no difference observed in the yields when the reaction was done in a normal hood
and in a glove box that normally has strictly inert conditions.
Since the coupling reaction favored the isolation of the starting material and the
mono-phosphonated derivatives in higher yields, it was hypothesized that reversing the
order of the coupling reactions i.e. starting with the formation of the carbon-nitrogen
bond, then isolating the favored mono-amine derivative and cross-coupling this
compound to its phosphonate derivative would result to the isolation of better yields of 220. However, these efforts too were not successful, because TLC analysis showed the
formation of only trace amounts of a new product, compared to the starting material.
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Figure 2-8: MS (MALDI) Spectrum for TBP 2-20 (M= 2H)
2-5:

Conclusion and Future Work
The several routes that were discussed and employed in this Chapter for the

synthesis of asymmetric tetrabenzoporphyrins, which are precursors to their amphiphilic
water-soluble derivatives, did bring forth the desired compounds but in very low yields.
However, a lot of progress was made in that other alternative routes can be tried and also
several reaction conditions can be played around with to try and optimize the yields. The
work done in this Chapter also holds a lot of promise because these compounds are novel
and most of the synthetic methodologies that were used were adopted mainly from
methodologies used on tetraphenylporphyrin derivatives and other compounds. The
cross-coupling reactions that were used had a lot of potential but solubility was one of the
major hindrances to this synthetic route’s success. Alternatively, the 2 + 2 MacDonald’s
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route was also a facile methodology which had its set backs such as acidolysis and sterics
resulting to extensive chromatographic procedures. All in all, a novel asymmetric
tetrabenzoporphyrin 2-20 was synthesized, this compound has application as
photosensitizer for (PDT) of tumors, as antiviral agent for blood sterilization, and as
fluorescent maker for the labeling and analysis of nucleic acids and other biomolecules by
fluorescence detection using confocal microscopy.
2-6:

Experimental Section

The All experiments were performed under argon atmosphere in oven-dried glassware
following the standard schlenk techniques. Solvents used as reaction media were distilled
immediately before use. THF and Toluene were distilled from Na/Benzophenone.
Methylene chloride was distilled from calcium hydride. 1HNMR spectra were recorded
on a Bruker AC-250 (250 MHz, 300 MHz, 400 MHz 1H) spectrometer in deuterated
chloroform (CDCl3: 7.27 ppm). Chemical shifts (δ) are given in parts per million relative
to tetramethylsilane (TMS, 0 ppm); multiplicities are indicated as br (broad), s (singlet), d
(doublet), t (triplet), q (quartet) and m (multiplet).
Analytical TLC was performed on Scientific Adsorbent Company Inc. silica gel plate and
alumina gel plate. Flash column chromatography was performed using silica gel
(Scientific Adsorbent Company Inc. 40-63 µM particle size, 60 Å pore size). Electronic
absorption spectra were measured using a Perkin-Elmer Lambda 35 UV-vis
spectrophotometer. Mass Spectra were obtained at LSU Mass Spectometry Facility.
Ethyl 4, 5, 6,7-tetrahydroisoindole carboxylate (2-8)
To a solution of 1-nitro-1-cyclohexene (2.7 mL, 23.9 mmol) in freshly distilled dry THF
(30 mL), was added ethyl isocyanoacetate (2.7 mL, 23.9 mmol) and DBU (3.6 mL, 23.7
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mmol) at 0°C, and the mixture was stirred at room temperature for 15h. The reaction
mixture was then washed with dilute acid (10% HCl, 100 mL) and extracted into
ethylacetate (3 × 100 mL), dried over sodium sulfate and solvent evaporated under
vacuum. The brown oil residue was chromatographed on a silica gel column eluting with
10% ethyl acetate and Hexane, to give pure yellow crystals of the title pyrrole 4.15 g in a
90% yield. Mp = 80-82°C: 1H NMR (250MHz) δ (ppm) 8.77 (s, br, NH), 6.64 (d, α-H, J
= 3 Hz), 4.29 (q, 2H, CO2CH2CH3), 2.82 and 2.54 (t, 2H, each, α CH2), 1.74 (m, 4H, β
CH2) 1.34 (t, 3H, CO2CH2CH3): MS (MALDI) m/z 193.12 (M+).
5-(Phenyl)-1,9-ethylesterDipyrromethane (2-9: R = H, Br, NHAc)
Pyrrole 2-8 (2 g, 10.32 mmol) was dissolved in 80 mL of freshly distilled dichlomethane
and degassed with argon for approximately five minutes. Montmorillonite K10 clay
(2.1g) was then added and the round bottom flask sealed. TFA (4.0 mL, 51. 9 mmol) was
then added followed by benzaldehyde (6.9 mmol). The reaction was allowed to stir under
argon for 12h before TLC analysis showed completion of the reaction. The reaction
mixture was then filtered through a 150 mL plug packed with silica gel to remove the
excess benzaldehyde. The filtrate was then collected and washed with 100 mL of water
and 100 mL of aqueous sodium bicarbonate. The organic layer was then collected, dried
over sodium sulfate and solvent removed via rotary evaporator. Recrystallization from
dichloromethane and methanol afforded a beige solid in an overall yield of 60-70%. R =
Br: (1.9 g, 70%) 1H NMR (250 MHz) CDCl3 δ (ppm) 8.4 (s, br, 2H, NH), 7.28 (d, Ar-H,
J = 8.3 Hz), 6.91 (d, Ar-H, J = 8.3 Hz), 5.41(s, 1H), 4.27 (q, 2H, CO2CH2CH3) 2.79 and
2.52 (t, 4H each, CH2) 1.73 (m, 8H, CH2), 1.32 (t, 3H, CO2CH2CH3): MS (MALDI) m/z
553.10 (M+).
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R = NHAc: (1.64 g, 60%) 1H NMR CDCl3 δ (ppm) 8.27 (s, br, 2H, NH), 7.35 (d, Ar-H, J
= 8.6 Hz), 7.30 (br, s, 1H, 1NH) 7.15 (d, Ar-H, J = 8.3 Hz), 5.40 (s, 1H), 4.28 (q, 2H,
CO2CH2CH3) 2.78 and 2.50 (t, 4H each, CH2) 1.73 (m, 8H, CH2), 1.56 (s, 3H, CH3) 1.33
(t, 3H, CO2CH2CH3): MS (MALDI) m/z 532.80 (M+).
R = H: (1.71 g, 70%) 1H NMR CDCl3 δ (ppm) 7.8 (s, br, 2H, NH), 7.52-7.17 (m, 5H, ArH), 5.43 (s, 1H), 4.22 (q, 2H, CO2CH2CH3) 2.71 and 2.43 (t, 4H each, CH2) 1.73 (m, 8H,
CH2), 1.33 (t, 3H, CO2CH2CH3): MS (MALDI) m/z 475.52 (M+).
5-(Phenyl)-1,9-unsubstituted Dipyrromethane (2-6: R = H, Br, NHAc)
Dipyrromethane 2-9 (0.393 g, 0.71 mmol) was suspended in ethylene glycol (32 mL) and
NaOH (0.67 g, 16.75 mmol). The solution was then heated at 100°C for 30 minutes to
saponify the ethyl ester groups before refluxing at 195°C for 35 minutes to decarboxylate
the carboxylic groups. An orange precipitate formed on cooling down the hot ethylene
glycol solution to room temperature. 10-15 mL of water was added to the flask to
enhance further precipitation and the reaction flask stored in the fridge for another 12
hours. The reaction mixture was then filtered, and the precipitate washed with water
before being dried under vacuum. The yield obtained of the title compound (R = Br) was
(0.181 g, 65% yield). 1H NMR CDCl3 (300 MHz) δ (ppm) 7.43 (s, br, 2H, NH), 7.28 (d,
Ar-H, J = 8.3 Hz), 6.91 (d, Ar-H, J = 8.3 Hz), 6.41 (s, 2H, αH) 5.41(s, 1H), 2.79 and 2.52
(t, 4H each, CH2) 1.73 (m, 8H, CH2): MS (MALDI) m/z 394.23 (M+).
R = NHAc: 1H NMR CDCl3 δ (ppm) 7.45 (s, br, 2H, NH), 6.86 (d, Ar-H, J = 8.6 Hz),
6.62 (d, Ar-H, J = 8.3 Hz), 6.38 (s, 2H, α-H) 5.40 (s, 1H), 2.78 and 2.50 (t, 4H each,
CH2) 1.73 (m, 8H, CH2), 1.56 (s, 3H, CH3): MS (MALDI) m/z 375.55 (M+).
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R = H: 1H NMR CDCl3 δ (ppm) 7.7 (s, br, 2H, NH), 7.42-7.13 (m, 5H, Ar-H), 6.35(s,
2H, α-H), 5.43 (s, 1H), 2.71 and 2.43 (t, 4H each, CH2) 1.73 (m, 8H, CH2): MS (MALDI)
m/z 316.89 (M+).
5-Phenyl-1,9-Diformyldipyrromethane (2-7)
1,9-unsubstituted dipyrromethane 2-6 (R = H) 0.68g, 1.65 mmol was dissolved in TFA
15 mL and the flask evacuated of air and filled with argon. The reaction was allowed to
stir under argon for 10 minutes cooled down to 0°C and trimethyorthoformate (10 mL,
0.095 mmol) added drop wise to the reaction mixture. The mixture was then allowed to
stir for an additional 30 minutes before removal of the ice bath and equilibration to room
temperature. Completion of the reaction was confirmed via TLC analysis and the reaction
mixture was washed with (2 × 100 mL) of sodium bicarbonate and 100 mL of brine
solution. The organic fraction was then collected and dried over sodium sulfate and the
solvent rota-evaporated off. Recrystallization from dichloromethane and methanol gave
white flaky crystals of the desired product in 0.25 g, 35% yield. R = H: 1H NMR CDCl3
(300 MHz) δ (ppm) 10.22 (s, 2H, Aldehyde), 9.28 (s, 2H, NH), 7.35(m, 3H, ArH), 7.10
(m, 2H, ArH) 5.50 (s, 1H), 2.80 (t, 4H each, CH2) 1.75 (m, 8H, CH2): MS (MALDI) m/z
372.11 (M+).
4-Bromo-N-Benzoylmorpholine
To a 200 mL round bottom flask equipped with a dropping funnel and flushed with argon
was added morpholine (2.4 mL, 27.5 mmol), dry dichloromethane 28 mL and
triethlyamine (8.56 mL, 61.8 mmol). 4-bromobenzoylchloride (5.6 g, 24.5 mmol) in dry
dichloromethane 50 mL was added dropwise over a period of 1hour. The colorless
solution (containing a white precipitate) was stirred at room temperature for 1hour before
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heating to reflux for 2 hours. The reaction was cooled and washed with 2M HCl (5× 100
mL), water (2 × 100 mL), once with 100 mL of saturated aqueous sodium bicarbonate
solution, once with 100 mL of brine, dried over sodium sulfate and evaporated under
vacuum to yield a yellow oil. Crystallization on standing produced 6 g of a white solid
(92% yield). 1H NMR 250MHz: (CDCl3) δ 7.57 (d, 2H, ArH, J = 6.6 Hz), 7.30 (d, 2H,
ArH, J = 6.6 Hz), 3.70 (br, s, 8H, CN4H8O).
5-(4-Bromophenyl)- 1,9-bis(4-bromophenyl)-diacylateddipyrromethane (2-10)
To a 100 mL round bottom flask flushed with argon was added 4-bromo-Nbenzyolmorpholine (1.37 g, 5.09 mmol) and freshly distilled POCl3 (1 mL, 10.7 mmol).
The suspension was warmed to 35°C before being cooled to room temperature and stirred
for 6h. Dipyrromethane 1-7 (R = Br) 0.52 g, 1.27 mmol dissolved in 20 mL of dry 1,2dichloroethane was then added to the Vilsmeier reagent before being allowed to stir at
room temperature for 14h. Aqueous Sodium Carbonate (40 mL) was then added to the
red solution and the mixture stirred at room temperature for fifteen minutes and then at
reflux for 45 minutes. The reaction mixture was then allowed to cool before being
washed with 100 mL of water and 100 mL of brine and finally dried over sodium sulfate.
The solvent was then reduced via vacuum and the red oil obtained purified by silica gel
chromatography eluting with 1% methanol in dichloromethane. The yield obtained of the
desired product 2-10 was 0.69g in a 70% yield. 1H NMR CDCl3 (300MHz) δ (ppm) 10.02
(s, br, 2H, NH), 7.48 (d, 4H, Ar-H, J = 8.3 Hz), 7.28-7.34 (2d, 6H, ArH), 6.91 (d, 6H,
ArH, J = 8.3 Hz), 5.47 (br, s, 1H) 2.35(t, 6H, CH2), 2.25(t, 6H, CH2), 1.70 (m, 10H,
CH2): MS (MALDI) m/z 775.34 (M+).

71

5-(4-Bromophenyl)-1,9-(4-bromophenyl)-dicarbinoldipyrromethane (2-5)
NaBH4 (0.66 g, 17.8 mmol, 50 equivalents) was carefully added in small portions (0.2 g
each) over 20 minutes to a stirred solution of dipyrromethane 2-10 (0.27g, 0.34 mmol) in
THF-MeOH (2:1, 9 mL). The reduction progress was followed on TLC (alumina;
ethylacetate-hexanes 1:1). Within 5 minutes a new spot of rf 0.5 was observed
(monoreduced product), but this compound was fully converted to a second product with
rf 0.2 (diol) after 2 hours. The reaction mixture was quenched with water and then
extracted into dichloromethane. The organic phase was dried over sodium sulfate and the
solvent removed to afford a pale yellow oil.
5,10,15-Tri(4-bromo-phenyl)-20-(acetamido-phenyl)-2:3,7:8,12:13,17:18-butano[Ni(II)]-porphyrin (2-4)
Due to its limited stability, dicarbinol-dipyrromethane 2-5 (0.34 mmol) was immeadiately
dissolved in acetonitrile (34 mL) and condensed with 1,9-unsubstituted dipyrromethane
2-6 (R = NHAc, 0.135 g, 0.34 mmol). The solution was cooled to 0 °C while under argon
for 10 minutes and then NH4Cl (0.18g, 3.4 mmol) was added followed by BF3.OEt2 (4.2
µL, 0.034 mmol). The solution instantly darkened, and the progress of the reaction was
followed by UV-Vis. After 1hour, DDQ (0.37 g, 1.62 mmol) and triethylamine (0.4 mL)
were added and the mixture stirred at room temperature for 30 minutes followed by
heating at reflux for 1hour. The entire solution was then washed with 100 mL of NaHCO3
and extracted into dichloromethane, dried over sodium sulfate and solvent evaporated to
dryness under vacuum. The residue was re-dissolved in 25 mL of toluene, 10 equivalent
excess of nickel(II)acetate added and the reaction mixture heated at reflux for 12 hours.
The metallation was followed by UV-Vis to completion and once complete, the toluene
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was evaporated off and the residue purified on an alumina gel column eluting with 1:1
petroleum ether-dichloromethane solution to afford the desired Ni(II)-Asymmetric
porphyrin in > 10% yield (20 mg) as the second band. Recrystallization from
dichloromethane afforded pure red crystals of 1-1. 1H NMR (330 MHz) CDCl3 δ: 7.81 (d,
J = 8.0 Hz), 7.76 (d, J = 8.4 Hz), 7.73 (d, J = 8.3 Hz), 6.95 (d, J = 8.3 Hz), 2.35 (br, s,
4H), 2.23 (br, s, 12H), 1.4 (br, s, 16H): MS (ESI-MALDI) m/z 1186.89 (M+)
5,10,15,20-Tetra(4-bromo-phenyl)-2:3,7:8,12:13,17:18-tetrabenzoporphyrin (2-18)
Freshly distilled dry dichloromethane (214 mL) was added to a round bottom flask fitted
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.25 g, 2.14 mmol) and 4bromo-benzaldehyde (0.39g, 2.14 mmol) were added and the solution was stirred at room
temperature under a slow steady stream of argon for 15 min. The flask was then shielded
from ambient light and BF3•OEt2 (0.04 mL, 0.214 mmol) was added. This mixture was
then stirred for 1 h at room temperature. DDQ (0.7 g, 3.21 mmol) was added to the
reaction flask and the final solution turned dark pink instantly. This solution was refluxed
under argon for 1 h to give a dark green solution. The solvent was reduced to dryness
under vacuum and redissolved in dichloromethane and washed (4 × 100 mL) with
aqueous sodium bicarbonate solution, (3 × 100 mL) with water and dried over sodium
sulphate and concentrated under vacuo. The resultant compound was then redissolved in
toluene, the addition of a 5 mL saturated solution of Cu(II)Cl2 in methanol then ensued
and the corresponding solution refluxed for 12 h while monitoring by UV-Vis for a blue
shift in the soret band to 425 nm. Once the metallation was complete, the reaction
mixture was filtered through an alumina pad to get rid of the excess Cu(II)Cl2 and
evaporated to dryness. The metallated porphyrin complex (250 mg, 0.206 mmol) was
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weighed and dissolved in minimum amount of toluene, (0.37 g, 1.6 mmol) of DDQ added
to the solution that was then refluxed for fifteen minutes. The reaction was followed by
UV-Vis for the appearance of a strong q-band at ~ 640 nm and also by TLC. Upon
completion, the resultant solution was filtered through an alumina plug to get rid of the
excess unreacted DDQ and recrystallized out of chloroform and methanol giving 0.19 g,
80% yield of the 2-18, (M= Cu(II)). The corresponding free base derivative 2-18, (M=
2H) was obtained by redissolving the metallated complex in concentrated sulfuric acid
and stirring the resultant solution at room temperature for five minutes. UV-Vis was used
for following the reaction to complete demetallation. Upon completion, the resultant
mixture was quenched by pouring into an ice-bath and extracted into chloroform, filtered
through an alumina plug, dried over sodium sulfate and concentrated in vacuo to afford
the desired 2-18, (M= 2H) 0.18 g, quantitatively. UV-Vis (CH2Cl2): λmax (log ε) 467
(10.8), 553 (3.75), 593 (4.07), 643 (4.27), 698 (3.85): MS (MALDI) m/z 1121.7 (M+): 1H
NMR (CDCl3, 300 MHz) 8.51-8.45 (d, 8H, J= 8.23Hz, o-Ar) 8.13-8.11 (d, 8H, J= 8.23
Hz, m-Ar), 7.52 (s, 16H, Benzylic-H).
5,10,15-Tri(4-diethylphosphonate-phenyl)-(4-bromophenyl)-2:3,7:8,12:13,17:18tetrabenzoporphyrin (2-19)
80 mg, 0.06 mMol of Tetrabenzoporphyrin 2-18 (M= Cu(II)) and 7 mg, 0.006 mmol of
Pd(PPh3)4 were placed in an oven dried Schlenk tube. The tube was capped with a rubber
septum and evacuated and backfilled with argon, this procedure was done three times. 60
mL of toluene was cannulated to the schlenk tube and the tube purged with argon for five
minutes. The resultant solution was then sonicated under argon until the compound had
solubilized. 5 mL of triethyl amine and (0.19 mL, 0. 2 mmol) of diethylphosphite were
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then added and the resultant solution refluxed at 100 °C for 96 hours following by TLC
for the consumption of the starting material. After 96 hours, there was no significant
increase in the yield of the desired product and ther reaction was stopped and quenched
by the 100 mL of water. The resultant reaction mixture was diluted with chloroform and
washed (3 × 100 mL) with water so as to get rid of the unreacted diethyl phosphite. The
solution was then dried over sodium sulfate and concentrated in vacuo. Purification was
done on a silica gel column with eluting with a gradient solution of 10% acetone in
chloroform and gradually increasing the polarity to 30% acetone in chloroform. 2-19 was
obtained as green crystals 16 mg in 20% yield. MS (MALDI) m/z 1374.33 (M+)
5,10,15-Tri(4-diethylphosphonate-phenyl)-(4-disilyl-hexamethyl-amino-phenyl)2:3,7:8,12:13,17:18-tetrabenzoporphyrin (2-20)
The general procedure mentioned previously was used to couple 2-19 with lithium
hexamethyl disilyl amide (LiHMDS) using Pd(PPh3)4. 2-19 (16 mg, 0.012 mmol) and 2
mg, 0.0012 mmol of Pd(PPh3)4 were put in an oven dried schlenk tube. 5 mL of toluene
was then added to the septum sealed tube via syringe and (0.01 mL, 0.018 mmol) of
LiHMDS. The tube was then heated at 80 °C for 12 hours under argon. The reaction was
followed by TLC for the total consumption of 2-19. The reaction was stopped and solvent
concentrated in vacuo. The resultant residue was purified using preparative TLC using
silica gel and eluting with 1% methanol and chloroform so as to get rid of the excess
triphenylphosphine ligand and the slightly unreacted starting material. The desired
compound collected was the less polar band on the plate. This compound was then
demetallated following the general demetallation procedure mentioned previously and the
desired 2-20 isolated was 13 mg, 85% yield. 1H NMR (CDCl3, 300 MHz) 8.51-8.28 (d,
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10H, Ar-H), 8.04-7.89 (d, 6H, Ar-H), 7.31-7.11(m, 16H, Benzylic-H), 4.34 (m, CH2,
12H, phosphonate ester), 1.76-1.53 (t, CH3, 18H, phophonate ester), -1.10 (NH, 2H); MS
(MALDI) m/z 1387.48 (M+)
2-7:
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Chapter 3: Novel Synthetic Routes to Biliverdins and their Metallated Derivatives
3-1:

Introduction
Bilverdins are open-chain tetrapyrrole compounds widely distributed in nature

either free or bound to protein.1 Open-chain tetrapyrroles are found in nature as catabolic
products (e.g., the neurotoxic bilirubin in the bile fluid), as the chromophores of
biliproteins performing important photo-biological functions, as pigments in lepidopters
(e.g., biliverdin IXγ), and as chlorop[hyll degradation products in senescent plants.2
Biliverdin derivatives have a helical surface,3 and have attracted attention as
chromophores of remarkably high flexibility, having the potential to adopt a large
number of configurational, conformational and tautomeric forms.4 They also have
characteristic spectroscopic properties (UV-Vis, CD, and NMR)5 and display a variety of
biological and chemical activity, which frequently imply coordination to a metal center.6
Biliverdins have been shown to display antioxidant and antiviral activities,7 redox
activity,8 coordinating ability,9 photochemical isomerization and energy transfer.10 Most
syntheses of open-chain tetrapyrroles have been carried out on simple model compounds
and have utilized either of two synthetic strategies. The first of these is based on
biosynthetic theory and involves the oxidative cleavage of porphyrins, chlorins and
related materials.11 The second involves stepwise syntheses that utilize suitably
functionalized dipyrromethenone derivatives. In nature, the in vivo cleavage of heme (31), catalyzed by the enzyme heme oxygenase, occurs selectively at the meso-α carbon to
form verdoheme (3-2) via a meso-hydroxyheme, which reacts with a second molecule of
oxygen to produce biliverdin IX α (3-3) after loss of the meso-α carbon as CO and
demetalation (Scheme 3-1).12 Both electronic and steric effects exerted by the protein
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control the regioselectivity of heme cleavage by heme oxygenase.13 However, the in vitro
chemical oxidation of heme (3-1), normally accomplished using O2-ascorbic acid or O2hydrazine in aqueous pyridine (the so-called coupled oxidation)14 produces all four
isomeric biliverdins. This process has been widely used as a model of the heme
oxygenase catalyzed reactions.15
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Owing to the low symmetry in biliverdin type compounds, their synthesis requires a
multi-step route. As mentioned above, some of the early studies done on the synthesis of
biliverdins utilized the suitably functionalized dipyrromethenone derivatives of types 3-4
and 3-5 (Scheme 3-2) to synthesise asymmetric biliverdin derivatives.16 Coupling of
dipyrromethone 3-4 and 3-5 gave moderate yields of linear tetrapyrrole derivatives. This
approach afforded good control on the stereo and regiochemical feature as well as the
oxidation states at the crucial ring positions. However, synthesis of the monocyclic
pyrrolic derivatives, which are the precursor building blocks to the dipyrromethenones, is
very challenging.
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A variety of other reaction conditions have also been used for the photo- and
chemical oxidations of porphyrins as a synthetic route to open chain tetrapyrroles, these
include H2O2 in pyridine, thallium(III)17 and cerium(IV) salts,18 and O2-NaOMe in
methanol/THF.19 These reactions typically produce formylbiliverdins (e. g. 3-7, from
magnesium octaethylporphyrin)20 and biliverdin (e.g. 3-3, via extrusion of CO) from
meso-unsubstituted

porphyrins,

and

aroyl-substituted

bilenes

from

meso-

tetraarylporphyrins, such as TPP (3-8). The yields obtained in these reactions are usually
low to moderate, and depend on reaction conditions and the presence and nature of the
coordinated metal ion. While a myriad of approaches to the oxidation of porphyrins that
typically produce formyl-biliverdins and biliverdins have been developed, a satisfactory,
high-yield preparative procedure for such compounds has been lacking.
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In this Chapter, the facile and high yield preparation of novel benzoylbiliverdins
from the chemical oxidation of metal-free dodeca-substituted porphyrin 3-8 and some of
its derivatives and the high yield preparation of corresponding novel metallobenzoylbiliverdins will be discussed.
3-2:

Results and Discussion
The chemical oxidation of the zinc(II) complex of TPP was first reported by

Smith and coworkers21 using thallium(III) trifluoroacetate and nitrate salts. The purple
major product obtained (in 17% yield) was assigned structure 3-10. The UV-Vis
spectrum of this compound in CHCl3 showed two broad bands at 345 and 565 nm.22 The
photo-oxygenation of the Zn(II), Cd(II), bis-Tl(I) and Mg(II) complexes of TPP also gave
3-10 as the major product, along with trace amounts of benzoyl-bilverdin 3-11.23
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The oxygen atoms in 3-10 and 3-11 were shown to come from a single O2
molecule (thus a one-molecule mechanism), by experiments performed under different
18

O2/16O2 ratios and subsequent MS analyses. Benzoylbiliverdin 3-11 was therefore

considered an “unstable” intermediate in the formation of 3-10, obtained from
demetallation and addition of two hydrogens to the metal complex of 3-11 during
reaction work-up. In parallel with the early studies conducted by Fuhrhop on metallooctaethylporphyrin,20a the structure of 3-10 was subsequently proposed as 3-12,19,

24

bearing an additional oxygen atom at the α-carbon, presumably from ready addition of
water to 3-11. Several studies were done in different solvents (methanol and ethanol) and
confirmed there is in fact addition of solvent at the meso-position. The structure 3-12 was
assigned based on

13

C-NMR and MS data, which showed the existence of a quaternary

meso-carbon at δ 75.0 and a molecular ion consistent with 3-12, although loss of water
was readily observed by MS, and base peaks consistent with both 3-10 and 3-11, were
also observed. Under nitrating conditions, using either a mixture of sulfuric and nitric
acids25 or N2O4 in organic solvents,26 TPP (3-8) and its Mg(II) and Zn(II) complexes also
produced 3-10 (3-11 or 3-12) as a side product.
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Our synthetic approach entailed treating a concentrated trifluoroacetic acid (TFA)
solution of 3-9 with NaNO2 in the presence of ambient oxygen conditions under which
TPP 3-8 normally undergoes regioselective nitration at the para-positions of the mesophenyl rings.27 The product of this reaction for (3-9, R=H) was, however, not the nitroderivative but biladienone 3-18; this was obtained in a combined yield of 77% as a
mixture of two interconvertible stereoisomers, structures of which were fully
characterized by spectroscopic and crystallographic methods. However, oxidation of 3-9
(R= C9H19), affords biladienone 3-18 (R= C9H19) in 10 % yield and bilatrienone 3-19 in a
70 % yield along with slight traces of starting material.
The synthesis of meso-tetraaryl tetrabutanoporphyrins (Ar4TCHP) 3-9 is well
documented.17 Ar4TCHP 3-9 was synthesized by condensation of tetrahydroisoindole (316) with either 4-nonylbenzaldehyde (3-15) or commercially available benzaldehyde as
shown in Scheme 3-5. 4-Nonylbenzaldehyde 3-15 was synthesized by treating 1bromooctane with magnesium turnings in diethyl ether at 0 ºC for 30 minutes affording
the corresponding octyl-magnesium bromide Grignard that was not isolated but
immediately treated with 4-bromobenzaldehyde affording the corresponding 1-(4bromophenyl)-1-hydroxynonane 3-13 in 97% yield (Scheme 3-6). The reaction was
quenched by addition of water, and was extracted into dichloromethane, dried over
sodium sulphate and purified on a silica gel column eluting with 3:1 hexane/ ethyl acetate
affording pure 3-13 as a pale colored oil. This compound was characterized by 1H NMR
and had two sets of doublets at 7.5 and 7.3 ppm corresponding to the ortho and meta
protons.
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A triplet corresponding to the proton on the carbon with the hydroxyl functional
group appeared at 4.6 ppm, the hydroxyl group signal appeared at 1.9 ppm while the
resonances corresponding to the methylene carbons appearing between 2.0 and 1.2 ppm
and the CH3 protons as a triplet at 0.93 ppm. 3-13 was then treated with
trimethylsilylchloride and sodium iodide followed by condensation with sodium
boronhydride in DMSO to give the corresponding 4-bromophenylnonane 3-14 in 79%
overall yield (Scheme 3-6).
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The purification of 3-14 was performed by extraction into a solution of hexanes
from the DMSO layer, drying the corresponding hexane layer over sodium sulphate and
purifying the oil on a silica gel column eluting with hexane. This compound was
characterized using 1H NMR and had two doublets at 8.11 and 7.52 ppm, corresponding
to the ortho and meta protons. The para CH2 protons appeared at 2.92 ppm as a multiplet
and the methylene protons on the nonanyl chain appeared between 2.3 and 1.2 ppm. A
triplet peak corresponding to the CH3 group appeared at 0.94 ppm. Formylation of the 4bromophenyl-nonane using the Vilsmeier reagent gave the corresponding aldehyde 3-15
in 65% yield (Scheme 3-6). 3-14 was first dissolved in THF and treated with n-BuLi and
DMF at -78 ºC. Acidic workup, followed by extraction into hexane afforded a pale
yellow oil of 3-15 that was purified on a silica gel column eluting 3:1 solution of hexane
and ethyl acetate. This compound was characterized by 1H NMR giving a similar
spectrum to the precursor compound 3-14 the only difference being the aldehyde peak
signal at ~ 9.6 ppm. Figure 3-1 shows a 1H NMR spectrum of aldehyde 3-15.
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Figure 3-1: 1H NMR of 4-nonanylbenzaldehyde (3-15) in CDCl3 at 300 MHz

The tetrahydroisoindole ester precursor of 3-16 was synthesized via BartonZard28b condensation using commercially available ethyl isocyanoacetate and 1nitrocyclohexene affording the corresponding protected 4,5,6,7-tetrahydroisoindole in
90% yield; this was then deprotected using a one pot basic hydrolysis reaction to give 316 in 85% yield.
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Figure 3-2: 1H NMR spectrum of ArTCHP (3-9, R= C9H19) at 300 MHz
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Figure 3-3: 13C NMR Spectrum of ArTCHP 3-9 (R= C9H19) in CDCl3 at 300 MHz

Ar4TCHP 3-9 were synthesized in high yields (65-70%) by condensation of 3-16
with either benzaldehyde (3-15, R= H) or 3-15 (R= C9H19) with a catalytic amount of
BF3.OEt2 (Scheme 3-5). Porphyrins 3-9 were purified by using the same procedure of
first filtering through an alumina plug followed by purification on an alumina gel column
eluting with 2% methanol in dichloromethane. Porphyrin 3-9 (R= C9H19) was
characterized by 1H NMR, (see Figure 3-2) the spectrum had two doublets corresponding
to the ortho and meta protons at 8.11 and 7.52, and a multiplet at ~ 2.97 ppm
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corresponding to the para methylene group. The 13C NMR of this symmetric porphyrin
had a total of 16 carbon signals (Figure 3-3) while its MS (MALDI) showed as expected
the corresponding molecular ion peak at 1335.4.

3-9

(R= H) also gave a similar 1H NMR

spectrum to 3-9 (C9H19) with slightly shifted resonances and MS (MALDI) with a
molecular ion peak at 831. 75.
The chemical oxidation was then effected by adding 6 equivalents of NaNO2 to a
concentrated solution of 3-9 (R=H, C9H19) (45 mg) in TFA (3 mL) under air and at room
temperature. When 3-9 (R=H) was oxidized, the major purple product isolated in 77%
yield, was bilverdins 3-18, along with 6% recovered starting material and trace amounts
of polynitrated products. Because of the core-deformation from planarity in dodecasubstituted porphyrins (3-9), as can be seen in the X-ray crystal structure in Figure 3-4,
these compounds generally have lower oxidation potentials compared with their related
octa- and tetra-substituted porphyrins.28 The green color of the acidic reaction mixture
immediately changed to brown. After 10 minutes the reaction was quenched with water
and neutralized with aqueous sodium bicarbonate solution. When this procedure was
performed under an inert atmosphere of argon, only starting material porphyrin was
recovered, indicating that air oxygen is essential, and is probably added to one of the
porphyrin meso-positions. In addition, when the reaction was performed using
dichloromethane as a solvent and a catalytic amount of TFA, or in the absence of TFA,
only starting material (3-9) was recovered. When a radical scavenger (2,6-ditertbutyl-4methylphenol) was added to the reaction mixture the ring opening reaction was
completely inhibited.
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Figure 3-4: The Side view X-Ray Crystal structure 3-9 (R= H) showing the porphyrins
core deformity from planarity (with chloroform atom)
These results suggest that the porphyrin macrocycle is initially oxidized to the
corresponding π-cation radical by NO+ and, upon reaction with air/ oxygen, ring-opening
occurs so as to relieve steric strain. Figure 3-5, shows the postulated ring opening
mechanism. The reaction of TFA and NaNO2 affords the nitrosonium ion (NO+)27b
according to equation 3-1, which oxidizes the porphyrin ring to the π-cation radical.

CF3COOH + NaNO2

HNO2 + NaOCOCF3

H+
HNO2

HO-NO

H2O + NO+

Eq 3-1

Nucleophilic addition of the dioxygen molecule at the meso-position of the
corresponding porphyrin π-cation radical affords 3-20, which is then reduced by the
nitrosoion to give porphyrin (3-21), that then forms the four membered dioxetane23d ring
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(3-22) which is sterically hindered and thus readily opens up to the bilverdin derivative.
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Figure 3-5: Postulated Ring-Opening Mechanism of Dodecasubstituted Porphyrin

Two distinct tetrapyrroles of (3-18) that were purple and pink in color, were
isolated after work-up and purification by column chromatography. The purple band was
less polar than the pink band and purification was effected using a gradient of neat
dichloromethane and

gradually increasing

the polarity

to

2%

methanol

in

dichloromethane. Both tetrapyrroles show broad absorption bands in the UV-Vis, which
indicates significant conformational flexibility, because in solution, bilverdins exist in
several conformations.28 Mizutani and co-workers also isolated the purple and pink
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fractions upon chemical oxidation of iron(III) tetraarylporphyrins and reported that the
so-called “pink” biliverdin could be photoisomerized to the “purple” biliverdin while the
reverse isomerization could not proceed.29
The 300 MHz 1H NMR spectra showed the asymmetry of both tetrapyrroles, i.e.,
for the purple, three N-H signals and one O-H signal appearing at 11.5, 11.2, 9.0 and 6.0
ppm, respectively. These disappeared from the “purple” biliverdin upon performing a
deuterium oxide shake. The presence of a doublet at around ~ 7.7 ppm due to the ortho
protons on the benzoyl group is distinguishable from the complex resonances between
7.8 and 7.3 ppm due to the aromatic protons. The

13

C NMR spectrum of the purple

biliverdin also showed a benzoyl carbonyl peak at 187 ppm, the lactam carbonyl at 174
ppm, and a quaternary carbon at 75 ppm. A series of peaks between 144-120 ppm
representing the sp2 carbons and another set between 26 -18 ppm equivalent to the sp3
carbons were also observed. The tetrapyrrole that was pink in color on the other hand had
a 1H NMR spectrum with three N-H peaks appearing at 12.5 and 9.46 and one shifted
upfield at around 3.7 ppm, a singlet corresponding to the hydroxyl group appeared at 4.1
ppm. Deuterium oxide shake resulted to the disappearance of the three N-H protons and
the hydroxyl singlet peaks. The

13

C NMR spectrum for the “pink” linear tetrapyrrole

differed only slightly from the “purple” linear tetrapyrrole with almost similar carbonyl
absorptions appearing at 187.03 and 172.41 ppm and had a quaternary carbon peak at
77.7 ppm. Characteristic benzoylbiliverdin fragments were observed in high resolution
ESI for both chromophores; these had M+Na ion peaks at m/z 903.4249 and 903.4224 for
the pink and purple tetrapyrroles, respectively. Oxidations were also carried out using
anhydrous methanol, ethanol, and methylamine to quench the reactions, and while
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methylamine gave no addition product at all, the methanol and ethanol adducts were
formed in almost negligible amounts as inferred from the appearance of near-baseline m/z
913 and 927 peaks. Both steric and electronic factors may be invoked to account for the
above observations. Unfortunately, the amounts of the above products obtained were not
enough for any further analyses to be performed.
Chemical oxidation of 3-9 (R=C9H19), resulted in the isolation of mainly
bilatrienone 3-19 in 70% yield and biladienone 3-18 in 10% yield. The biladienone (3-18)
isolated was also purple in color and had similar 1 H NMR spectrum as the one with R= H
(Figure 3-6). However, the resonances of 2NH peaks were almost overlapping and
appeared at 11.6 and 11.4 ppm respectively, while the third NH peak appeared distinctly
at 8.9 ppm. Two distinct doublets corresponding to the ortho protons on the benzoyl
group appeared at 7.58 and 7.42 ppm. The 13C NMR spectrum also biladienone 3-18 had
similar resonances as its counterpart with the quaternary carbon appearing at ~ 74 ppm.
Bilatrienone 3-19 was also characterized by 1H NMR. However assignment of the peaks
corresponding to 3-19 on the proton spectrum was more challenging. 4 small broad peaks
at 12.8, 12.5, 11.9 and 10.8 ppm were tentatively assigned to correspond to the NH peaks.
This was confirmed by deuterium oxide shake that resulted to the complete disappearance
of all these peaks. The aromatic region had a series of complex resonances with one
distinct doublet at 8.22 ppm. From the 1H NMR, it seemed that the bilatrienone existed as
two conformers and from the integration of the NH peaks, both conformers existed in a
1:1 ratio. The 13C spectrum of 3-19 also looked almost similar to biladienone 3-18, with
overlapping four carbonyl resonances, which was a further confirmation of the existence
of two conformers.
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Figure 3-6: 1H NMR of Biladienone 3-18 (R= C9H19) in CD2Cl2 at 300 MHz

However, this spectrum evidently lacked the typical quaternary carbon resonance peak
observed in the other pigments. This compound was also characterized by MS (MALDI),
giving a molecular ion peak at 1368.21.
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3-3:

Conformation Studies of Biliverdins
Biliverdins usually have the helical all-syn conformation due to an efficient

intrachromophoric hydrogen bond system based on the N-H....N-H bonding network.
Studies carried out on biliverdin derivatives have shown that the ε(vis)/ε(UV) ratio is a
function of the verdin molecular extension. An increase in ratio indicates a change in the
porphyrin-like helically coiled form (5Z, 10Z, 15Z) to a more extended form, (e.g., 5Z,
10E, 15Z or 5E, 10Z, 15Z), where the ratio is similar to that of polyenes.30, 31 The first
detailed study of the geometry of free bile pigments stemmed from studies done by
Moscowitz et al. who postulated a cyclohelical porphyrin like structure in solution for
urobilins.31b
Free biliverdins adopt the ZZZ helicoidal conformation with an ε(vis)/ε(UV) ratio of
0.25 in agreement with molecular orbital calculations.32,33,34 Helicoidal (ZZZ)–biliverdins
could be photoisomerized to their extended EZZ or EZE conformers but the later
reconverted back to their helical forms.35 In our study, the ε(vis)/ε(UV) of the purple and
pink biliverdin conformers was 0.47 and 0.64, respectively, indicating a more stretched
conformation for the pink conformer than the purple one. In addition to this, the
biliverdin derivatives produced from the chemical oxidation of 3-9 (R=C9H19) were
bilatrienone 3-19 and biladienone 3-18 with hardly any traces of its pink conformer. This
could be a result of the bulky alkyl substituent on the phenyl ring which will inhibit the
EZ isomerization of the C4-C5 bond; similar results were reported by Mizutani et al. for
etiobiliverdin; These authors ascribed the energy difference between the ZZZ and EZZ
isomer to the steric repulsion between the β-alkyl groups and the pyrrole ring.18
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It might be possible that the sole product of the chemical oxidation of porphyrin
3-9 (R= C9H19) is bilatrienone 3-19 along with some traces of starting material. However
upon work up and chromatographic purification, biladienone 3-18 is obtained by addition
of a water molecule across the methine carbon bridge affording 3-18. This could be
further argued by the fact that upon subjecting 3-18 to higher temperatures, e.g., 40 °C,
compound 3-19 was isolated. This was confirmed by thin layer chromatography and UVvis and 1H NMR spectroscopies. No cotton effect signal was observed when circular
dichroism (CD) studies were done on 3-19. This compound could be CD inactive as a
result of the existence of both the M and P helical conformers as a racemic mixture in
equal ratio in the solution. Circular dichroism studies done on formally achiral bilidiones
of the biliverdin type derivatives36 indicate that there is a uniform population of two
enantiomeric conformers 3-23 and 3-24 (Scheme 3-7), which differ in their sign of
rotation and are in equilibrium with each other. Several authors have reported that the
equilibrium (helical chirality’s) of biliverdin type derivatives can be shifted by
dissolution of the compound in chiral solvents,37 or by adsorption to the chiral
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biopolymer serum albumin38 and chiral amino acid esters and amines39 so as to observe
the cotton effects.
A final confirmation of the molecular structure of the benzoylbiliverdin 3-18 (R=
H), and bilatrienone 3-19 was provided by X-ray crystallography (Figure 3-7 and 3-8).
An examination of the ORTEP drawing for the X-ray structure of the title biliverdins 318 (obtained by slow diffusion of hexane into a solution of chloroform) shows the
compound to be a biladienone, with the third meso-carbon (C15) being quaternary and
bearing a hydroxyl group. The existence of the –OH group is thus unequivocally
established and corroborates the structural conclusions reached using

13

C NMR data,

which showed the presence of a quaternary meso- carbon at δ 75 ppm. Within a single
crystal, two molecules of the biliverdin associate with each other to form
intermolecularly hydrogen-bonded pairs. Triads of hydrogen bonds exist about an
inversion center, with the participating groups being the lactam unit on one molecule and
the benzoyl carbonyl, the pyrrole –NH, and most importantly, the meso-OH on the other.
The meso-OH•••O (1) bond, though slightly extended, lies at a nearly perfect hydrogenbonding angle of ~179.2°, thus allowing for moderately strong hydrogen bonds; the
remaining hydrogen bonds lie within 20% of the optimum angle of 180°. Stabilization
offered by the intermolecular association may be the raison d’etre for the hydroxyl group
and may explain the readiness of the initially formed bilatrienone 3-19 to add a molecule
of water across its double bonds to give the above biliverdin 3-18. The same, along with
steric factors, may also explain why oxidations done in methanol, ethanol, or
methylamine media almost completely failed to give the corresponding addition products
or gave only in negligible quantities.
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Figure 3-7: X-Ray Crystal Structure of Biladienone 3-18 (R=H)

One consequence of the hydrogen bonding is that it predisposes the C (4)=C (5)
double bond into an E- configuration, making the (EZ)- biladienone conformation the
most stable one for this biliverdin. This, however, does not discount the possibility of
various other conformations that may arise out of bond-rotation about the above double
bond.
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Figure 3-8: X-Ray Crystal Structure of Bilatrienone 3-19 (R=C9H19)

Theoretical calculations done by Dr. Brahma Ghosh, formerly of Smith research
group, (B3LYP/6-31G∗) do in fact predict the existence of various stereoisomers of the
title biliverdin, which differ in energies by 6-10 Kcal/mol at room temperature, and may
explain why the novel benzoylbiliverdin is obtained as different colored forms, the violet
and the pink. In fact, similar isomeric biladienones were obtained by Mizutani et al,
although from β-unsubstituted porphyrin (TPP), and under oxidation different oxidation
conditions than the one reported in this Chapter.
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3-4:

Syntheses of Metallo-biliverdin Derivatives
R

R

O
O

1. TFA, NaNO2

NH N
R

R

2. M(OAc)2

N HN

N
R
N

R
R= H

3-9

Scheme 3-8

N
R

M
N

R
R= H
M = Ni(II), Cu(II), Zn(II)
3-25

The metallo-biliverdins 3-25 (Scheme 3-8) were prepared by treating the linear
tetrapyrroles 3-18 with the appropriate metal salts. Both nickel(II) and copper(II) were
inserted at reflux in toluene, using the corresponding acetates and in the presence of
pyridine. On the other hand, zinc(II) was inserted using chloroform as the solvent and a
saturated solution of the zinc(II) acetate in methanol. During the metallation of 3-18 and
3-19 with Cu(II) and Ni(II)acetate, a compound that was deep blue in color and had a
strong absorption at λmax 650 nm was isolated, if Ni(II) is complexed, it is metallated.
The 1H NMR spectra show one broad singlet N-H peak at 8.95 ppm, a multiplex of peaks
was also observed at the aromatic region, showing the asymmetry of the molecule. This
feature suggested the coordination of the nickel atoms to three nitrogens and one oxygen
atom. This is in agreement with that of a nickel and copper complex reported by J. Callot
et al.40
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Figure 3-9: X-Ray crystal structure of Ni(II)-Biliverdin 3-25

The results of this compound were also confirmed using low-resolution mass
spectrometry, which gave a molecular ion peak at 936.3. However crystal growth of this
compound was also greatly hampered due to the fact that this compound was rapidly
changing to the metallated benzoylbiliverdin (3-25, M= Ni (II)) over a short period of
time.
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The Zn(II) and Ni(II)-biliverdins had similar 1H NMR spectra, showing two
distinct sets of doublets, downshifted at 8.04 - 7.72 ppm, corresponding to the ortho
aromatic protons of the benzoyl group. The remaining aromatic protons appeared upfield,
clustered between 7.64 and 7.21 ppm. A sharp singlet corresponding to two CH2 protons
of the cyclohexenyl ring adjacent to the benzoyl group, appeared downfield around 2.4
ppm and the remaining CH2 cyclohexenyl protons appeared as a complex set of peaks
between 2.2 and 1.1 ppm that were very challenging to assign as a result of the
asymmetric nature of the compound.
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Figure 3-11: X-Ray Crystal Structure of Ni(II)-benzobiliverdin 3-26

The

13

C NMR spectra of metallo-biliverdin 3-25 (M= Ni(II) showed, as expected, two

carbonyl resonances at 189.3 and 181.8 ppm, aromatic carbons between 162.5 and 128.3
ppm, and the remaining carbons appeared between 31.2 and 22.6 ppm. 3-25 (M= Ni(II))
was also characterized using X-ray crystallography as is shown in Figure 3-9. The
aromatization to Ni(II)-benzoylbiliverdin 3-26 was effected by reflux of Ni(II)-biliverdin
3-25 in toluene with eight equivalents of DDQ for fifteen minutes (Scheme 3-9).
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The reaction was followed to completion by TLC and UV-Vis. UV-Vis of the
reaction mixture showed a broad Q band at ~ 890 nm compared to the starting material
The reaction mixture was purified by passing through an alumina plug and preparative
thin layer chromatography eluting with 3:1 dichloromethane/ petroleum ether isolating
mainly the partially aromatized 3-26 which was characterized by X-ray crystallography
as shown in Figure 3-11. 3-26 was also characterized by MS (MALDI) giving a
molecular ion peak at 904.82. MS (MALDI) spectrum of the reaction mixture before
purification had a peak of lower intensity corresponding to the fully aromatized
Ni(II)benzobiliverdin 3-27 at 902. 34.
The 1H NMR spectrum of 3-26 had similar signals at the aromatic region as 3-25,
the most distinct difference was the several doublet peaks that appeared between 6.5-5.0
ppm corresponding to the benzylic-protons. Attempts to optimize the yields of the fully
aromatized derivative 3-27 were hampered because increasing the reaction time resulted
in a lower yield and increase in decomposition products that were correlated to the baseline spot on the TLC plate. Several reaction parameters were changed like refluxing the
precursor Ni(II)-biliverdin 3-25 at higher temperature without the DDQ, this reaction was
followed by TLC and even after refluxing for 12 hours at 150 °C in toluene, there was no
evidence of the formation of any new products. It was therefore concluded that during
oxidation, 3-26 was not as stable to DDQ as anticipated succumbing to decomposition
therefore lowering the yields of the oxidation material. 3-26 was obtained in very low
yields of 25%. Oxidation experiments of 3-25 with mild oxidizing agents like pchloroanilin, were not investigated.
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3-5:

Conclusion and Future work

A novel versatile synthetic methodology was developed for the synthesis of stable
benzoylbiliverdin derivatives in relatively high yields. Previous methodologies reported
utilize harsh conditions and long routes that require several purification procedures and
report low to moderate yields of the desired compound. With this route, biliverdins with
sensitive substituents can be isolated and a variety of diamagnetic metals and lanthanides
have the potential of being inserted into the biliverdin core resulting in a significant
change in the photophysical and chemical properties of the biliverdin derivatives.
Biliverdins have been reported to possess antioxidant and antiviral activity. Therefore
developing a route to the synthesis of these stable complexes will allow the exploration of
the potential properties of this unique bile pigments. Electrochemical (redox activity) of
the metallo-benzoyl biliverdin derivatives were evaluated by Dr. Karl Kadish, in order to
understand their potential physiological roles.40b
3-6:

Experimental

All experiments were performed under inert argon atmosphere using a Schlenk line.
Melting points were measured with an Electrothermal melting point apparatus. The 1HNMR spectra were obtained using either a Bruker ARX-300 or a DPX-250 for the 300
MHz and the 250 MHz, respectively. Reactions were all monitored using silica gel TLC
plates from Sorbent Technologies (200 µm). Chemical shifts (δ) are given in parts per
million relative to tetramethylsilane (TMS, 0 ppm); multiplicities are indicated as br
(broad), s (singlet), d (doublet), t (triplet), q (quartet) and m (multiplet). Analytical TLC
was performed on Scientific Adsorbent Company Inc. silica gel plate and alumina gel
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plate. Flash column chromatography was performed using silica gel (Scientific Adsorbent
Company Inc. 40-63 µM particle size, 60 Å pore size).
Electronic absorption spectra were measured using a Perkin-Elmer Lambda 35 UV-vis
spectrophotometer. Mass Spectra were obtained at LSU Mass Spectometry Facility.
All solvents were purchased from Fisher. DCM was dried by distilling over CaH2 and
THF was dried by distilling first over LiAlH4 then distilling over sodium and
benzophenone. The low resolution MS experiments reported as FAB (Fast Atom
Bombardment) were measured with Finnigan MAT 900, and the High Resolution MS
(HRMS) experiments were measured using an Applied Biosystems Q Star XL
electrospray (ESI) MS. Elemental analysis experiments were performed by Midwest
Microlab, LLC.
Synthesis of 1-(4-Bromophenyl)-1-nonanol (3-13)
1-Octylbromide (50 mmol, 10.8 g) in diethyl ether (50 mL) under argon was treated with
magnesium turnings at room temperature and stirred for 30 min to give the corresponding
octyl-magnesium bromide. This reaction mixture was then cooled down to 0 °C and
bromobenzaldehyde (40 mmol, 6.75 g) was added to the solution slowly before being
stirred for 1 h. The reaction mixture was then quenched and washed with water and dried
over anhydrous Na2SO4; the organic solvents were then reduced under vacuum and the
yellow oil obtained was taken up in hexane and purified by silica gel chromatography,
using 3:1 hexane and ethyl acetate solution as the eluant. 1-(4-Bromophenyl)-1-nonanol
(3-13) was obtained in 97% yield (14.6 g). 1H NMR 300 MHz (CDCl3,), 7.45 (d, 2H, oAr), 7.20 (d, 2H, p-Ar), 4.61 (s, broad, 1H), 1.98 (s, 1H, OH) 1.9-1.2 (m, 14H), 0.85 (t,
3H): MS (FAB) m/z 299.17(M+)
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Synthesis of 4-Bromophenyl nonane (3-14)
3-13, (50 mmol, 14.9 g) was dissolved in 150 mL acetonitrile, trimethylsilylchloride (300
mmol, 27 mL) and sodium iodide (300 mmol, 45 g) were added to the corresponding
solution and stirred under argon for 12 h at room temperature. The reaction mixture was
then washed with an aqueous solution of Na2S2O3, dried over anhydrous Na2SO4 and
solvent was reduced under pressure to afford an orange oil. This orange oil was then
diluted with DMSO (150 mL) and NaBH4 (75 mmol, 2.85 g) was added slowly. The
resultant solution was stirred under argon for 12 h. The yellow solution was then
extracted into hexane and purified by silica gel chromatography using hexane as the
eluent. The first band collected was 4-bromophenylnonane (10.7 g, 76.3%). 1H NMR 300
MHz (CDCl3,), 7.42 (d, 2H, o-Ar), 7.08 (d, 2H, m-Ar), 2.60 (t, 2H,) 1.58-1.29 (m, 14H),
0.91 (t, 3H): MS (FAB) m/z 282.16 (M+)
Synthesis of 4-nonanylbenzaldehyde (3-15)
3-14, (15 mmol, 4.25 g) was dissolved in freshly distilled THF and the reaction mixture
was cooled down to –78 °C. n-BuLi (46 mmol, 26.5 mL) was then added drop wise and
the mixture was stirred at –78 °C for 1 h. DMF (46 mmol, 3.0 mL) was then added to the
mixture drop wise and stirred under argon for 1 h. The ice bath was removed and the
reaction mixture was allowed to warm up to room temperature. The reaction mixture was
then quenched with 1M HCl (100 mL), extracted into hexanes (3 × 100 mL), washed
with water and finally dried over anhydrous Na2SO4. The solvent was evaporated off to
afford a yellow oil which was once again purified by silica gel chromatography using a
3:1 mixture of hexane and ethyl acetate as the eluant to give 4-nonanylbenzaldehyde as
an oil (2.3 g, 65% yield). 1H NMR 300 MHz (CDCl3,), 10.0 (sharp s, 1H, aldehyde) 7.82
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(d, 2H, o-Ar), 7.36 (d, 2H, p-Ar), 2.74 (m, 2H) 1.69-1.29 (m, 14H), 0.93 (t, 3H): MS
(FAB) m/z 233.26 (M+)
5,10,15,20-Tetraphenyl-2:3,7:8,12:13,17:18-tetra-butanoporphyrin (3-9) R= (H,
C9H19)
Freshly distilled dry dichloromethane (214 mL) was added to a round bottom flask fitted
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.25 g, 2.14 mmol) and 4nonanyl-benzaldehyde (0.5 g, 2.14 mmol) were added and the solution was stirred at
room temperature under a slow steady stream of argon for 15 min. The flask was then
shielded from ambient light and BF3•OEt2 (0.04 mL, 0.214 mmol) was added. This
mixture was then stirred for 1 h at room temperature. DDQ (0.7 g, 3.21 mmol) was added
to the reaction flask and the final solution turned dark pink instantly. This solution was
refluxed under argon for 1 h to give a dark green solution. The solvent was reduced to
dryness under vacuum and the resulting residue was dissolved in dichloromethane and
filtered on an alumina plug so as to get rid of the excess unreacted DDQ and then purified
by alumina column chromatography using 2% methanol in dichloromethane for elution.
Recrystallization from hot methanol afforded purple crystals of the title porphyrin (0.5 g,
70% yield). R= C9H19, 1H NMR 300 MHz (CDCl3), 8.11-8.08, (d, 8H, J= 7.7 Hz, o-Ar)
7.52-7.49 (d, 8H, J= 7.8 Hz, m-Ar) 2.97-2.92, (t, 8H, each, CH2) 2.33-1.29 (m, 40H,
CH2), 0.94-0.92 (t, 12H, CH3): UV-Vis (CH2Cl2) λmax 446 nm (ε 66,084), 542 nm (5052),
615 nm (3720), 679 nm (5698) : MS (MALDI) m/z 1335.30 (M+): Anal. Calcd. for
C96H126N4: C 84.03, H 9.56, N 4.09. Found: C 84.23, H 9.35, N 4.24: 13C NMR, 300 MHz
(CDCl3) δ 144. 1, 140.7, 136.2, 129.1, 118.5, 37.4, 33.5, 33.1, 31.29, 31.24, 30.97, 30.64,
27.3, 25.1, 24.2, 15.7
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R= H, 1H NMR 300 MHz (CDCl3, drop of d-TFA), 8.42 (s, 8H, o-Ar) 7.91 (s, 12H, pand m-Ar) 2.52, 2.04, 1.79, 1.71 (broad s, 8H each, CH2) -0.51 (s, 4H, NH): UV-Vis
(CH2Cl2) λmax 441 nm (ε 145,600), 672 (9300): UV-Vis (dication, CH2Cl2) λmax 459 nm
(214,200), 612 nm (13,000), 670 nm (25,000): MS (MALDI) m/z 831.75 (M+).
Benzoylbiliverdins (3-18):
Porphyrin 3-9, R= H (100 mg, 0.12 mmol) was dissolved in TFA (3.0 mL) and NaNO2
(33 mg, 0.48 mmol) was added to the solution while stirring under air at room temperature
for 3 min. The reaction mixture was quenched by pouring into water (50 mL), followed
by extraction with dichloromethane (6 x 25 mL). The organic layers were washed twice
with saturated aqueous NaHCO3 (2 x 100 mL), once with water (100 mL), and dried over
anhydrous Na2SO4. The solvent was removed under vacuum and the residue was purified
by alumina column chromatography using a gradient elution, starting with pure
dichloromethane. The polynitrated porphyrins and unreacted starting material were eluted
first. A few drops of triethylamine were added and the polarity of the eluting solvent was
increased to up 2% methanol in dichloromethane. The major violet band was then eluted
and obtained in 60% yield (62 mg) after evaporation of the solvent. This compound was
closely followed by a pink band, giving a 20% yield (20 mg). For the violet band: mp
194-196 °C. UV-Vis (CH2Cl2) λmax 341 nm (ε 19,200), 574 (41,100): 1H NMR 300 MHz
(CD2Cl2), 11.62, 11.27 (2 broad s, NH, 2H), 9.00 (singlet, NH, 1H), 7.62-7.57 (d, o-ArH,
2H), 7.51-7.35 (Ar-H, 18H), 6.01 (s, OH, 1H), 3.7 (m, CH2, 2H) 2.49-1.2 (m, CH2, 30H):
HRMS for M+Na ion peaks at m/z 903.4224. Anal. calcd for C60H56N4O3: C 74.51, H 6.85,
N 5.78. Found: C 73.93, H 6.93, N 6.03: 13C NMR (CDCl3) δ 187.1, 174.5, 144.6, 143.3,
141.8, 139.8, 138.7, 137.7, 135.2, 133.0, 132.7, 132.3, 131.5, 130.4, 130.0, 129.8, 129.7,
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129.5, 128.9, 122.7, 120.5, 75.8, 55.0, 26.7, 26.2, 25.4, 24.7, 24.4, 24.3, 24.2, 23.6, 22.8,
22.3. For the pink band: mp 170-173 °C: UV-Vis (CH2Cl2) λmax 341 nm (ε 21,700), 508
(13,800). 1H NMR 300 MHz (CD2Cl2), 12.57, 9.46 (2 broad s, NH, 2H), 7.56-7.18 (Ar-H,
20H), 4.13 (s, OH, 1H), 3.7 (broad s, NH, 1H) 2.41-1.32 (m, CH2, 32H): HRMS for M+Na:
found m/z 903.4249. Anal. calcd for C60H56N4O3: C 74.51, H 6.85, N 5.78. Found: C 73.71,
H 6.36, N 6.33: 13C NMR (CDCl3) δ 187.0, 172.4, 145.3, 144.6, 143.9, 141.6, 140.9, 139.2,
139.0, 137.9, 135.3, 132.9, 132.6, 132.3, 131.4, 130.6, 130.4, 130.1, 130.07, 130.00, 129.8,
129.5, 129.4, 129.3, 128.7, 128.1, 127.1, 122.7, 117.6, 77.7, 33.1, 32.5, 26.4, 25.4, 25.2, 24.9,
24.7, 24.6, 24.5, 24.2, 24.0, 23.5, 22.8, 22.2, 15.6
From porphyrin 3-9, R= C9H19, (100 mg, 0.074 mmol) was dissolved in TFA (2. 0 mL) and
NaNO2 (30 mg, 0.45 mmol) was added and a similar experimental procedure to that
reported above was followed. The solvent was removed under vacuum and the resulting
residue was taken up in chloroform and purified using a gradient elution of chloroform
and 1% methanol/chloroform, on an alumina column. The first green band eluted with
pure chloroform (71 mg, 70%) yield was compound 3-19. The violet band 3-18, R=
C9H19 (11 mg, 10%) was eluted next with 1% methanol/chloroform solution. Trace
amounts of the starting material were eluted last from the column. For 3-19: Mp 245-247
°C: UV-Vis (CH2Cl2) λmax 332 nm (ε 30,600), 447 (31,600), 683 (7800): MS (MALDITOF) m/z 1368.3 (M+): 1H NMR 300 MHz (CDCl3) ppm, 12.8, 12.5, 11.9, 10.8 (broad s,
4NH) 8.22-6.75 (m, Ar-H, 16H), 2,76-1.33 (m, CH2, 64H), 0.94 (m, CH3, 12H): Anal. calcd
for C96H126N4: C 80.05, H 9.38, N 3.89. Found: C 80.07, H 9.07, N 3.83. For 3-18, R=
C9H19, Mp 185-190 °C: UV-Vis (CH2Cl2) λmax 345 nm (ε 47,000), 576 (22,700): MS
(Maldi-TOF) m/z 1386.4 (M+): 1H NMR 300 MHz (CDCl3), 11.61, 11.42 (2 broad s, NH,
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2H), 8.86 (singlet, NH, 1H), 7.56 (d, o-Ar, J= 8.0 Hz, 2H), 7.40 (d, m-Ar, J= 8.0Hz, 2H), 7.37.1 (m, Ar-H, 14H), 6.10 (s, OH, 1H), 2.7-0.8 (m, CH3, 64H), 0.1 (t, CH3, 12H): Anal. calcd
for C96H128N4: C 83.19, H 9.31, N 4.04. Found: C 82.98, H 9.24, N 4.12. 13C NMR (CDCl3)
δ 172.2, 163.5, 146.6, 145.3, 144.3, 143.5, 143.2, 139.6, 138.8, 137.7, 136.6, 135.6, 135.1,
134.2, 133.5, 131.1, 129.8, 128.9, 128.5, 128.3, 127.2, 125.3, 120.6, 119.4, 74.1, 36.1, 35.8,
35.7, 32.1, 31.8, 31.6, 29.8, 29.7, 29.6, 29.5, 29.1, 24.9, 24.1, 23.4, 23.0, 22.9
Synthesis of Ni(II)-biliverdin 3-25
3-18 (81 mg, 0.09 mmol) was dissolved in toluene (20 mL) and an excess of nickel(II)
acetate (24 mg, 0.1 mmol) was added to the solution with stirring. The final mixture was
refluxed for 24 h. The reaction mixture was cooled down to room temperature and the
solvent was removed under vacuum. Purification was performed on an alumina plug to
remove excess metal acetate, followed by column chromatography on alumina using
dichloromethane/petroleum ether 3:1 for elution. The product was collected and recrystallized from dichloromethane/methanol to give the Ni(II)-biliverdin in quantitative
yield (84 mg). Mp 245-247 °C: UV-Vis (CH2Cl2) λmax 318 nm (ε 28,900), 439 (23,500),
802 (9800): MS (ESI) m/z 918.9 (M+):

13

C NMR (CDCl3) 189.3, 181.8, 162.5, 159.1,

149.8, 149.3, 146.4, 145.1, 142.9, 141.9, 140.3, 140.0, 139.5, 138.3, 134.6, 134.5, 133.2,
132.5, 132.3, 131.4, 130.2, 130.0, 129.9, 129.8, 129.6, 129.5, 129.2, 128.3, 31.2, 27.5,
27.3, 27.0, 26.5, 26.1, 25.9, 25.8, 24.8, 24.7, 24.5, 24.3, 24.2, 22.6, 15.6; 1H NMR
(CDCl3, + 1 drop of d-TFA) 8.04-7.21(m, ArH, 20H), 2.39-1.10 (m, CH2, 32H). HRMS for
C60H52N4O2Ni+Na: calculated 941.3341, found 941.3353: Anal. Calcd. for C60H52N4O2Ni: C
72.70, H 6.11, N 5.66. Found: C 73.19, H 6.14, N 5.15.

114

Synthesis of Cu(II)-biliverdin (3-25)
The metal free benzoylbiliverdin prepared as described above (100 mg, 0.12 mmol) was
dissolved in 20 mL of toluene and copper(II) acetate (239 mg, 1.2 mMol) was added to
the solution with stirring. The final mixture was refluxed for 8 h, cooled down to room
temperature and the solvent was then removed under vacuum. Purification on an alumina
plug served to remove excess metal acetate, and this was followed by column
chromatography on alumina using dichloromethane/petroleum ether 3:1 for elution. The
main band was collected and re-crystallized from dichloromethane/methanol to give the
title biliverdin (80mg, 75% yield). M.p. 262-265 °C: UV-Vis (CH2Cl2) λmax 326 nm (ε
28,200), 420 (24,200), 481 (28,400), 806 (10,400): MS (ESI) m/z 924.63 (M+): HRMS for
C60H52N4O2Cu+Na: calculated 946.3284, found 946.3284: Anal. Calcd. for C60H52N4O2Cu:
C 73.67, H 5.98, N 5.73. Found: C 73.86, H 5.81, N 5.28
Zn(II)-benzoylbiliverdin (3-25)
The metal free benzoylbiliverdin prepared as described above (100 mg, 0.12 mMol) was
dissolved in 20 mL of CHCl3 and 5 mL of saturated solution of zinc(II) acetate in
methanol was added to the solution with stirring. The final mixture was refluxed for 8 h,
cooled down to room temperature and the solvent was then removed under vacuum. The
residue was redissolved in dichloromethane (20mL) and this solution was washed once
with saturated aqueous NaHCO3 (100 mL), once with water (100 mL) and then dried
over anhydrous NaSO4. Recrystallization from dichloromethane/methanol gave the title
biliverdin (66mg, 60% yield). Mp 174-177 °C. UV-Vis (CH2Cl2) λmax 329 nm (ε 21,900),
446 (17,200), 752 (6300): HRMS for C60H52N4O2 Zn: calculated 925.3460, found
925.3473:

1

H NMR (CDCl3) 7.90-7.25 (m, ArH, 20H), 2.40-1.30 (m, CH2, 32H).
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3-7:
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Chapter 4: Syntheses of Symmetric
Tetrabenzoporphyrin Derivatives
4-1:

and

Asymmetric

Water-Soluble

Introduction
As porphyrins continue to be one of the most extensively investigated class of

substances known, research on tetrabenzoporphyrins (TBPs) has progressed relatively
slowly despite an ongoing interest in the synthesis and properties of these and other
extended porphyrin macrocycles.1 As pointed out by Bonnett, the chemistry of TBPs has
been relatively neglected due to their synthesis being difficult.2 TBPs form a class of
stable compounds with attractive properties as models for naturally occurring tetrapyrrole
derivatives. They are macrocyles that contain four fused aromatic subunits at the β-pyrrolic
positions2c and appear to be very promising because they display notable stability and
unique chemical, physical and spectroscopic properties. The extension of their πconjugated systems results in better-defined spectral features with absorption bands
significantly shifted to the infrared region compared to the parent porphyrins.3
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Figure 4-1: Generic structures of TBP, Ar4TBP and Phthalocyanine
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The importance and the development of synthetic methodologies to TBP systems
(4-1) was inspired from its resemblance to phthalocyanine (4-2) as is shown Figure 4-1.
Phthalocyanines (4-2) are among the most studied classes of organic pigments having a
myriad of industrial applications that results in the production of hundreds of successful
patent applications yearly.4 They find applications as dyes and inks, catalysts, electrical
conductors and optical materials.5 Alongside the porphyrins, they also have suitable
properties to act as photosensitizers in photodynamic therapy (PDT) of cancer.6 The
importance of phthalocyanines has also led to the synthesis of other conjugated
macrocycles including napthalocyanines,7 hybrid structures such as tetraazaporphyrins8
and other macrocyles with an intermediary number of bridging nitrogen atoms.9 TBPs
absorb in the near IR; red shifted porphyrinoid chromophores have been the subject of
extensive studies over the last few years. This is due in part to their potential utility as
photosensitizers in PDT where, absorbance in the near IR region is preferred because
light penetration into tissue is considerably deeper. Tissues have endogenous
chromophores such as haemoglobin, myoglobin and cytochromes that are present in high
concentration and absorb light in the wavelength ranges 380-400 nm and 500-560 nm, as
do several porphyrin derivatives.10, 11Apart from applications in PDT, TBPs also posses
several other applications as opto-electronic materials, nonlinear optical materials, optical
limiters, luminescent markers for oxygen, near-IR biomolecule labeling dyes and pH
sensors in biomedical imaging.12
4-2:

Background on the Synthesis of Benzoporphyrin Derivatives
TBPs fall under a classical group of compounds known as benzoporphyrins that

were first discovered in trace amounts in various oil shales and petroleum. Other
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porphyrin derivatives that fall in this class are monobenzoporphyrins 4-3, 4-4 and e
dibenzoporphyrin 4-5 and 4-6, as shown in Figure 4-213
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Figure 4-2: Examples of benzoporphyrin derivatives

The syntheses of TBPs were first described by Helberger and coworkers from ocyanoacetophenone and various phthalimidines.14 Two main approaches were utilized in
the development of the synthetic methodology of benzoporphyrin derivatives. The first
approach was based on the fact that tetrabenzoporphyrins resemble phthalocyanine
derivatives and therefore mimicked the high temperature condensation using
phthalimidine derivatives in the presence of a metal template.15 The second approach was
adapted from the general porphyrin synthesis of condensation of pyrroles with mesocarbon donors. The pyrroles are replaced by isoindoles16 or its derivatives that are very
unstable and not easily synthesized.17 Since then, several improvements on the synthesis
of benzoporphyrin derivatives have been reported.
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Linstead et al18 was the first group to improve on Helberger’s synthesis of TBPs.
They investigated these tetrapyrrolic pigments and initially isolated impure TBP 4-11
from the reaction of o-cyanocinnamic acid 4-8 with zinc salts at high temperatures
(Scheme 4-1). They subsequently reported a higher yielding route to 4-11 by using a
zinc(II) acetate template19 of 3-carboxymethylphthalimidine (4-7) at elevated
temperatures (Scheme 4-1). Vogler and Kunkely20 also isolated 4-11 by the template
reaction of 2-acetylbenzoic acid (4-9) with zinc(II) acetate in the presence of aqueous
ammonia and molecular sieves at 400 °C. Condensation of phthalimide (4-10) or its
potassium salt with sodium acetate or malonic acid in the presence of zinc(II) acetate at
360 °C also afforded 4-11.21 The intial synthesis of TBPs by heating at 350-400 °C in the
presence of metal salts such as iron, zinc, magnesium, cadmium, or metallic acetates
afforded the corresponding metallo-TBPs usually very impure and requiring extensive
purification process. However, Voglers and Kunkleys synthesis affords the corresponding
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derivatives in a more pure form and in 17% yield; the free-base was isolated by
demetalation under acidic conditions. 22
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Metalated TBP derivatives have been also synthesized by pyrolysis of unstable
isoindoles in the presence of metals or metal salts, under an inert atmosphere, or by
refluxing in a high boiling solvent (1,2,4-trichlorobenzene or 1-chloronapthalene)
affording the symmetrical benzoporphyrins in low yields.23 Remy reported the synthesis
of 4-11 by a variation of the Rothemund methodology (Scheme 4-2) using isoindole 4-15
and formaldehyde in the presence of a metal or metal salt.1 High temperature conditions
are required for this condensation generally affording 4-11 in 53% yield and it was noted
that the absence of the metal salt, resulted in very low yields of 4-11. The corresponding
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condensation of 4-15 with benzaldehyde in the presence of a metal salt or 3benzylidenephthalimidine in the presence of zinc(II) acetate at high temperature afforded
a mixture of partially meso-substituted metallo- TBPs; the major product being the metal
complex of the tetraphenyltetrabenzoporphyrin.24 Vicente et al2b developed milder and
more modern synthetic methods to prepare 4-11. They prepared pyrrole 4-12 and 4-13
using Barton Zard conditions25, which upon reduction of the ester with lithium aluminum
hydride, followed by cyclotetramerization in acetic acid and oxidation with DDQ, gave
the phenylsulfonyl-substituted porphyrin 4-14 (mixtures of isomers) in 60% yield. Base
promoted elimination of the phenylsulfinate units, followed by dehydrogenation with
DDQ in refluxing toluene, gave 4-11 in 53% overall yield (Scheme 4-2). Ono et al26 were
able to circumvent the instability of the isoindole by using a masked isoindole. 4,7dihydro-4,7-ethano-2H-isoindole ester (4-16) was reduced with lithium aluminum
hydride to the carbinol followed by acid catalysed cyclotetramerization and oxidation
with DDQ, affording porphyrin 4-17 in 30% yield. Tetrabenzoporphyrin 4-11 was then
obtained quantitatively in very pure form by heating 4-17 at 200 °C, which resulted in the
extrusion of 4 equivalents of ethylene, possibly via a retro-Diels-Alder process. Other
synthetic routes to benzoporphyrins are the condensation of benzodipyrromethene
hydrobromides,27 and from Diels-Alder type reaction involving β-vinyl porphyrins and
activated dienophiles.28 Unsubstituted TBP (4-11) is notoriously insoluble as compared with
porphyrins, in part because of their extended, planar π-conjugated systems and their
pronounced tendency for π- π stacking. The evaluation of the physicochemical properties
of these29 compounds over the years has been slow, tardy and hampered as a result of the
extremely low solubility properties of benzoporphyrins (4-11). Nevertheless, tetraaryl-
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substituted tetrabenzoporphyrins, Ar4TBPs (4-1, R= Ar) show enhanced solubility properties.
The increased solubility of Ar4TBPs relative to TBPs is probably a result of their
considerably non planar structure, due to the steric crowding induced by the four meso-aryl
substituents.30 In this Chapter, the total synthesis of symmetric water-soluble metallotetraaryl tetrabenzoporphyrins (M-Ar4TBP) will be discussed in addition to some
preliminary photophysical evaluation.
4-3:

Results and Discussion
The ability to simply change the central metal ion allows for variation in the

overall optical properties and also provides some fine-tuning capabilities of porphyrin
derivatives. Generally, metalloporphyrins contain two kinds of metals; the regular or
irregular metals. Regular metals have only a small effect on the optical absorption and
emission spectra, while the reverse occurs for the irregular metals.31 In this Chapter, the
synthesis of several TBP derivatives with different diamagnetic metals in the inner core
will be discussed. The effects of the central metal ion on the optical absorption and
emission properties will be discussed in addition to the effect of changing the watersolubilizing groups at the periphery of the TBPs.
5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18butanoporphyrin, 4-18 (M= 2H) was synthesized by condensation of butano-pyrrole and
4-methyl formylbenzoate following Lindsey’s reaction conditions.32 The butanopyrrole
synthesis is described in Chapter 3 (3-16). The synthesis and purification of 4-18 (M=
2H) is similar to the one utilized in the synthesis of porphyrin 3-9 and is also described in
detail in Chapter 3.
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This compound was obtained in 60% yield and characterized by both 1H NMR and MS
(MALDI). The 1H NMR for 4-18 (M= 2H) has a multiplet peak corresponding to the
ortho and meta protons between 8.56-8.5 ppm. A singlet peak corresponding to the
methyl on the ester group appeared at 4.14 ppm, while several multiplet peaks
corresponding to the methylene protons appeared upfield in the spectrum (Figure 4-3). As
expected, a molecular ion peak was observed in the MS (MALDI) spectrum at 1064.3.
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Subsequent aromatization to the corresponding TBP derivative requires the conversion of
the free-base porphyrin into a metal complex. Literature reports that aromatization of the
free-base porphyrin to the TBP derivatives results to either no reaction or decomposition
of the macrocycle.2b This is because on adding DDQ, the free-base dodecasubstituted
porphyrins that are generally non-planar and thus possess high affinity for protons, form
dications that are inert to oxidation.33 Another plausible reason is explained in literature
using the Single Electron Transfer (SET)34 theory that is proposed to be the main
pathway taken during oxidation. SET normally occurs during oxidation affording the
corresponding π-cation radical. However, unlike metallo-porphyrins, the π-cation
radicals of free-base porphyrins are highly transient species. This is because in the latter,
the electron spin density is concentrated either at the meso-position or in the imine
nitrogens, but because the meso-position is sterically hindered by the phenyl groups, the
electron spin density is concentrated at the imine nitrogens resulting in easy protonation
of these groups.35
Porphyrin 4-18 (M= Cu(II)) was prepared by treating a solution of 4-18 (M=2H)
with a ten equivalent excess of Cu(OAc)2.2H2O, a few drops of triethylamine and
refluxing in toluene. The reaction was monitored by UV-Vis until completion of the
metal insertion. The choice of metal was dependant upon the ease of demetallation upon
aromatization to the corresponding TBP 4-19 (M= 2H). Zinc metal can also be used for
the aromatization, however, the zinc(II) complex is very acid labile and can be
demetallated very easily in slightly acid media affording a mixture of metal-free and
metallated complex that require tedious purification measures.24a The copper(II) complex
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could only be fully characterized by MS (MALDI) due to its paramagnetic nature.

Figure 4-3: 1H NMR of 4-18 (M= 2H) in CDCl3 at 300 MHz
Porphyrin 4-18 (M= Cu(II)) was isolated quantitatively, and its MS (MALDI)
shows a molecular ion peak at 1123.9. Treatment of 4-18 (M= Cu(II)) with excess DDQ
under reflux in toluene afforded the corresponding TBP complex 4-19 (M= Cu(II)) in
80% yield. This complex was demetallated by stirring at room temperature for five
minutes in concentrated sulfuric acid, and the free-base 4-19 (M= 2H) was isolated in
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85% yield. The reaction was followed to completion by UV-Vis untill a red-shifted Soret
band appeared at ~ 500 nm. Despite the harsh conditions required for demetallation, there
were only slight traces of hydrolysis of the ester side groups. The mixture was poured
into ice water followed by extraction into chloroform quenched. The chloroform was
concentrated to dryness under vacuo, and the residue redissolved in chloroform and
filtered through an alumina plug to get rid of the very polar partially hydrolysed methyl
ester derivatives. TBP 4-19 (M= 2H) was obtained in 85% yield and was characterized by
MS (MALDI) giving the corresponding molecular ion peak at 1047.5, while the 1H NMR
had signals corresponding to the ortho and meta-protons as doublets at 8.65 and 8.5 ppm,
a broad signal of clustered peaks at 7.3 ppm corresponding to the 16 benzylic protons and
the methyl ester peak at 4.17 ppm.
Several diamagnetic metals were then inserted into the inner core of 4-19 (M=
2H). In the past decade, there has been enormous progress in the synthesis of
metalloporphyrins resulting to an almost complete “Porphyrin Periodic Table”.36a The
porphrin complexes reported contain nearly every metal and semimetal in the Periodic
Table. The series of diamagnetic metals investigated were as follows; Al(III), Ga(III),
In(III), Mg(II), Zn(II), Pd(II), Ni(II) and Sn(IV). The main reason of studying these metal
complexes with several oxidation states was to investigate the effect of the nature of the
metal and associated axial ligand(s) on the optical absorption and emission spectra as
well as the aggregation (solubility of the TBPs). The procedures that were adopted to
insert these metal ions were patterned after procedures for metal insertions on several
phthalocyanine and tetraphenylporphyrin derivatives.36 However, some of these
procedures were not successful in our study.
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Insertion of Al(III) into the inner core of 4-19 (M=2H) was attempted by
refluxing a mixture of Al(III)Cl3 and 4-19 (M=2H) in pyridine, while following the
reaction by UV-Vis. However, even after refluxing the solution for several hours, the
UV-Vis spectrum had absorbances of the protonated form of 4-19, despite using pyridine
as the solvent media. A different route utilizing an aluminum salt that was less Lewis
acidic and had previously been successful on metallation of phthalocyanine was
attempted.37 Al(Me)3 in toluene was added to 4-19 (M=2H) dissolved in toluene and
refluxed under argon and the reaction followed to completion by UV-Vis. However,
insertion of this metal was not successful even after refluxing the reaction mixture for
several days. An alternative route that involved the metallation of the precusor nonaromatized free-base porphyrin (4-18, M= 2H) was not successful either. Insertion of
Ga(III) into 4-19 (M=2H) was not as successful as anticipated. The salt that was used was
Ga(III)Cl3, which is a very hygroscopic salt, that fumes on exposure to air and is also
very Lewis acidic. This procedure was carried out by refluxing a solution of Ga(III)Cl3
and 4-19 (M=2H) in dimethylformadide38 with a few drops of triethylamine and followed
by UV-Vis. The reaction was let to go for 12 hours, but never went to completion
because the UV-Vis spectrum had a sharp Q-band at ~ 660 nm that is typical of TBP
systems, but there was still some absorbance peaks at 490 nm that corresponded to the
starting material. Nevertheless, the reaction was stopped and purified on a short alumina
column. The first band eluted with pure chloroform corresponded to the non-metallated
species and the polar Ga(III)-TBP complex was eluted by a more polar 2% methanol in
chloroform solution. However the yield isolated for this compound was only 20%. This
compound was characterized by 1H NMR in d-chloroform.
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Figure 4-4: 1H NMR of 4-19 (M= Zn(II)) in DMSO at 300 MHz

The spectrum had two multiplet peaks at 8.62 and 8.42, respectively, corresponding to
the ortho and meta protons on the phenyl groups, while the benzylic protons also
appeared as two sets of multiplets at 7.36 and 7.14 ppm and the methyl ester groups
appeared at 4.2 ppm.
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Metallation of 4-19 (M= 2H) by reflux with In(III)Cl3 patterning the previous
procedure were not successful, however 4-18 (M= 2H) was easily metallated
quantitatively with In(III)Cl3 by refluxing in pyridine for 1 hour. The reaction was
followed by UV-Vis to completion and was purified by evaporating off the pyridine in
vacuo, redissolving the porphyrin in chloroform and washing it with water (3 × 100 mL)
to get rid of the excess salt. The solution was then dried over sodium sulfate, evaporated
to dryness and filtered through an alumina plug. The compound was characterized by MS
(MALDI) with a molecular ion peak at 1177.99 and 1H NMR, a multiplet ~ 8.53-8.23
corresponding to the ortho and meta protons, while the methyl group on the ester
appeared at 4.15 ppm and the signals corresponding to the methylene protons appearing
between 2.9 and 1.3 ppm. UV-Vis had a Soret band at ~ 443 nm and a Q band at ~ 574
nm. The metallated In(III)-TCHP complex was then aromatized to the TBP complex
using the aromatization procedure as described above. This reaction was followed by
UV-Vis for the strong q-band at ~ 650 nm that is typical of TBPs and afforded the
In(III)TBP-complex in 75% yield. The In(III)-TBP complex was also characterized by 1H
NMR, giving a similar spectrum to its non-aromatized precursor, the only difference was
that there was a new set of multiplet peaks corresponding to the benzylic protons between
7.4 and 7.2 ppm, and the complete disappearance of the methylene signals.
Insertion of the diamagnetic metals Sn(IV), Zn(II), Ni(II), Mg(II) and Pd(II) was
relatively simple and fast by refluxing the corresponding metal salts with 4-19 (M=2H) in
DMF.39 However, metallation with Sn(IV) using Sn(II)Cl2 required longer reflux hours,
but the reaction was complete within 6 h.
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Figure 4-5: 13C NMR of 4-19 (M= Zn(II)) in CDCl3 at 300 MHz

TBP 4-19 (M=2H) was metallated with magnesium methoxide (Mg(OMe)2) salt, the
insertion was complete in less than one hour, while acetate salts of Ni(II), Pd(II) and
Zn(II) were used for their respective metallations. It is important to note that metallation
of 4-19 (M=2H) using Pd(II)Cl2 was not successful even after refluxing for several hours,
only trace amount of the desired product were isolated. However, metallation with
Pd(OAc)2 afforded the Pd(II)-TBP complex in quantitative yield. The complexes were
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characterized by MS (MALDI), 1H NMR, 13C NMR and UV-Vis giving almost identical
proton spectra with the signals slightly shifted. Figure 4-4 shows the 1H NMR of Zn(II)TBP complex. They were also characterized by UV-Vis affording typical TBP spectra
with two bands, the Soret band between 440-460 nm and one sharp Q-band between 640660 nm.40 The Q-band of the Pd(II)-TBP and Ni(II)-TBP complexes gave the highest
extinction coefficient.
Metallation reactions are normally affected by the basicity of the corresponding
porphyrin.33 Metal affinity increases with decreasing basicity. These studies were
confirmed by comparing the ease of demetallation of Zn(II)-TBP and Zn(II)-tetraaryltetrabenzoporphyrin.24a It was easier to demetallate the latter with TFA in chloroform,
compared to Zn(II)-TBP. Non-aromatized precursors that are very basic are harder to
metallate than their corresponding aromatized derivatives. Nevertheless, metallation is
also affected by other factors such as the size of the metal ion and the solvent used. It is
well known that the size of a metal ion is affected by its oxidation state and periodic table
trend.41 This explains why among the group III metals, it was easier to metallate 4-18
(M=2H) with indium(III) than aluminum(III) and gallium(III) salts. The UV-Vis of the
metallo-TBP synthesized complexes is shown in Figure 4-6. The effect of changing the
diamagnetic metal on the UV-Vis spectrum was not as significant as expected. As a result
of the square planar coordination adopted by the Ni(II) and Pd(II)-TBP complexes, these
compounds have very high planar symmetries and are not highly distorted out of
planarity because of a lack of axial ligands resulting to blue shifts observed in their
respective spectrum. The rest of the TBP complexes have the ability of coordination to
one or two axial ligands resulting to some distortion of the TBP-complexes out of the
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plane, having the metal ion not lieing within the porphyrin core.41c The metallo-TBP
complexes with hydrolysed methyl ester groups (4-20) were synthesized by adding a
saturated solution of NaOH in methanol to a solution of the metallo-TBP complexes in
THF and heating at 40 °C for 6 hours.41b
Zn(II)TBP
Ni(II)TBP
Pd(II)TBP
2H-TBP
Sn(IV)TBP
In(III)TBP
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Absorbance
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0.0
400

500

600

700

Wavelength/nm

Figure 4-6: Absorbance Spectrum of Metallo-TBP Complexes (4-19) at 50 µM in
CHCl3
The reaction mixture was cooled down to room temperature, and the resultant
carboxylic acid metallo-TBP complexes precipitated out of solution upon dropping the
pH to ~ 5 by dropwise addition of 1M HCl. The corresponding precipitates of the
metallo-TBP derivatives 4-20 were isolated quantitatively as dark greenish powders. The
precipitates were washed several times with water to get rid of the excess NaOH salt and
with dichloromethane to get rid of unreacted organic impurities. The precipitates were
dried in vacuo and characterized using MS (MALDI) and 1H NMR. 4-20 (M= 2H, Ni(II),
Pd(II), Zn(II), Sn(IV), In(III)), gave molecular ion peaks at 991.37, 1047.02, 1095.49,
1051.77, 1109.97, 1104.71 corresponding to each metallo-TBP carboxylic acid
derivative. The Mg(II)-TBP complex was hydrolysed using the same procedure, however
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on dropping down the pH of the reaction solution to 5 using 1M HCl, the magnesium
metal came out. This complex was very acid labile and using a more dilute solution of
HCl did not hamper the demetallation process.

Figure 4-4: Emission Spectra of TBP Complexes at 50 µM in DMSO

The water-soluble metallo-TBP optical characteristics were studied in DMSO and
PBS solution. Figure 4-4 shows the emission spectra of Sn(IV)-, Zn(II)- and In(III)-TBP
4-20, respectively. The studies were done using 50 µM solutions in DMSO while exciting
at 645 nm. Sn(IV)-, Zn(II)- and In(III)- TBPs had the highest fluorescent quantum yields
of 7, 1 and 0.5%, respectively, the rest of the complexes Pd(II), Ni(II) and the free base
porphyrin fluoresce very weakly giving quantum yields of < 1%. Comparing the
absorption spectra and the emission spectra of the metallo-TBP derivatives, it is evident
that there is no significant effect when changing the metal ion in the optical absorption
spectra but substantial change in optical emission properties. Several other authors have
also reported these optical properties on different metallo-porphyrin derivatives.42
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Water-soluble TBP derivatives with a different solubilizing group ie phosphonic
acid groups, were synthesized according to Scheme 4-4. TBP 4-21 (M= Cu(II)), was
obtained from the synthesis described in Chapter 2 involving a palladium(0) crosscoupling reaction of 2-18 (M= Cu(II)) with diethylphosphite and was isolated as one of
the side products in 25% yield. However, this compound can also be synthesized by
condensation of diethylphosphite benzaldehyde and butanopyrrole patterning the same
procedure mentioned earlier used to synthesize 4-18 (M= 2H) in 45% yield. TBP 4-21
(M=Cu(II)) was characterized by MS (MALDI) giving a molecular ion peak at 1421.87
and was demetallated using H2SO4 as described above, affording 4-21(M= 2H) with a
molecular ion peak at 1360. 42. The 1H NMR of 4-21 (M= 2H) had two sets of multiplets
corresponding to the ortho and meta protons at 8.21-8.07 ppm, and benzylic protons also
appearing as a multiplet at 6.95-6.83 ppm. The CH2 protons on the phosphonate ester
group appeared as a quartet at 4.23 ppm while the CH3 protons appeared as a triplet at
1.48 ppm. TBP 4-21 (M= Sn(IV)) was synthesized in quantitative yield by refluxing 4-21
(M= 2H) with SnCl2 in DMF for six hours. The metallation reactions were monitored by
UV-Vis. The reaction was stopped and cooled to room temperature, followed by
evaporation of the DMF solution. TBP 4-21 (M= Sn(IV)) was then redissolved in
chloroform and purified on an alumina column eluting with 7:3 chloroform and acetone
solution due to its polarity. The compound was also characterized by MS (MALDI)
1479.3 and 1H NMR. The hydrolysis to the phosphonic acid groups (4-22) was done by
dissolving TBPs 4-21 in minimum amount of dichloromethane and adding an excess of
trimethylsilylbromide (TMSBr). The resulting reaction mixtures were stirred for 24 hours
under argon at room temperature. The TMSBr and dichloromethane were then evaporated
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off, and the compound redissolved in basic aqueous methanol and stirred at room
temperature for another 6 h. TBP 4-22 was also obtained quantitatively and characterized
by MS (MALDI) X. The photophysical properties of 4-22 (M= 2H, Sn(IV)) were studied
by Dr. Irina Nestorov; the UV-Vis obtained were typical of TBP-complexes, no
fluorescence was observed with TBP 4-22 (M= 2H) however, the Sn(IV) complexes
flouresced at 717 nm when excited from both the Soret and the Q-bands with a stokes
shift of 46 nm.
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The water-soluble nido-carboranyl-TBP 4-25 was synthesized in 43% overall
yield from condensation of butanopyrrole43 and carboranylbenzaldehyde,44 as shown in
Scheme 4-5. Porphyrin 4-23 was obtained in 60% yield under Lindsey condensation
conditions and metallated with Cu(II) quantitatively, using copper(II) chloride in
refluxing toluene. Cu(II) acetate was not used because lower yields of the
metalloporphyrin were isolated as a result of partial deboronation of the carborane cages
to the corresponding nido-carborane derivatives.
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Oxidation of the porphyrin Cu(II) followed by demetallation afforded closo-carboranylTBP 4-24 in 75% overall yield. The water-soluble TBP 4-25 was obtained in 95% yield
by deboronation of the closo-carborane cages of 4-24, using tert-butylammonium
fluoride in THF,45 followed by cation exchange on a Dowex 50WX2-100 resin in the
sodium salt.43 In the presence of pyridine/piperidine43 the deboronation reaction was
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incomplete, even after 48 h at room temperature. TBP 4-25 was highly soluble in polar
organic solvents, such as acetone, methanol and DMSO, and sparingly soluble in water.
Porphyrins 4-23, 4-24 and 4-25 were characterized by MS (MALDI), UV-Vis and 1H
NMR. An X-ray crystal structure of the Cu(II) complex of 4-24 was obtained by growing
the crystals by slow diffusion from chloroform into methanol. TBPs 4-24 and 4-25
display absorption spectra characteristic of TBP’s, with red-shifted bands compared with
porphyrin 4-23.

Figure 4-7: X-ray Crystal Structure of Cu(II)-carboranyl TBP

The 1H NMR spectra of TBPs 4-24 in acetone show two distinctive doublets for
the ortho- and meta-phenyl protons around 8 ppm, broad signals for the benzo protons
around 7 ppm, a singlet for the CH-carborane protons appeared at 4.33 pm, and broad
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signals for the BH between 2.6 ppm and 1.5 ppm for the BH proton and NH protons
appearing at -1.04 ppm. The water-soluble TBP 4-25 had a similar 1H NMR spectrum as
TBP 4-24 with the aromatic and benzylic protons appearing at the same resonances. The
only difference is that there was an up field shift for the singlet corresponding to the 4
CH protons which now appeared at 2.69 ppm. In addition, the four protons on the openface of the carborane cages of TBP 4-25 appear as a broad singlet at –2 ppm. The MS
obtained for porphyrins 4-23, 4-24 and 4-25 gave molecular ion peaks with MS (MALDI)
at 1401.15, 1385.03 and 1433.61, respectively. TBP 4-25 also fluoresced weakly at 630
nm when excited at 511 nm.
4-4:

Conclusion

An expeditious route to the synthesis of several water-soluble TBP derivatives was
developed. Several water-solubilizing groups were attached to the TBPs periphery and
several diamagnetic metal ions in the TBPs core. So far, the photophysical evaluations do
not reveal any significant change in the absorption spectrum with the Soret bands and Qbands clustering at around 440-460 nm and 640-660 nm, respectively. However, there
was a significant change in the emission spectra evident with the high fluorescence
quantum yields exhibited by Sn(IV)-TBP. The preliminary biological evaluations done of
the intracellular uptake and phototoxicity show that TBP 4-22 (M= 2H) and TBP 4-20
(M= 2H) are taken up more compared to the TBP 4-22 (M= Sn(IV)) and TBP 4-20 (M=
Pd(II)). This is probably because the free-base TBPs aggregate and are taken in more into
the cells via endocytosis. The phototoxicity evaluations also correlate to the cellular
uptake results with TBP 4-22 (M= 2H) being most toxic when exposed to dose light (1J/
cm2). The corresponding TBP complexes with carboxylic and phosphonic acid groups
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localized in the vesicles and also exhibited low dark toxicity at concentrations as high as
100 µM. TBP 4-25 fluoresced weakly, and localized in the cell lysosome and had very
low dark toxicity with no significant cell death even at concentration as low as 300 µM.46
Animal toxicity studies reveal that there were no clinical, biochemical, or
histopathological effects observed which could be attributed to administration of
compounds 4-25. The maximum tolerated dose was only limited by the solubility of the
extract, and was thereby determined to be 160 mg/kg at an administered concentration of
4 mg/ml.47
4-5:

Experimental
Commercially available starting materials were purchased from Sigma-Aldrich

and used without further purification. All solvents were purchased from Fisher Scientific
(HPLC grade) and either directly used or dried and distilled according to literature
procedures. Silica gel 60 (70-230 mesh, Merck) and alumina grade III (70-230 mesh
ASTM) were used for column chromatography. Analytical thin-layer chromatography
(TLC) was performed on Merck 60 F254 silica gel (precoated sheets, 0.2 mm thick). 1HNMR spectra were obtained using a Bruker DPX 250 MHz or 300 MHz spectrometer;
chemical shifts are expressed in ppm relative to TMS (0 ppm). Electronic absorption
spectra were measured on a Perkin Elmer Lambda 35 UV-Vis spectrophotometer and
fluorescence spectra on a Perkin Elmer LS55 instrument. Low resolution MS analyses
were conducted at the LSU Mass Spectrometry Facility on a Bruker Prolix III MALDITOF mass spectrometer, and the HRMS were conducted at the Ohio State University
Mass Spectrometry and Proteomics Facility. Melting points were measured on an
Electrothermal MEL-TEMP instrument.
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5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-butanoporphyrin
(4-18 (M= 2H))
Freshly distilled dry dichloromethane (300 mL) was added to a round bottom flask fitted
with a reflux condenser, under argon. 3:4-Butanopyrrole (0.35 g, 3 mmol) and 4-methyl
formylbenzoate (0.49 g, 3 mmol) were added and the solution was stirred at room
temperature under a slow steady stream of argon for 15 min. The flask was then shielded
from ambient light and BF3•(OEt)2 (0.04 mL, 0.214 mmol) was added. This mixture was
then stirred for 1 h at room temperature. DDQ (1.02 g, 4.5 mMol) was added to the
reaction flask and the final solution turned dark pink instantly. This solution was refluxed
under argon for 1 h to give a dark green solution. The solvent was reduced to dryness
under vacuum and the resulting residue was dissolved in dichloromethane and filtered on
an alumina plug so as to get rid of the excess DDQ and then purified by alumina column
chromatography using 2% methanol in dichloromethane for elution. Recrystallization
from hot methanol afforded purple crystals of the title porphyrin (0.46 g, 60% yield). 1H
NMR 300 MHz (CDCl3), 8.58-8.5, (m, 16H, o and m-ArH) 4.12 (s, 12H), 2.15-2.0 (m,
16H, CH2), 1.25-1.15 (m, 16H): UV-Vis (CH2Cl2) λmax nm Log ε 473 (5.4), 618 (4.2),
676 (4.37): Maldi (MS) 1064. 35
Synthesis of Cu(II)-5,10,15,20-tetra(methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18butanoporphyrin (4-18, M= Cu(II))
An excess of Cu(OAc)2.2H2O was added to a solution of porphyrin (200 mg, 0.18 mmol)
dissolved in 20 mL of toluene with a few drops of triethylamine. The mixture was
refluxed for 6 hours and the conversion monitored by UV-Vis spectroscopy in
chloroform for the complete upon dissappearance of the Soret band at ~ 440 nm. The
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mixture was passed through a quick alumina plug and eluting with chloroform to get rid
of excess salt. The solvent was evaporated to dryness and the residue recrystallized out of
chloroform and methanol affording 0.18 g of pure reddish crystals of 4-18 (M= Cu(II)) in
98% yield. Maldi (MS) 1123.91 : UV-Vis (CH2Cl2) λmax nm (Log ε) 429 (5.25), 562
(4.25), 597 (4.1)
Cu(II)-5,10,15,20-tetra(methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18benzoporphyrin (4-19, M= 2H)
(100 mg, 0.08 mmol) of 4-18 (M= Cu(II)) was dissolved in 50 mL of toluene. An eightfold excess of DDQ was added and the mixture was refluxed for 15 minutes. During
refluxing the color changed from a red-brown color to deep green. The mixture was
allowed to cool, diluted with chloroform and filtered through an alumina plug eluting
with chloroform. The solvent was removed in a vacuum and the remaining solid
recrystallized from chloroform and methanol to affording a blue-greenish crystals 78 mg,
in 80% yield. Maldi (MS) 1107.32.91 : UV-Vis (CH2Cl2) λmax nm (Log ε) 445 (5.23), 602
(4.19), 650 (4.86)
(60 mg, 0.05 mmol) of 4-19 (M= Cu(II)) was dissolved in 10 mL of H2SO4 and the
mixture stirred at room temperature for 5 minutes. The UV-Vis of the spectrum had the
Soret band of the dication at ~ 502 nm and demetallation was considered complete upon
dissappearance of the Soret band of Cu complex. The mixture was poured into ice water
and extracted into basic chloroform. The solvent was evaporated in vacuo and the
resultant residue passed through an alumina plug eluting with chloroform and
recrystallized out of chloroform and methanol affording 48 mg of 4-19 (M= 2H) in 85%
yield as a green powder. 1H NMR 300 MHz (CDCl3), 8.63, (m, 16H, ArH) 7.2 (br, s,
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16H) 4.68 (s, 12H), -1.05 (s, 2H, NH): UV-Vis (CDCl3) λmax nm (Log ε) 467 (5.48), 595
(4.32), 644 (4.65), 701 (4.26): Maldi (MS) 1047.56: 13C NMR (300 MHz): 167.8, 146.6,
135.3, 131.2, 130.7, 126.8, 126.8, 124.7, 115.5, 53.1
20 mg, 0.019 mmol of 4-19 (M= 2H) in THF and 2 mL of a saturated NaOH solution in
methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH
lowered to ~ 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of
the solution and was washed with water (3 × 100 mL) and dichloromethane 100 mL. 18
mg of the carboxylic acid derivative was obtained in 95% yield. MS (Maldi) 991.37
Zn(II)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18benzoporphyrin (4-20, M= Zn(II))
50 mg (0.04 mmol) of 4-19 (M= 2H), 2 mL of a Zn(OAc)2 saturated solution in methanol
and 10 mL of dimethylformadide were refluxed under argon for 30 minutes. The
conversion was monitored by UV-Vis to completion. The solution was cooled to room
temperature and the DMF evaporated off to dyrness and the residue redissolved in
chloroform and filtered through an alumina plug eluting with chloroform that had a few
drops of triethylamine. The product was recrystallized out of chloroform and methanol
affording 40 mg of 4-19 (M= Zn(II)) in a 80% yield. 1H-NMR 300 MHz (CDCl3), 8.568.49, (m, 16H, o and m-ArH) 7.33-7.30 (m, 8H) 7.07-7.04 (m, 8H) 4.68 (s, 12H): UV-Vis
(DMSO) λmax nm (Log ε) 472 (5.9), 614 (3.99), 658 (4.09): Maldi (MS) 1112. 25 :

13

C

NMR, 300 MHz ; 165.21, 158.78, 158.51, 158.24, 149.12, 144.32, 140.12, 137.51,
13215, 128.74, 43.31.
The corresponding methly ester groups were hydrolysed to carboxylic acid groups by
dissolving 20 mg, 0.02 mmol of 4-19 (M= Zn(II)) in THF and adding 2 mL of a saturated
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NaOH solution in methanol and heating the corresponding mixture at 40 °C for 6 hours.
The reaction was let to cool and the pH lowered to 5 by adding dropwise 1 M HCl
solution. A green precipitate crushed out of the solution and was washed with water (3 ×
100 mL) and dichloromethane 100 mL. 20 mg of the carboxylic acid derivative was
obtained in 94% yield. MS (Maldi) 1056.9
Sn(IV)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18benzoporphyrin (4-20, M= Sn(IV))
50 mg (0.04 mmol) of 4-19 (M= 2H), 2 mL of a Sn(Cl)2 saturated solution in methanol
and 10 mL of dimethylformadide were refluxed under argon for 6 h. The conversion was
monitored by UV-Vis to completion. Similar purification procedure mentioned above
was followed. However, during filtration through an alumina plug, 2% methanol in
chloroform was used instead, affording 45 mg of the desired compound in a 85% yield.
1

H-NMR 300 MHz (CDCl3), 8.70-8.52, (m, 16H, o and m-ArH) 7.53-7.15 (m, 16H) 4.21

(s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 463 nm (4.84), 662 nm (4.2): Maldi (MS)
1165. 3 : 13C NMR, 300 MHz ; 165.21, 158.78, 158.51, 158.24, 149.12, 144.32, 140.12,
137.51, 13215, 128.74, 43.31.
20 mg, 0.017 mmol of 4-19 (M= Sn(IV)) in THF and 2 mL of a saturated NaOH solution
in methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH
lowered to 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of
the solution and was washed with water (3 × 100 mL) and dichloromethane 100 mL. 17
mg of the carboxylic acid derivative was obtained in 90% yield. MS (Maldi) 1109.9
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Ni(II)-5,10,15,20-tetra(4-carboxylic-acid)phenyl-2:3,7:8,12:13,17:18-benzoporphyrin
(4-20, M= Ni(II))
A 2 mL saturated solution of Ni(OAc)2 and another of Pd(OAc)2 in methanol were added
to two flasks respectively each containing 50 mg (0.04 mmol) of 4-19 (M= 2H)
dissolved in 10 mL of dimethylformadide ; the following solutions were refluxed under
argon for 1 h. The procedure mentioned previously was patterned. The desired Ni(II)TBP complex and Pd(II)-TBP complex were isolated in 85% and 80% yield respectively
affording 37 mg and 36 mg of the respective complexes.
Ni(II)-TBP
1

H-NMR 300 MHz (CDCl3), 8.40-8.08, (m, 16H, o and m-ArH) 7.07-6.91 (m, 16H) 4.05

(s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 450 nm (4.84), 648 nm (4.42): Maldi (MS)
1103. 92: 13C NMR, 300 MHz (CDCl3) 167.6, 145.7, 138.5, 158.24, 137.0, 134. 2, 131.1,
130.8, 125.7, 123.7, 115.3, 52.9.
Pd(II)-TBP
1

H-NMR 300 MHz (CDCl3), 8.56-8.37, (m, 16H, o and m-ArH) 7.21-7.08 (m, 16H) 4.16

(s, 12H): UV-Vis (DMSO) λmax Log ε 445 nm (4.32), 610 nm (4.06): Maldi (MS) 1152.
87:

13

C NMR, 300 MHz CDCl3; 167.2, 146.1, 138.1, 137.6, 134.1, 130.8, 130.4, 125.7,

123.8, 117.3, 53.6.
20 mg, 0.018 mmol of 4-19 (M= Ni(II)) and 20 mg, 0.017 mmol of (M= Pd(II)) in two
round bottomed flasks each in THF and with 2 mL of a saturated NaOH solution in
methanol were heated at 40 °C for 6 hours. The reaction was let to cool and the pH
lowered to 5 by adding dropwise 1 M HCl solution. A green precipitate crushed out of
each solution and was washed with water (3 × 100 mL) and dichloromethane 100 mL. 18
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mg of Ni(II)-derivative and 17 mg of Pd(II)-derivative of the carboxylic acid derivative
were obtained in 95% and 91%yield respectively. MS (Maldi) 1047.02 for the Ni(II)derivative and 1095.49 for the Pd(II) derivative.
5,10,15,20-Tetra[(4-methoxycarbonyl)phenyl-2:3,7:8,12:13,17:18-butanoporphyrin
4-18 (M= In(III))
80 mg, 0.075 mmol of 4-18 (M= 2H) was dissolved in 10 mL of pyridine, and a 3 mL
solution of saturated InCl3 in methanol added to the mixture. The mixture was refluxed
under argon for 1 hr while monitoring by UV-Vis to the complete metal insertion. The
reaction was then allowed to cool and pyridine evaporated off to dryness under vacuo.
The residue had a purple-greenish color was redissolved in chloroform and washed with
water (3 × 100 mL) so as to get rid of the excess salt. The solvent was dried over sodium
sulfate, redissolved in chloroform and filtered through an alumina plug isolating pure
In(III)-porphyrin complex in 90% yield, 79 mg. 1H NMR 300 MHz (CDCl3), 8.53-8.23,
(m, 16H, o and m-ArH) 4.15 (s, 12H) 2.93 (br s, 16H), 1.16-1.30 (m, 16H): UV-Vis
(CH2Cl2) λmax nm (Log ε) 443 (5.05), 574 (4.02): Maldi (MS) 1177.07:

13

C NMR, (250

MHz) CDCl3 168.9, 148.2, 148.0, 143.7, 136.1, 131.7, 130.6, 130.3, 119.7, 54.0, 33.1,
28.6, 24.9, 24.2
60mg, 0.05 mmol of 4-18 (M= In(III)) was dissolved in 5 mL of toluene and 92mg, 3.2
mmol of DDQ added to the resultant mixture. The same aromatization procedure
followed by work up was patterned affording 4-19 (M= In(III)) in 43 mg in a 75% yield
as deep green crystals. 1H NMR 300 MHz (CDCl3), 8.40-8.08, (m, 16H, o and m-ArH)
7.07-6.91 (m, 16H) 4.05 (s, 12H): UV-Vis (DMSO) λmax nm (Log ε) 462 (4.87), 642
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(4.07): Maldi (MS) 1162. 81:

13

C NMR, 250 MHz (CDCl3) 167.5, 147.3, 145.2, 143.6,

138.5, 134. 8, 131.5, 130.8, 129.4, 128.6, 127.3, 125.7, 125.3,117.0, 53.0
5,10,15,20-Tetra[4-(diethylphosphonate)phenyl-tetrabenzoporphyrin(4-21)
80 mg, 0.06 mmol of Tetrabenzoporphyrin 2-18 (M= Cu(II)) and 7 mg, 0.006 mmol of
Pd(PPh3)4 were placed in an oven dried Schlenk tube. The tube was capped with a rubber
septum and evacuated and backfilled with argon, this procedure was done three times. 60
mL of toluene was cannulated to the schlenk tube and the tube purged with argon for five
minutes. The resultant solution was then sonicated under argon until the compound had
solubilized. 5 mL of triethylamine and (0.19 mL, 0.2 mmol) of diethylphosphite were
then added and the resultant solution refluxed at 100 °C for 96 hours following by TLC
for the consumption of the starting material. After 96 hours, there was no significant
increase in the yield of the desired product and the reaction was stopped and quenched by
adding 100 mL of water to the reaction mixture. The resultant reaction mixture was
diluted with chloroform and washed (3 × 100 mL) with water so as to get rid of the
unreacted diethyl phosphite. The solution was then dried over sodium sulfate and
concentrated in vacuo. Purification was done on a silica gel column with eluting with a
gradient solution of 10% acetone in chloroform and gradually increasing the polarity to
30% acetone in chloroform. 4-21(M= Cu(II)) was obtained as green crystals 22 mg in
25% yield. MS (MALDI) m/z 1421.87 (M+): 1H NMR 300 MHz (CD3OH), 8.21-8.07,
(m, 16H, o and m-ArH) 6.95-6.83 (m, 16H) 4.30-4.22 (q, 16H), 1.48-1.35(t, 24H)
22 mg, (0.015 mMol) of 4-21 (M= Cu(II)) was dissolved in concentrated sulfuric acid
and stirred at room temperature for five minutes. The reaction was quenched following
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the demetallation procedure previously mentioned affording 20 mg of pure 4-21 (M= 2H)
quantitatively. MS (MALDI) m/z 1360.42 (M+)
4-21 (M= Sn(IV) was synthesized by refluxing 20 mg (0.014 mmol) of 4-21 (M= 2H) in
DMF and excess SnCl2 for six hours. The reaction was stopped and the reaction mixture
cooled down to room temperature before evaporating off the DMF. The reaction mixture
was then redissolved in chloroform and washed with 100 mL of water. The solvent was
then dried over sodium sulfate, evaporated and purified on an alumina column eluting
with 7:3 chloroform and acetone affording 18 mg of 4-21 (M= Sn(IV) in 86% yield. MS
(MALDI) m/z 1479.3 (M+): 1H NMR 300 MHz (CD3OH), 8.66-8.62, (m, 8H, o and mArH) 8.34-8.27 (m, 8H), 7.47-7.28 (m, 16H) 4.41-4.28 (q, 16H), 1.49-1.44 (t, 24H)
5,10,15,20-Tetra[4-(phosphonic acid)phenyl-tetrabenzoporphyrin (4-22) (M= 2H)
A solution of 4-21 (M= 2H) in dichloromethane (15 mg, 0.01 mmol) and TMSBr (0.5
mL, 3.7 mmol) was stirred at room temperature. After 24 hours, the solvent was removed
under reduced pressure and the residue dissolved in 5 mL of methanol and 1 mL of 0.1 M
NaOH solution and stirred at room temperature for half an hour. The pH of the solution
was dropped to ~ 5 by the dropwise addition of 1M HCl and a green precipitate crushed
out of solution. The precipitate was washed with water (3 × 100 mL) and 100 mL of
dichloromethane and dried under vacuum to afford 15 mg of desired compound in
quantitative yield.
5,10,15,20-Tetra[4-(o-carboranyl)phenyl]-2:3,7:8,12:13,17:18-butanoporphyrin
23)

(4-

3:4-Butanopyrrole (0.13 g, 1.06 mmol) and of 4-(o-carboranyl)benzaldehyde (0.26 g, 1.06
mmol) were dissolved in dried, freshly distilled dichloromethane and the solution was stirred
at room temperature under argon for 15 minutes. The reaction flask was shielded from
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ambient light and BF3•OEt2 (0.02 mL, 0.106 mmol) was added. This solution was stirred for
1 h at room temperature before DDQ (0.36 g, 1.59 mmol) was added and the final mixture
refluxed under argon for 1 h to give a dark green solution. After cooling down to room
temperature, the solvent was evaporated under vacuum and the resulting residue was purified
by alumina grade III column chromatography using dichloromethane for elution.
Recrystallization from methanol gave purple crystals of the title porphyrin (0.22 g, 60%
yield). m. p. > 300 °C; 1H NMR (CDCl3, drop of d-TFA, 300 MHz): δ 8.36 (d, 8H, J = 8.27
Hz, o-PhH), 8.03 (d, 8H, J = 8.27 Hz, m-PhH), 4.33 (s, 4H, carborane-CH), 3.5-1.3 (br, 40H,
BH), 2.36 - 1.15 (m, 32H, CH2), -0.47 (s, 4H, NH). UV-Vis (CH2Cl2): λmax nm (log ε) 466
(4.52), 617 (3.36), 674 (3.60) nm. HRMS (MALDI) m/z 1401.1681, calculated for
C68H94N4B40 1401.1582.
5,10,15,20-Tetra[4-(o-carboranyl)phenyl-tetrabenzoporphyrin (4-24)
To a solution of 4-23 (150 mg, 0.11 mmol) in toluene (20 mL) was added an excess of
copper(II) chloride (143 mg, 1.06 mmol). The mixture was refluxed until the reaction was
complete, for about 2 h, as evidenced by TLC and UV-Vis spectrophotometry. The solvent
was evaporated under vacuum, the residue dissolved in dichloromethane (150 mL) and
washed once with aqueous saturated NaHCO3 and once with water before being dried over
anhydrous Na2SO4. After removal of the solvent under vacuum the remaining residue was
purified by alumina grade III column chromatography using dichloromethane for elution.
The Cu(II)-porphyrin was recovered in quantitative yield upon precipitation using
dichloromethane/ethanol. To a solution of this Cu(II)-porphyrin (150 mg, 0.102 mmol) in
toluene (20 mL) was added excess DDQ (185 mg, 0.82 mmol) and the final mixture was
refluxed for 15 minutes. During reflux the color of the solution changed from red to deep
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green. The mixture was then allowed to cool down to room temperature, diluted with
chloroform (150 mL) and washed once with aqueous saturated NaHCO3 and once with
water. The solvent was removed under vacuum, and the remaining residue was purified
by alumina grade III column chromatography using chloroform for elution.
Recrystallization from methanol afforded Cu(II)-tetrabenzoporphyrin (110 mg) as dark
green crystals in 75% yield. Cu(II)-Tetrabenzoporphyrin (110 mg, 0.076 mmol) was
dissolved in concentrated sulfuric acid and stirred at room temperature for five minutes.
The solution was poured into a water/ice bath and extracted with chloroform (4 x 150
mL). The organic layers were collected, dried over anhydrous Na2SO4 and the solvent
evaporated under vacuum. The resulting residue was recrystallized from methanol to give
green crystals of the title compound (105 mg) in quantitative yield from Cu(II)tetrabenzoporphyrin. M. p. > 300 °C; 1H NMR (acetone-d6, 250 MHz): δ 8.34 (d, J = 8.35
Hz, 8H, o-PhH), 8.17 (d, J = 8.35 Hz , 8H, m-PhH), 7.49-6.93 (br m, 16H, benzoH), 5.55 (s,
4H, carborane-CH), 3.5-1.4 (br, 40H, BH), -1.04 (br s, 2H, NH). UV-Vis (CH2Cl2): λmax nm
(log ε) 467 (10.10), 553 (3.80), 593 (4.00), 643 (4.37), 698 (3.90) nm. HRMS (MALDI)
m/z 1385.0347, calculated for C68H78N4B40 1385.0326.
5,10,15,20-Tetra[4-(nido-carboranyl)phenyl-tetrabenzoporphyrin

(4-25)

Tetrabenzoporphyrin 4-24 (25 mg, 0.018 mmol) was added to a 1 M solution of
Bu4NF•3H2O in THF (0.32 ml, 1.08 mmol) and the solution was refluxed for 6 h. After
cooling down to room temperature, the solvent was removed under vacuum, the residue
dissolved in dichloromethane and washed once with water before being dried over
anhydrous Na2SO4. The solvent was evaporated under vacuum, the residue redissolved in
methanol and purified on a Sephadex LH-20 column, using methanol for elution. The
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resulting residue was dissolved in 40% aqueous acetone and passed slowly through a
Dowex 50WX2-100 resin in the sodium form. The porphyrin fraction was collected,
dried under vacuum, redissolved in 60% aqueous acetone and passed twice through the
ion-exchange resin. Removal of the solvent under vacuum gave the title
tetrabenzoporphyrin (24 mg) in quantitative yield as a green powder. M. p. > 300 °C; 1H
NMR (acetone-d6, 250 MHz): δ 8.04 (d, J = 8.22 Hz, 8H, o-PhH), 7.82 (d, J = 8.22 Hz,
8H, m-PhH), 7.48-7.28 (br m, 16H, benzoH), 2.69 (s, 4H, carborane-CH), 2.9-1.3 (br,
36H, BH), -1.13 (s, 2H, NH), -2.25 (br s, 4H, BH). UV-Vis (CH2Cl2): λmax (log ε) 464
(5.2), 542 (3.73), 585 (3.97), 637 (4.27), 694 (3.60) nm. LRMS (MALDI-TOF) m/z
1433.619.
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Chapter 5: Synthesis of 5,10,15-Triaryl-2:3,7:8,12:13,17:18-Butanocorroles and
5,10,15-Triaryl-2:3,7:8,12:13,17:18-Benzocorroles
5-1:

Introduction
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Figure 5-1: Porphyrin, Corrole and Corrin Structure

Corroles (5-2) are porphyrinoid compounds in which one of the meso atoms is
replaced with a direct pyrrole-pyrrole bond.1 They were first synthesized more than 30
years ago, and were an outcome of Johnson’s and Kay’s research, as they were trying to
use corroles as a precursor to the synthesis of the corrin ring while trying to develop a
synthetic methodology to vitamin B12.2 Corroles (5-2) are considered to be intermediates
between porphyrins (5-1) and corrins (5-3) because of their structure (Figure 5-1).3 The
structure of corroles was first confirmed by an X-ray crystal structure by Harrison et al in
1971.4 These authors reported that the structure was not strictly planar because of the
short C-N bonds induced by the direct C1-C19 carbon link. Unlike D4h symmetry
possessed by unsubsituted porphyrins (5-1), unsubstitued corroles (5-2) posses a C2v
symmetry which is as a result of steric strain in the macrocylic ring which normally
forces the molecule slightly out of the plane of the four nitrogens.5
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Corroles are aromatic in nature retaining an 18-π electron system that is in close
resemblance to porphyrins. The inner core hydrogens atoms are subject to shifts giving
rapidly interconverting structures. Dyke et al.6 and Ghosh et al.7 did extensive theoretical
calculations that suggested a fast NH tautomerisation in free-base corroles with no
significant energy difference between the possible tautomers (Scheme 5-1). As a result of
high stability and intense color, corroles qualify as porphyrin-like macrocyles having
spectroscopic and chemical properties that reveal a close relationship to porphyrins.
Corrroles have UV-Vis spectra that show intense absorptions around 400 nm and weaker
bands at ~ 500-600 nm that can be related to the Soret and Q bands of porphyrin systems,
indicating the presence of an aromatic system. Corroles also have luminescent properties
with emission bands at ~ 600 nm and very short Stokes-shifts.8 The 1H NMR spectra of
corroles reveal a diamagnetic current effect with all resonances showing significant shifts
similar to those observed in the porphyrin analogues.9 A unique property of corroles is
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that they have three inner core protons and are therefore trianionic ligands with a smaller
cavity compared to porphyrins, corroles also tend to stabilize metals of higher oxidation
states.10 The free-bases of corroles are usually more acidic than porphyrins, easily
forming monoanionic species in slightly basic media while retaining their aromaticity
(have a Soret Band).8a They also generate monoprotonated derivatives with dilute acids,
the addition of the proton occurring at the inner core nitrogen atom while still retaining
their Soret band in the absorption spectrum. However, stronger acids tend to cause
significant changes in the absorption spectra resulting to the disappearance of the Soret
band because of meso-protonation either at positon 5 or 15, which results in a interruption
of the π-conjugation system.11
Corroles find applications as catalysts because of their ability to stabilize metals
of high oxidation states, such as Ni(III), Cu(III), Fe(IV) and Co(IV), among others. They
have been shown to be good catalysts for epoxidations, cyclopropanations,
hydroxylations12 and aziridination,13 in addition to finding applications as molecular
magnets and sensors. Aviezer et al also demonstrated certain corroles to have potential as
anti-tumor candidates.14
5-2:

Historical Background on the Syntheses of Corroles
Corroles have been the focus of significant synthetic efforts in recent years, which

have led to the discovery of facile synthetic methods to make corroles and their metal
complexes.15 The synthetic pathways leading to corroles, however are still rather small in
number, albeit, a large body of work has been conducted in recent years towards general
approaches to differently substituted corroles, mainly by the group of Paolesse16 and
Gross.17 Most corroles synthesis known till 1999 involved biladiene cyclization,18 meso-
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carbon or sulfur extrusion of meso-thia-porphyrin,19 or synthesis from mono-pyrrole
precursors.20
5-2-1: Biladiene Cyclization
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The most general method used to synthesize corroles was the cyclization of a,c-biladiene.
The synthesis of an a,c-biladiene is described in detail in Chapter 1, Scheme 1-5; it
involves the condensation of a dipyrromethane dicarboxylic acid (1-19, R= H) with two
equivalents of a formylpyrrole (1-20) in the presence of HBr.8a The cyclization of the a,cbiladiene unit to the corrole was first carried out photochemically using a basic
methanolic solution, by addition of excess ammonia or sodium acetate, affording the
desired compounds in 20-60% yields.8a Later synthesis reported on cyclizations without
irradiation using various oxidizing agents under basic conditions.21 It was hypothesized
that the reaction went through the formation of a bilatriene followed by rapid cyclization,
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following a free radical pathway. However, this hypothesis was refuted because
cyclization reactions were not affected in any way by free radical scavengers.22 Another
postulated mechanism involving the two-electron oxidation of the bilatriene and a
subsequent conrotarory cyclization to give the corrole, was permitted using WoodwardHofmann rules.23 meso-Substituted corroles were synthesized by treating 5phenyldipyrromethane-1,9-dicarboxylic (5-4) acid with 2 equivalents of 2-formylpyrrole
(5-5) in the presence of hydrogen bromide, affording the crystalline a,c-biladiene
dihydrobromide (5-6) that was then cyclized to afford 10-substituted corrole (5-7) in
good yield (Scheme 5-2).24 Metal-free corroles were synthesized by cyclization of 1,19dibromo-a,c-biladiene dihydrobromides25 by refluxing in DMF. The precursor a,cbiladiene was synthesized by condensation of two dipyrromethenes using Friedel-Crafts
alkylation developed by Johnson and co-workers.
5-2-2: Synthesis from Monopyrroles
Cobalta-corroles (5-10) have also been synthesized by the treatment of 5hydroxymethylpyrrole carboxylic acid (5-8) with acidic ethanol, in the presence of
cobalt(II) acetate and triphenylphospine, in 25% yield. This reaction is postulated to
occur via formation of dipyrromethene (5-9) intermediate which then self condenses to
afford the desired corrole; this reaction conditions are reported to favor the porphyrin,
however no porphyrin was isolated.25 The use of 2-formylpyrrole under the same acidic
conditions and using same cobalt(II) ions afforded a porphyrin and three corroles instead.
It was postulated that the corrole mixture was because of the intermediacy of the
dipyrromethenes.26 It is interesting to note that the use of other metals i.e nickel(II) and
copper(II) in the above reaction afforded only porphyrin.
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meso-Substituted corrole (5-12) has also been reported to be synthesized by the reaction
of pyrrole (5-11) and benzaldehyde in a 1:3 ratio in refluxing acetic acid for four hours in
6% yield (Scheme 5-4).27 Corroles have also been reported as side products during
porphyrin synthesis using aldehydes and pyrroles.28
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5-2-3: Synthesis from Bipyrroles
Johnson et al29 showed that corrole (5-14) could be synthesized by a Mac-Donaldtype (2 + 2) cyclization via the treatment of 2,2’-bipyrrole-5,5’-dicarboxylic acid (5-12)
with the 1,9-diformyldipyrromethane (5-13) in the presence of acid. These authors
showed that the presence of a metal salt (Co(II)acetate) and triphenylphosphine was
imperative, because the reaction failed without the metal salt due to the possible
formation of a macrocyclic octapyrrole.30 This reaction was also reported to work if the
fomyl groups were put on either dipyrromethane derivative (Scheme 5-5).
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5-2-4: Synthesis from Macrocycle Ring Contraction
This synthesis involves the macrocyclic ring contraction of non-aromatic mesothiaphlorin (5-17) by the loss of the sulfur atom through an electrocyclic reaction. 5-17
was synthesized from the (2+2) acidic condensation of dipyrrylsulfide dialdehyde (5-15)
with dipyrromethane (5-16).31 The corresponding corrole (5-18) was isolated in 60%
yield by heating 5-17 in o-dichlorobenzene in the presence of PPh3 (Scheme 5-6).32
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Lower yields of 5-18 were reported in the absence of the triphenylphosphine and when
there were only alkyl substituents32 present probably because of the instability of the
corresponding meso-thiaphlorin intermediate. A radical process as the reaction pathway
was ruled out because the presence of radical scavengers such as hydroquinones or tertbutyl catechol did not affect the yields of the reaction; this ruled out a radical mechanism
and indicating a concerted reaction. Further developments on this synthesis have not been
reported because of the difficulty in the synthesis of the sulfur containing starting
material and because this approach does not offer significant advantages as to other
synthetic approaches.1
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5-2-5: Functionalization of Corroles
Unlike porphyrins,33 the modification of peripheral positions of corroles has not
been studied and explored in detail. The major set back demonstrated is the easy
decomposition of the corrole ring.34 The only reactions reported in literature concern the
alkylation’s and subsequent rearrangements of the free-base and metallo-corroles35 and
Vilsmeier reaction24b of free-base corrole. The synthesis of metallo-corroles was reported
immediately after the discovery of free-base corroles.36 Several metals have been
successfully incorporated utilizing either the cyclization of 1,19-dideoxybiladienes–a,c
under the templating effect of a metal or the introduction of a metal into the free-base.37
The developments of synthetic methodology to metallo-corroles have been mostly
derived from the extensive knowledge available in porphyrin chemistry.38 In the
following Chapter, the syntheses of novel Cu(III)-5,10,15-triphenyl-butano corrole and
its corresponding benzo derivative will be discussed.
5-3:

Results and Discussion
The synthetic methodology to Cu(III)-5,10,15-triphenylbutano corrole (5-20) was

adopted from the recent synthesis reported by Paolesse et al.39 These authors reported the
synthesis of 5,10,15-triphenyl-corrole without the concomitant formation of porphyrin by
solventless condensation of a 10:1 molar ratio of pyrrole and aldehyde in the presence of
a catalytic amount of TFA. However, the methodology presented here was tailored to the
nature of the starting material. Pyrrole 5-19 is a solid at room temperature, and therefore
had to be dissolved in minimum dichloromethane and condensed with aldehyde
(benzaldehyde or 4-methylformylbenzoate) in a 5:1 ratio and stirred at room temperature
for 10 minutes under argon followed by the addition of BF3.OEt2 (Scheme 5-7).
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The resultant mixture was stirred for two hours and an absorbance was observed by UVVis at ~ 488 nm, DDQ was added and stirred for another 6 hours at room temperature to
ensure that the oxidation was complete. The corresponding free-base corroles were not
isolated but the reaction mixture was washed with basic water several times to get rid of
the excess DDQ, dried over sodium sulfate and the solvent evaporated in vacuo. The
resultant residue was then redissolved in dichloromethane and stirred at room
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temperature with an excess of CuCl2 for 24. The reaction was monitored by UV-Vis to
completion for a Soret band at ~ 400 nm that is typical of metallated Cu(III)-corroles.
Once complete, when R= H (Scheme 5-7), the resultant mixture was filtered through a
silica plug to get rid of the base line oligopyrrolic material and eluted with chloroform,
the desired metallo-corrole was eluted first as a red fraction. The red fraction was then
purified further on preparative silica gel chromatography, eluting with 55:45 chloroform
and hexane affording the desired corrole 5-20, (R= H) in 8% yield. During purification,
the first band to be eluted was olive green in color which has also been observed by
several authors and reported in literature, followed by a bright red band with an
absorbance band at 427 nm which was the Cu(II)-porphyrin and the desired corrole was
eluted third with a Soret band at 409 nm.
Corrole 5-20, (R= CO2Me) was isolated in 10% yield and there was no formation of the
porphyrin. The Soret band for this compound was observed at 413 nm. Purification was
carried out relatively easily on a silica gel column eluting with chloroform. TLC showed
only one spot and there was no need to purify further by preperative TLC.
Several experiments were carried out by changing the molar ratios of the reactants
to try and optimize the yields. A 10:1, 5:1 and 4:1 molar ratio of butanopyrrole and
benzaldehyde were evaluated, but there was no significant increase in the yield of the
reaction and the formation of porphyrin was not evaded. An increase in the pyrrole ratio
resulted in the isolation of lots of unreacted starting material and in addition to this, the
reaction also had to be done in relatively small scale of (2-3 mMol). An increase in
corrole yield was observed with less formation of porphyrin when 4-methylformyl
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benzoate was used probably as a result of the increased electrophilicity on the aldehyde.

Figure 5-1: 1H NMR of Cu(III)-5,10,15-triphenylbutanocorrole (5-20, R= H) in CD2Cl2
at 300 MHz

The synthesis of corrole using 4-nonylbenzaldehyde was not successful, and only
afforded trace amounts of Cu(III)-corrole that was not isolated. This reinforces the
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presumption of isolation of low yields of corrole based on the electrophilic nature of the
aldehyde used.

Figure 5-1: 1H NMR of Cu(III)-5,10,15-Tri(4-methylcarboxylate-phenyl)-butanocorrole
(5-20, R= CO2Me) in CD2Cl2 at 300 MHz
Corroles 5-20 (R= H, CO2Me) were characterized by 1H NMR, MS (MALDI) and
X-ray crystallography. For 5-20 (R= H), the 1H NMR showed a multiplet of peaks
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between 7.38- 7.23 ppm corresponding to the ortho, meta and para protons on the phenyl
rings.

Figure 5-3: X-ray Crystal Structure of Cu(III)-5,10,15-Triphenylbutanocorrole (5-20, R=
H)
A peak at 2.95 ppm corresponded to the 4 methylene protons on the cyclohexene rings
adjacent to the directly linked pyrrolic units. The rest of the methylene protons appeared
between 1.64 and 0.79 ppm as clustered peaks. MS (MALDI) had a molecular ion peak at
803.94. Corrole 5-20 (R= CO2Me) was also characterized by 1H NMR giving almost
similar resonances as for R= H, with the ortho and meta protons in the aromatic region
appearing as sets of multiplets at 8.04- 7.94 ppm and 7.45-7.41 ppm, respectively. The
methyl groups on the esters did not appear as a single peak but as a singlets at 3.95 and

170

3.87 ppm, while the methylene protons on the cyclohexene rings adjacent to the direct
pyrrolic link appeared at 2.95 ppm.

Figure 5-3: An x-ray crystal of Cu(III)-5,10,15-triphenylbenzocorrole (5-21, R= H)

The rest of the methylene peaks also appeared clustered between 1.6 and 1.82 ppm. MS
(MALDI) had a molecular ion peak at 955.07. The subsequent formation of the
aromatized derivative 5-21(R= H) was carried out patterning the procedure followed in
the previous chapters. However, 5-21 was isolated in very low yield probably due to the
unstable nature of the corrole towards peripheral reactions.40 Prolonged oxidation times
resulted in a significant decrease of the yield of 5-21 (R= H). 5-21 (R= H) was purified
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on an alumina gel plug eluting with chloroform and because of the low solubility of this
compound, the plug had to be washed with lots of chloroform, because it was evident that
the compound was precipitating out of solution. This compound was characterized by MS
(MALDI) with a molecular ion peak at 793.73 and by X-ray crystallography. The crystals
were grown by the slow diffusion of methanol into dichloromethane. 1H NMR spectrum
obtained did not have distinct peaks in chloroform, as a result of solubility problems, and
the peaks could not be assigned easily.
5-4:

Conclusion

Two new novel compounds, Cu(III)-5,10,15-butanocorrole and its benzo derivatives were
synthesized from synthetic methodology adopted from Paolesse et al. These compounds
were obtained in very low yields as has also been reported by several authors. The first
X-ray crystal structures of these compounds are presented. These compounds can
stabilize metal ions of higher oxidation states and can therefore have applications as
catalysts, molecular magnets and also do have potential as PDT agents as a result of the
red shifted absorbance observed in Cu(III)-5,10,15-benzocorrole (5-21).
5-5:

Experimental
Commercially available starting materials were purchased from Sigma-Aldrich

and used without further purification. All solvents were purchased from Fisher Scientific
(HPLC grade) and either directly used or dried and distilled according to literature
procedures. Silica gel 60 (70-230 mesh, Merck) and alumina grade III (70-230 mesh
ASTM) were used for column chromatography. Analytical thin-layer chromatography
(TLC) was performed on Merck 60 F254 silica gel (precoated sheets, 0.2 mm thick). 1HNMR spectra were obtained using a Bruker DPX 250 MHz or 300 MHz spectrometer;

172

chemical shifts are expressed in ppm relative to TMS (0 ppm). Electronic absorption
spectra were measured on a Perkin Elmer Lambda 35 UV-Vis spectrophotometer and
fluorescence spectra on a Perkin Elmer LS55 instrument. Low resolution MS analyses
were conducted at the LSU Mass Spectrometry Facility on a Bruker Prolix III MALDITOF mass spectrometer, and the HRMS were conducted at the Ohio State University
Mass Spectrometry and Proteomics Facility. Melting points were measured on an
Electrothermal MEL-TEMP instrument.
Cu(III)-5,10,15-tri(4-methylcarboxylate-phenyl)-butanocorrole (5-20, R= CO2Me)
Butanopyrrole (5-19) (0.25g, 2.1 mmol) was dissolved in 6 mL of dichloromethane and
allowed to stir to a homogenous solution under argon. 4-Formylmethylbenzoate (68 mg,
0.42 mmol) was then added to this solution and the solution stirred for another ten
minutes. BF3. OEt2 was then added and reaction was stirred in the dark for two hours at
room temperature while monitoring the reaction using UV-Vis for a broad porphyrinogen
peak at ~ 510 nm. Upon completion, 0.05 g, 0.21 mmol of DDQ was added to the
reaction mixture and allowed to stir for 12 h. UV-Vis had a band at ~ 460 nm. The
reaction mixture was then diluted with chloroform, and washed 2 × 100 mL of aqueous
sodium bicarbonate solution to get rid of the unreacted DDQ, washed with water and
dried over sodium sulfate. To ease up on purification, the free-base corrole was not
isolated, but immediately metallated with copper, by stirring in dichloromethane with an
excess of CuCl2 at room temperature for 24 hours. The mixture was purified on a quick
silica gel column eluting with chloroform and the first red fraction was collected with a
Soret band at 413 nm was obtained in 38 mg, 10% yield. MS (MALDI) 955.07: 1H NMR
(CDCl3, 300 MHz): δ 8.04-7.94 (m, 6H, o-PhH), 7.45-7.28 (m, 6H, m-PhH), 3.95-3.87 (s,
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9H, CH3), 2.96 (s, 4H, 2CH2), 2.26-0.86 (m, 28H, CH2): UV-Vis (CH2Cl2): λmax nm (log ε)
413 (5.06), 536 (3.95)
Cu(III)-5,10,15-triphenyl-butanocorrole (5-20, R= H)
Butanopyrrole (0.25g, 2.1 mmol) 5-19 was dissolved in 5 mL of dichloromethane and let
to stir for ten minutes. Benzaldehyde (0.04 mL, 0.41 mmol) and 5 µL (0.03 mmol) of
BF3.OEt2 were then added to the reaction and let to stir for another 2 hours. The same
procedure mentioned previously was patterned uptil the metallation. The metallation was
considered complete when a Soret band at 408 was evident. The reaction mixture was
then purified through a silica gel plug, eluting with chloroform and the first red band
eluted was collected. The red fraction was redissolved in dichloromethane, and purified
on an alumina gel preparative TLC eluting with 55:45 chloroform/hexane. The first band
was the Cu(II)-butanoporphyrin and the second reddish brownish band was the desired 521(R= H) and was obtained in 31 mg, 8% yield. MS (MALDI) 803.94: 1H NMR
(CDCl3, 300 MHz): δ 7.38-7.23 (m, 15H, o, m, p-PhH), 2.96 (s, 4H, 2CH2), 1.64-1,12 (m,
28H, CH2): UV-Vis (CH2Cl2): λmax nm (log ε) 409 (4.39), 552 (3.56)
Synthesis of Cu(III)-5,10,15-triphenyl-benzocorrole (5-21)
20 mg, 0.02 mMol of 5-20 (R= H) was dissolved in toluene and DDQ (45 mg, 0.19
mMol) was added to the mixture before heating at reflux for 5 minutes. The reaction was
followed by TLC (alumina) for the appearance of a green streak at the baseline. Once the
reaction was complete, the mixture was allowed to cool and filtered through an very short
alumina plug and eluted with around 100 mL of chloroform. UV-Vis, had an absorbance
band similar to that of Cu(II)-TBP complexes with a split Soret band. MS (MALDI)
793.73: UV-Vis (CH2Cl2): λmax nm (log ε) 447 (4.57), 459 (4.5), 598 (3.78), 647 (4.1)
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